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A HISTORIC VIEW OF PREGNANCY AS MYSTERY –THE WOMB AT THE 
CENTER OF ATTENTION 
Throughout history, mankind has been in awe of pregnancy. The ability to bear an heir came 
not only with great power, but also with an enormous responsibility that, for many centuries, 
has defined a woman’s worth. The lack of power to control reproductive success inspired 
some of the earliest medical investigations known, at times when female health was otherwise 
underrepresented in medicine. Already around 2000 B.C., the Egyptian Kahun Gynaecological 
Papyrus documents the desire to understand the mysterious process of fertility, representing the 
first evidence of the special role that has been ascribed to the womb throughout ancient times 
(1, 2). Many of these Egyptian concepts depicting the womb as cause for many (if not all) issues 
of women’s health were reinforced by the ancient Greeks (3). Theories of the womb (ὑστέρᾱ 
- hystera) as origin also for mental (and thus gender specific) illness were prominent until the 
twentieth century1. Moral perceptions hampered the extent to which male medical professionals 
could examine the female reproductive system. A forward leap in the understanding of uterine 
health could not be made until the role of physician was not exclusive to men anymore, and the 
taboos around the menstrual cycle were challenged by feminist movements in the 1960s and 
early 1970s (4). Current globalized clinical practice now permits us to look beyond mythological 
and religious associations with female health. Still, there is much left to discover to understand 
the magic of pregnancy. 
THE GATEKEEPER FUNCTION OF THE UTERUS 
Even when all conditions are optimal, human reproduction is relatively inefficient and each cycle 
the probability of conception is merely 30-40% (5). In an attempt to answer the question “Where 
have all the conceptions gone?”, Roberts and Lowe (1975) hypothesized that the relatively low 
incidence of birth defects amongst the population results from a natural selection of fit embryos 
(6). A large part of pregnancies are lost before women are aware of it, as up to a third of “occult 
pregnancies” go unnoticed (Figure 1) (5, 7). This window of high fragility continues until mid-
gestation (8, 9). Up to 15-20% of pregnancies end in a loss before 28 weeks of gestation (10). 
About half of these cases are explained by cytogenetic abnormalities of the embryo (11). These 
miscarriages result not only from the embryo’s failure to interact with the uterine wall, but from an 
inability on the maternal side to receive the incoming cells (12, 13). The uterine mucosa, termed 
endometrium, or decidua once it is at its receptive stage towards the end of the menstrual cycle, 
actively senses quality of the embryo (14). This selection during implantation, a first checkpoint, 
has to be extremely well-regulated. On the one hand, failure of the decidua to allow implantation 
1 It was not until 1980 that “Hysteria” was removed from Diagnostic and Statistical Manual of Mental Disorders (15).
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of high-quality embryos is seen in recurrent implantation failure (RIF), mostly perceived as 
infertility. On the other hand, failure to exclude erroneous embryos in the peri-implantation period 
likely leads to miscarriage later on during gestation. Thus, the decidua holds a key role. Even 
after correct implantation is achieved, this highly specialized tissue continues to determine the 
faith of pregnancy in a second checkpoint: through enabling formation of the placenta. 
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Figure 1. Only a third of all conceptions lead to the birth of a living baby. 
The majority of conceptions is lost prior to recognition of the pregnancy. A third of all conceptions are carried to live birth. 
The majority of recognized miscarriages occurs in the first trimester. *After 28 weeks of gestation, pregnancy loss is termed 
“stillbirth”. Adapted from Macklon et al. 2002, Nilsson et al. 2014.
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THE ENDOMETRIUM - FERTILE GROUND ENABLING GROWTH OF A 
HEALTHY PLACENTA 
The placenta connects the fetus to the maternal circulation; a vital bond that forms the basis for 
all further development of the child. The placental membranes form a safe cocoon with a well-
regulated internal environment for the baby to thrive in (Figure 2). Correct placenta formation 
is not only an essential prerequisite to avoid pregnancy loss, but also determines fetal and 
neonatal health. Structural impairments of the placenta cause pregnancy complications such as 
intrauterine growth restriction (IUGR) and pre-eclampsia (PE), with possible long-term effects on 
health of mother and child (16). Placenta formation depends on a complex interplay of maternal 
and fetal cells. Trophoblast cells of fetal origin have to invade the spiral arteries and replace 
their endothelium to successfully attach to the vascular system of the mother. These fetal cells 
are semi-allogeneic, a hybrid of half paternal and half maternal genes. The field of reproductive 
immunology aims to understand how these partially foreign cells evade the maternal immune 
system, the reactive mechanism to eliminate unfamiliar antigens. It is now established that, 
contrary to the initial hypothesis of Sir Peter Medawar in 1953, maternal immunity is not ignorant 
to the fetal cells, but tolerant (17, 18). How is this tolerance achieved? 
PUZZLING IMMUNITY OF THE PREGNANT UTERUS
The human decidua is abundantly equipped with immune cells that may react to the semi-
allogeneic fetal cells. In the peri-implantation period, Natural Killer (NK) cells (~60%), 
macrophages (10-20%), and T (3-10%) cells represent the most prominent local immune cell 
types (19-23). Upon conception, immune cells infiltrate the implantation site and levels of 
proinflammatory cytokines leukemia inhibitory factor (LIF), tumor necrosis factor (TNF)-α, and 
interleukin (IL)-6 rise in the endometrium (24). These local reactions are more than a mere side 
effect to the invading foreign antigens, as they belong to the physiological adaptations needed 
during this period. As such, increasing evidence shows that provoking a local immune reaction, 
by deliberately scraping the endometrial lining during in vitro fertilization (IVF), increases success 
rates in assisted reproductive technology (ART)(25-27). However, any inflammatory reaction of 
implantation, even physiological, needs to be well-contained. Excessive inflammation would 
threaten the baby and progression of pregnancy, leading to implantation failure, pregnancy loss, 
or pre-term labor (PTL). To maintain the balance between immunity and tolerance, decidual 



























Figure 2. Healthy pregnancy depends on a well-formed placenta.
It maintains fetal growth by providing the essential connection with the maternal circulation and it creates a protective 
environment.
KNOWN PARTS OF AN UNKNOWN PICTURE 
For a number of cell subsets, specialized characteristics of uterine immunity are known. Many of 
these underline the independence of decidual cells from systemic immunity. The most studied 
cell types in reproductive immunology are NK cells and T cells. 
NK cells
Decidual NK cells (dNK) display functional and phenotypic characteristics different from 
peripheral blood NK cells (pbNK) (21, 28). The two major subpopulations of NK cells are 
composed of CD56dim CD16+ (NKdim) and CD56bright CD16- (NKbright) cells. With their task 
as innate effector cells to eradicate virally infected and tumor cells, NKdim cells dominate the 
systemic pool of NK cells (~90%). NKdim cells are of potent cytotoxicity, containing many 
cytolytic granules such as granzymes and perforin (29). In the uterus, these major killers are 
almost absent where NKbright cells comprise around 90% of the local NK cells (30). NKbright 
cells are less cytotoxic but mainly secrete immunoregulatory cytokines, such as IL-10, IL-13, 
granulocyte – macrophage colony-stimulating factor (GM-CSF), interferon (IFN)-γ, and TNF-β
(31). Asides from contributing to the local immune environment, dNK cells also directly infl uence 
implantation. By secreting angiopoietin (Ang)‐1, Ang‐2, IFN-γ, and vascular endothelial growth 
factor (VEGF), they loosen vascular smooth muscle cells, and degrade extracellular matrix 
components (32, 33). Moreover, decidual NK cells enhance trophoblast migration through GM-
CSF secretion (34). Both processes facilitate spiral artery remodeling. This leads to the notion 
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that correct placenta formation and thus fetal development depends on the local actions of dNK 
cells (35). 
T cells
Building up on Medawar’s initial question “How does the pregnant mother contrive to nourish 
within itself, for many weeks or months, a fetus that is an antigenically foreign body”, research on 
T cells in pregnancy started from a transplantation point of view. In a transplantation setting, if un-
matched to the recipient, cells expressing allogeneic major histocompatibility complex (MHC) 
class I antigens fail to provide a self-signal (signal 1). In the presence of co-stimulatory signals 
(signal 2), cytolytic killing by CD8+ T cells is elicited (36). Additionally, MHC class II molecules 
may present the foreign antigens to CD4+ T cells, causing naïve T cells to differentiate into T 
helper (Th) cells. Th cells can in turn interact with B cells to initiate antibody-mediated killing, or 
directly promote the local immune reaction by secretion of pro-inflammatory cytokines (signal 
3). Based on this key role in rejection, local T cells were initially suspected to pose a danger to 
the “fetal transplant” and thus it seemed logical that they need to be silenced after conception. 
However, during pregnancy, decidual T cells are responsive and can eradicate infections. In 
practice, maternal blood is merely in contact with syncytiotrophoblast and extravillous trophoblast 
cells (EVT), both of which have extraordinary MHC characteristics. Syncytiotrophoblast do not 
express any MHC rendering them inert to T cell-mediated response (37). EVT express human 
leucocyte antigen (HLA)-C,-E, and -G and of these, only HLA-C is highly polymorphic (HLA-A, 
and -B are the major polymorphic inducers of allograft rejection). Decidual T cells are indeed 
capable of reacting to an HLA mismatch but this does not lead to killing of trophoblast cells 
as shown in co-culture experiments (38, 39). On the contrary, upon encounter of an HLA-C 
mismatch, T cell activation was shown to induce increased abundance of regulatory T cells 
(Treg) (39). Additionally, rather than stimulating Th cells of pro-inflammatory cytokine profiles 
(Th1: IFN-γ, TNF-α, TNF-β; Th17: IL-17, IL-22, IL-23), implantation provides signaling that allows 
for differentiation of Th cells that contribute to a tolerogenic environment (Th2: IL-4, IL-5, IL-10, IL-
13)(40, 41). Thus, with our improved understanding of T cell mediated immunity, the framework 
of inert T cells is set aside. 
Beyond NK- and T cell mediated immunity 
Still, also regarding the most studied cell types, we are still just beginning to collect the pieces 
of an unknown bigger picture. Many studies have pointed out that seeking to understand 
reproductive immunology goes beyond NK- and T cell mediated immunity. Interest in decidual 
myeloid cells (macrophages, dendritic cells, and granulocytes) is rising (42-47). As obtaining 




Not only maternal immune cells of the decidua have specialized regulatory functions. Previous 
studies suggest a number of different angles from which to investigate the balance between 
maternal and fetal cells: 
1) Trophoblasts possess mechanisms to facilitate immune evasion.
EVT express immune-modulatory receptors, which match ligands of dNK cells (HLA-G – LILRB1), 
macrophages (IL10R – IL10) , and T cells (PDL1- PD1) (48). Functionally, this for example translates 
to the ability of EVT to inhibit proliferation of T cells, and to induce differentiation of CD4+ T cells 
towards Treg cell in vitro (38, 49). Trophoblasts secrete cytokines that strongly impact the local 
immune environment. Examples are IL-34, which polarizes decidual macrophages towards a 
tolerogenic phenotype, and IL-35, which converts naïve T cells to IL-35-producing regulatory T 
cells and, in mice, thereby prohibiting pregnancy loss (49, 50).
2) Cells of the uterine tissue influence the local immune environment. 
Like trophoblast cells, cells of the uterus are equipped with surface molecules to facilitate 
tolerogenic ligand-receptor interactions with decidual immune cells (48). Through their secretion 
of indoleamine 2,3-dioxygenase (IDO) and prostaglandin E (PGE), decidual stromal cells (DSC) 
were shown to reduce NK cell proliferation and cytolytic activity, and inhibit dendritic cell (DC) 
differentiation (51). Additionally, DSC hamper local T cell accumulation through their reduced 
expression of Th1 cell - attracting chemokines as a result of epigenetic silencing (52). 
3)  External factors contribute to a tolerance-favoring milieu (e.g. seminal fluid, 
microbiota).
Adding to the complexity, there are even more contributors to consider than maternal and fetal 
cells. Seminal fluid was shown to regulate inflammatory gene expression in cervical and vaginal 
epithelial cells (53, 54). It contains soluble factors, such as transforming growth factor- β (TGF-β) 
and PGE, with the ability to modify the induction of Treg (55). Even though direct experimental 
evidence of uterine contribution of this immune-modulatory action is yet to be exposed, a 
contribution of seminal fluid to successful implantation is likely; contact with seminal fluid during 
the course of ART increased clinical pregnancy rates (56). Another external contributor able to 
enter the uterus, and modify immunity, are microbiota; a topic of heavy debate as the uterus 
was previously regarded sterile. The discussion on the contribution of bacteria to pregnancy 
success lifted up with the discovery of commensal colonization of the placenta, and with 16S 
rRNA sequencing techniques becoming more accessible, studies on endometrial and placental 
microbiota are rising (57-60). 
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The factors on this list are of a diverse nature; and it is near impossible to give a full account of 
them. Still, we have to consider more than a single piece of the puzzle, with an open mind, if we 
wish to understand the bigger picture. 
AIM AND OUTLINE OF THIS THESIS 
In this thesis, we aim to introduce new perspectives on the regulation of uterine immunity. 
In Part I of this thesis, we explore the highly specialized local immune adaptations induced by 
pregnancy. We focus on tissue of the uterine mucosa. In Chapter 2, we give an overview of the 
immune composition of the uterus. We examine how local immunity, especially NK and T cells 
of the endometrium, prior to implantation compare to the end of pregnancy. We dive deeper 
into the importance of specialized T cells in Chapter 3, highlighting the presence of distinct 
types of regulatory T cells in human decidua. In reproductive immunology, most studies revolve 
around cell types of large abundance in the uterus. Even though small in numbers, we consider 
the possible contribution of B cells to the local immune interplay in Chapter 4. To do so, we 
compare mucosal tissue of the non-pregnant uterus, during gestation, and upon delivery. We 
translate this knowledge on immune composition considering a broad spectrum of immune cells 
to patients suffering from recurrent miscarriages in Chapter 5. 
 
In Part II, we examine yet another contributor of small abundance but possibly far-reaching 
impact: microbiota of the uterus. Due to their low biomass, uterine microbiota are difficult to 
detect. While presence of uterine microbiota is thus debated, microbes of the gut have shown 
how immunity cannot be fully understood without taking microbiota into account. We describe 
the possible contribution of microbes and their compounds on uterine immune cells in Chapter 
6. Manipulating the microbial balance by antibiotics during gestation might have an impact on 
the direct environment of the growing baby. In Chapter 7 we investigate if disrupting the natural 
microbial composition translates to immune adaptation during pregnancy. Finally, we summarize 
and discuss the findings of this thesis in Chapter 8. 
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ABSTRACT
Pregnancy requires a delicate immune balance that nurtures the allogeneic fetus, while 
maintaining reactivity against pathogens. Despite increasing knowledge, data is lacking 
on the transition of pre-pregnancy endometrial lymphocytes to a pregnancy state. Here, we 
immunophenotyped lymphocytes from endometrium (MMC), term decidua parietalis (DPMC), 
and PBMC for direct comparison. We found that the immune cell composition of MMC and 
DPMC clearly differ from each other, with less NK-cells, and more NKT-cells and T-cells in DPMC. 
An increased percentage of central memory and effector memory T-cells, and less naive T-cells 
in DPMC indicates that decidual T-cells are more experienced than endometrial T-cells. The 
increased percentage of CD4+CD25highCD127- Treg in DPMC, including differentiated Treg, is 
indicative of a more experienced and tolerogenic environment during pregnancy. The Th cell 
composition of both MMC and DPMC was different from PBMC, with a preference for Th1 over 
Th2 in the uterine environment. Between MMC and DPMC, percentages of Th cell subsets did 
not differ significantly. Our results suggest that already before pregnancy a tightly controlled 
Th1/Th2/Th17 balance is present. These findings create opportunities to further investigate the 
underlying immune mechanism of pregnancy complications using menstrual blood as a source 
for endometrial lymphocytes.
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INTRODUCTION
Pregnancy requires a complex interplay of immune cells. Maternal lymphocytes need to 
accommodate the semi-allogeneic fetus and still maintain robust immune reactivity against 
pathogens. The barrier between the semi-allogeneic fetus and the maternal immune system 
is the placenta. At this fetal-maternal interface, maternal lymphocytes of the decidua come 
into close contact with cells of fetal origin, i.e. trophoblast cells. This contact occurs at two 
different sites, between invading trophoblast cells and the decidua basalis, which is the site of 
implantation, and chorionic trophoblast cells and the decidua parietalis, which are part of the 
membranes surrounding the fetus (1). These trophoblast cells have restricted HLA expression 
(HLA-C, HLA-E, and HLA-G). Direct response to fetal allogeneic HLA is primarily via HLA-C, but 
also indirect presentation of fetal antigens by maternal APCs can elicit an anti-fetal maternal 
leukocyte response (2-6). This restricted immune recognition makes that the uterine immune cell 
composition and phenotype is different from other mucosal sites (1).
Each month, during the menstrual cycle, the uterus prepares itself for pregnancy by a large influx 
of leukocytes in the endometrium. When implantation takes place, the number of leukocytes 
increases even further. Without implantation, the endometrial lining and its leukocytes are 
shed during  menstruation (7). Natural killer (NK) cells are abundantly present in the human 
endometrium (8, 9). Endometrial NK cells increase in number during the menstrual cycle, 
reaching a peak in the late secretory phase. If implantation occurs, endometrium will transform 
into decidua and the number of endometrial NK cells will increase even further and will make 
up 70% of the decidual leukocytes during the first trimester. These uterine NK cells are different 
from NK cells found in peripheral blood. They are characterized as being CD56brightCD16-, while 
NK cells found in peripheral blood are mainly CD56dimCD16+ (8, 10). Decidual NK cells produce 
specific cytokines and angiogenic factors to regulate invasion of fetal trophoblast cells and spiral 
artery remodeling (7, 10).
Besides NK cells, also T cells are a major cell population in the endometrium and decidua (8, 
11). Decidual T cells differ from peripheral T cells by expression of activation markers such as 
CD45RO, CD69, HLA-DR, and CD25 (12), but their function and mechanism of fetus-specific 
immune recognition remains poorly defined (13). It has long been thought that maternal tolerance 
towards fetal alloantigens was established by a predominance of T helper type 2 (Th2) immunity 
over Th1 immunity during pregnancy. However, this Th1/Th2 paradigm was found insufficient, 
since both Th1 and Th2 dominant immunity was observed in pregnancy complications (14). 
Th17 cells produce IL-17 and mediate the induction of inflammation (15). Higher levels of Th17 
cells were found in women suffering from recurrent pregnancy loss and preterm delivery (16-18). 
In contrast, mouse studies revealed that regulatory T cells (Treg) are essential for promoting 
immune tolerance towards the fetus, and activation of Treg is needed for pregnancy success, 
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while depletion of Treg was associated with pregnancy failure (19-22). Also, in humans, 
pregnancy complications, like recurrent pregnancy loss and preeclampsia, were found to be 
associated with lower numbers of Treg (23-26). Altogether, this suggests that a tightly regulated 
balance between Th1, Th2, Th17, and Treg cells is required for successful pregnancy.
Although much effort has been put in elucidating how the immune system contributes to 
pregnancy, particularly in mice, knowledge on human placentation is scarce. Especially little 
data is available on early implantation and placentation compared to term pregnancy decidual 
tissue. As local decidual immune regulation is paramount to successful pregnancy, immune 
phenotypic changes in the uterine immune environment that fit the notion of a well balanced 
Th1/Th2/Th17/Treg environment might be expected. In the present study, we made a detailed 
phenotypic and functional analysis of immune cells in both pre-implantation endometrium 
and in term decidua, with a focus on T cell subsets. We used menstrual blood as a source 
of endometrial cells because we showed previously, that with respect to cell composition and 
phenotypic characteristics, menstrual blood is very similar to biopsy-derived material (27). The 
results of this study will provide us with a more profound insight into which adaptations of the 
uterine immune system during pregnancy are important for pregnancy success.
RESULTS
The lymphocyte composition of term decidua differs from pre-pregnancy endometrium
Previously, comparisons between endometrium and decidua had to be inferred from separate 
studies since data on direct comparison of immune cell changes between endometrium and 
decidua are scarce. The recently designed method, whereby endometrial lymphocytes can 
be isolated from menstrual blood, allows for easier access to this material and opens up the 
opportunity to study pre-pregnancy endometrium together with decidual samples in the same 
set of experiments. Here, we directly compared the immune cell composition of menstrual blood 
(MMC), term decidua parietalis (DPMC), and peripheral blood (PBMC) mononuclear cells by 
using flow cytometric analysis (Figure 1). Since cell yield from decidua basalis was too low 
for the extensive analysis we did here, maternal lymphocytes in the decidua parietalis are in 
close contact with chorionic trophoblast cells, and active immune regulation seems to place at 
the decidua parietalis as well (31, 32), prompted our decision to opt for isolation of cells from 
decidua parietalis to study the fetal-maternal interface.
In accordance with previous studies, MMC and DPMC clearly differ from PBMC in percentages 
of lymphocytes, T cells, NK cells and NKT cells (7-9, 27, 33, 34), and contained primarily 
CD56+CD16- NK cells, while the majority of NK cells in PBMC were CD56+/-CD16+. In a direct 
comparison between MMC and DPMC, DPMC revealed a higher percentage of NK cells
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Figure 1. Lymphocyte composition of peripheral blood, menstrual blood, and term decidua. 
Mononuclear cells were isolated from peripheral blood (PBMC, n=17), menstrual blood (MMC, n=17), and decidua 
parietalis (DPMC, n=12). Percentages of lymphocytes (CD45+) based on side scatter (SS) and forward scatter (FS), T cells 
(CD56-CD3+; CD4+ and CD8+), NKT cells (CD3+CD56+), NK cells (CD3-CD56+; CD56+CD16+ and CD56+CD16-), 
and B cells (CD19+) were obtained by flow cytometric analysis. *p < 0.05, **p < 0.01, and ***p < 0.001 (lines indicate 
mean, non-parametric Kruskal-Wallis with Dunns post-hoc test).
(46.9%±16.4% and 24.3%±10.6% respectively). MMC (43.9%±15.10%) contained a significant 
lower percentage of T cells, with an increased CD4+/CD8+ ratio, as compared to DPMC 
(67.1%±10.66%). In addition, MMC contained significantly less NKT cells (1.2%±0.9% versus 
2.5%±1.1%) compared to DPMC. No significant difference in percentages of B cells between 
MMC and DPMC could be observed. Also, important to note is that MMC and DPMC derived 
lymphocytes are from mucosal origin since more CD69+ and CD103+, and less CD62L+ T and 
NK cells can found compared to PBMC (Supplementary Figure S2). After showing that MMC 
and DPMC clearly differ in immune cell composition, we investigated T cells in more depth for 
differences between pre-pregnancy endometrium and decidua. 
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Decidual T cells are more experienced than endometrial T cells
We next examined endometrial and decidual T cell subsets in more detail to know if the observed 
phenotype of more differentiated memory T cells in decidua compared to PBMC (35) would also 
apply to endometrium. Compared to MMC derived T cells, DPMC derived T cells revealed a 
significantly lower percentage of CD45RA+ (53.4%±8.8% and 17.2%±7.4%, respectively) and a 
higher percentage of CD45RO+ cells (28.9%±8.0% and 66.4%±11.7% respectively) (Figure 2b). 
In addition, we subdivided CD4+ and CD8+ T cells into naive T cells (CD45RA+CCR7+), effector T 
cells (Teff, CD45RA+CCR7-), effector memory T cells (EM, CD45RA-CCR7-), and central memory 
T cells (CM, CD45RA-CCR7+). Both CD4+ and CD8+ T cells present in DPMC were significantly 
less naive compared to MMC, while a significantly higher percentage of EM and CM T cells was 
present in DPMC (Figure 2c). Thus, over the course of pregnancy, decidual T cells appear to 
acquire an experienced and differentiated phenotype. 
To strengthen the claim that endometrial T cells are primed over the course of pregnancy and 
can differentiate towards a phenotype found in the decidua, we performed in vitro experiments 
whereby endometrial lymphocytes were stimulated with either rhIL-15 or anti-CD3/anti-CD28 
mAb microbeads alone, or in combination. The rationale for using IL-15 is because IL-2 is hardly 
detected in decidua and after implantation, endometrial NK cells start to differentiate as a 
result of local IL-15 production (9). After 5 days of culture, the distribution of T cell subsets was 
measured with flow cytometry in the same way as above. Endometrial T cells stimulated with 
anti-CD3/anti-CD28 mAb microbeads reveal a similar subset division as found in term decidual 
T cells, i.e. less naive T cells and more EM and CM T cells compared to control (medium) 
and day 0 (Supplementary Figure S3). Whereas stimulation with IL-15 alone was not sufficient 
to lead to a similar differentiation, IL-15 did appear to have an effect on T cell differentiation 
when administered together with anti-CD3/anti-CD28 beads and as compared to the bead alone 
condition, i.e. more EM and less CM T cells. This may suggest that T cells need an additional 
TCR trigger before they can differentiate towards a more mature phenotype. These in vitro data 
showed that endometrial lymphocytes can be differentiated towards a phenotype reminiscent of 
term decidual T cells, which lends further support for the notion that over the course of pregnancy 
decidual T cells appear to acquire an experienced and differentiated phenotype.
































































































































































































































































































































































































































The decidual immune environment is marked by a tolerance signature
The fetal-maternal interface is the major site where maternal immune cells come into contact 
with cells of fetal origin. Treg are important for regulation of the decidual immune environment 
and pregnancy success (19). DPMC contained significantly more CD4+CD25highCD127- Treg 
than MMC (9.5%±3.5% versus 5.2%±1.9%) (Figure 3b). We further subdivided Treg based on 
expression of CD45RA and CD25 (36). DPMC contained significantly more CD4+CD25highCD45RA- 
activated and differentiated Treg than MMC (8.4%±5.9% versus 2.4%±1.6%), while the 
percentage of CD4+CD25+CD45RA+ naive Treg did not differ significantly (1.3%±1.2% 
versus 1.9%±1.3%) (Figure 3c). Treg percentages in MMC did not differ from PBMC, but DPMC 
contained significantly less naive Treg compared to PBMC (1.3%±1.2% versus 3.4%±2.0%).
This suggests, that different from the pre-implantation endometrium, the human decidual
environment is marked by a immune signature that includes the activation and differentiation of Treg.
Figure 3. Distribution of regulatory T cells. 
(A) Representative staining of CD25, CD127, and CD45RA on CD4+ T cells from peripheral blood (PBMC, n=17), menstrual 
blood (MMC, n=16), and term decidua (DPMC, n=12). (B) Percentage of CD25highCD127- Treg within CD4+ T cells in 
PBMC, MMC, and DPMC. (C) Distribution of naive Treg (CD45RA+CD25+) and differentiated Treg (CD45RACD25++) in 
CD4+ T cells. **p < 0.01, and ***p < 0.001 (lines indicate mean, non-parametric Kruskal-Wallis with Dunns post-hoc test).
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Figure 4. Distribution of CD4+ Th cell subsets in peripheral blood (PBMC), menstrual blood (MMC), and 
term decidua (DPMC) and production of IFN-γ and IL-17 by CD4+ T cells.
(A, C) Representative gating for CCR6, CXCR3, and CCR4 on CD4+ T cells and for IFN-γ and IL-17 by CD4+ T cells from 
PBMC, MMC, and DPMC. (B) Th1, Th2, Th17, and nonconventional Th1 (Th1-like) CD4+ T cells can be classified based 
on the expression of CCR6, CXCR3, and CCR4 37. CCR6-CXCR3+CCR4-, Th1; CR6+CXCR3+CCR4-, Th1-like; CCR6-
CXCR3-CCR4+, Th2; CCR6+CXCR3-CCR4+, Th17 (PBMC n=17, MMC n=11, DPMC n=7). (D) Production of IFN-γ and 
IL-17 by CD4+ T cells from PBMC (n=12), MMC (n=15), and DPMC (n=7). *p < 0.05, **p < 0.01, and ***p < 0.001 (lines 
indicate mean, nonparametric Kruskal-Wallis with Dunns post-hoc test).
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The Th1, Th2, and Th17 cell profile is similar between endometrium and term deciduas
It is suggested that successful pregnancy requires a delicate Th1/Th2/Th17/Treg balance (14). 
To investigate this balance, we classified CD4+ cells as Th1, nonconventional Th1 (Th1-like), Th2, 
or Th17 cells, based on the expression of the chemokine receptors CCR6, CXCR3, and CCR4 
(37). Blood Th1-like cells were reported to have a mixed Th1/Th17 phenotype, i.e. production 
of RORC mRNA and IL-17, together with a higher production of TBX21 mRNA and IFN-γ than 
conventional Th1 cells, indicating higher Th1 activity (37). Th cell composition of MMC and 
DPMC were both different from PBMC, with significantly less Th2, and more Th1 cells in the 
uterine environment (Figure 4b). Between MMC and DPMC, percentages of Th1, Th2, Th17, and 
Th1-like cells did not differ significantly (Figure 4b). When investigating the intracellular cytokine 
expression profile after PMA/Ionomycin/Brefeldin stimulation, we observed a higher intrinsic 
capacity to express IFN-γ and IL-17 by DPMC CD4+ T cells (27.8%±15.4% and 4.4%±1.3% 
respectively) compared to CD4+ T cells from MMC (7.4%±3.3% and 2.6%±1.0% respectively), 
and also PBMC (7.5%±6.7% and 2.3%±1.3% respectively) (Figure 4d). 
In summary, a direct comparison between pre-pregnancy endometrium and term decidua 
reveals a activated immune signature, with more experienced conventional T cells and Treg. 
The distribution of Th subsets, defined by chemokine receptor expression patterns, did not differ 
significantly between endometrium and term decidua. However, the intrinsic capacity to produce 
IFN-γ and IL-17 was highest in term decidual CD4+ T cells, suggesting a possible role for both 
cytokines in the uterine environment during pregnancy.
DISCUSSION
Local decidual immune regulation is paramount to successful pregnancy. Previous studies 
investigating the phenotype of immune cells in endometrium and decidua are fragmented, and 
limited to comparing immune cells in either endometrium or decidua with their counterparts in 
peripheral blood (7-9, 27, 33, 34). Here, we performed a cross-sectional study, directly comparing 
the immune cell composition and functional capacity of pre-pregnancy endometrium and term 
decidua using flow cytometric analysis. We show clear differences in immune cell composition, 
suggestive of immune cell differentiation over the course of pregnancy, i.e. more experienced 
and less naive T cells and Treg in term decidua compared to pre-pregnancy endometrium. 
Analysis of the Th1/Th2/Th17/Treg subset composition showed that, while the distribution of 
Th1, Th2, and Th17 cells did not differ between term decidua and endometrium, there was a 
preference for Th1 over Th2 cells in the uterine environment compared to peripheral blood. 
The role of T cells in pregnancy has been subject to various studies. T cells were shown to be a 
major cell population in both endometrium and decidua, but their function and antigen-specificity 
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remains poorly defined (13). We observed mainly effector memory (EM) and central memory (CM) 
T cells at the end of pregnancy, and they were thus more experienced and differentiated than T 
cells from pre-pregnancy endometrium. This suggests that over the course of pregnancy, T cells 
at the fetal-maternal interface may differentiate. After implantation of a blastocyst, endometrium 
will modify to decidua, and cells of fetal origin will come in to contact with lymphocytes at the 
maternal-fetal interface. This contact might differentiate endometrial T cells towards a phenotype 
as seen in decidual tissue, as suggested by our in vitro assay. The target specificity of the T cells 
and exact trigger for this differentiation is unclear, but multiple triggers have been suggested 
to play a role, including fetal alloantigens like major histocompatibility complex antigens 
(MHC) (HLA-C in humans) (2, 4, 38), minor histocompatibility antigens (mHags) (6, 39), and/
or pathogen-derived antigens (40). In accordance, Tilburgs et al. previously reported that in 
addition to the lower numbers of naive T cells in decidual tissue, mainly EM and few CM CD8+ T 
cells were present in term decidua (35). 
Pregnancy induces local enrichment of Treg at the fetal-maternal interface (30, 41). These Treg 
play an important role in tolerance to the semi-allogeneic fetus and pregnancy in mice, since 
mouse studies showed that depletion of CD25+ Treg resulted in gestation failure in allogeneic 
pregnancies (20-22). We showed that the percentage of CD4+CD25highCD127- Treg was higher in 
decidua than in endometrium, suggesting a more tolerogenic environment during pregnancy. As 
previously reported by our group(27), no difference in the percentage of Treg in MMC and PBMC 
samples was observed. The increased percentage of Treg we found in term decidual tissue is 
comparable to percentages found in other studies (30). Based on the expression of CD45RA 
and CD25, human CD4+ T cells can be separated into differentiated Treg and naive Treg (36). 
We showed that term decidua contained more differentiated Treg than endometrium, while the 
presence of naive Treg was lower. In peripheral blood, these differentiated Treg were shown to 
be derived from recently activated naive Treg and were suggested to be the main effectors of 
suppression (36). In mice, it was shown that during the course of pregnancy Treg will acquire 
a protective regulatory memory phenotype to fetal antigen. These memory Treg persist after 
pregnancy and re-accumulate rapidly in a subsequent pregnancy (42). A similar phenomenon 
thus may take place in the uterus during human pregnancy.
Not only Treg, but the overall balance between Th1, Th2, Th17, and Treg cells is suggested to 
be of relevance for successful pregnancy (14). Th subsets can be classified by the production of 
particular cytokines by T cells, or by the expression of different chemokine receptors on T cells 
(37). Using a classification based on chemokine receptor expression patterns, we found that both 
term decidua and pre-pregnancy endometrium held relatively more Th1 cells, and less Th2 cells 
compared to peripheral blood. Our results thus showed that in the uterine environment, there 
is a preference of Th1 over Th2 cells. The same trend was also seen in first trimester decidua 
(43). This suggests that this preference is already present in pre-pregnancy endometrium 
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and stays over the course of pregnancy until term. Between term decidua and endometrium, 
the distribution of Th1, Th2, Th17, and Th1-like cells did not significantly differ. The similar Th 
cell distribution between endometrium and term decidua suggests that the pre-pregnancy 
endometrium might already be prepared for pregnancy. It can therefore be envisaged that 
women who experience recurrent miscarriages already have an imbalance in their endometrium 
affecting a successful pregnancy outcome. For instance, Shimada et al. (44) showed that in 
the endometrium of women with recurrent miscarriages less CD4+IFN-γ+ T cells were present. 
In-depth analysis of the Th1/Th2/Th17/Treg balance in the endometrium of women with fertility 
issues might give us more insight into the underlying pathogenesis of pregnancy complications 
and could potentially predict subsequent pregnancy outcome. Interestingly, when looking at the 
actual intrinsic capacity of CD4+ T cells to express IL-17 and IFN-γ intracellular, we found more 
expression of IFN-γ and IL-17 by decidual T cells compared to peripheral and endometrial CD4+ 
T cells. In first trimester decidua, the percentage of IL-17+ T cells was also found to be higher 
compared to peripheral blood (16, 45), while the expression of IFN-γ was lower (46). Although 
IFN-γ and IL-17 have been related to pregnancy complications, and an excess of inflammation 
was associated with a negative impact on pregnancy outcome (16, 18, 45, 47, 48), the presence 
of IFN-γ+ and IL-17+ T cells in healthy term decidua suggests that these cytokines may play an 
important role during pregnancy. IFN-γ for instance, was shown to be essential for implantation, 
decidual integrity and placental growth in mice (47, 49). IL-17 plays an important role in host 
defense against pathogens (15), but it was also shown that IL-17 increases the production of 
progesterone by JEG-3 cells and supports the survival, proliferation and invasive capacity of 
trophoblast cells (50-52). The presence of normal, balanced levels of IFN-γ and IL-17 could 
play a role during placentation and/or prevention of intrauterine infection, but this is still far from 
understood. While we did not show a difference in the capacity of peripheral and endometrial 
CD4+ T cell to express IL-17, Hosseini et al. (53) showed more IL-17+CD3+ T cells in menstrual 
blood compared to peripheral blood. This difference can be explained by a different gating 
approach since we looked at percentage of CD4+ T cells, while they looked at CD3+ T cells. When 
we would gate our data in a similar way, we found a similar, although not significant, difference 
between peripheral and menstrual blood. This can be explained by the higher percentages in our 
peripheral blood samples (average 4.5%) compared to theirs (average 0.9%). Several reasons 
could explain this discrepancy: duration of stimulation (4h vs 6h) or differences in stimulus and/
or concentration used (PMA (12.5 ng/ml)/Ionomycin (500 ng/ml)/Brefeldin A (5 µg/ml) by us 
versus PMA (25 ng/ml)/Ionomycin (500 ng/ml)/Monensin (1 µM/ml) by them).
A limitation or our study is that we were not able to study decidual tissue at several time-points 
during pregnancy, to actually show the changes that occur with time. We could only infer this from 
the data collected from pre-pregnancy endometrium (implantation stage) and term decidua. 
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In conclusion, we showed that the immune cell composition of pre-pregnancy endometrium 
differs from term decidua, but with a similar distribution of Th1, Th2, and Th17 cells. At the end of 
pregnancy, the uterine immune environment appears to be marked by a tolerogenic phenotype 
with more experienced T cells and Treg with a potential beneficial phenotype. How exactly the 
phenotype of the uterine immune cells is shaped and how this differentiation is maintained is 
unclear, Therefore, in follow-up studies, we aim to explore the influence of different immune 
triggers on immune cells in the uterine environment before and during pregnancy. This may add 
insight to our understanding of the pathogenesis of pregnancy complications. 
MATERIALS AND METHODS
Blood and tissue sampling 
Paired peripheral blood and menstrual blood was collected from 17 healthy women with regular 
menstrual cycles. Hormones can modulate immune cell responses and change the natural 
menstrual cycle (28, 29). To avoid any artificial effect on the hormonal balance, none of the 
menstrual blood donors used any hormonal contraceptives like birth control pill or an intra-
uterine device. See Supplementary Table S1 for donor characteristics. 10 ml of peripheral 
blood was collected in ACD-A tubes. Menstrual blood was collected during the first 36 hours of 
menstruation using a menstrual cup (Femmecup Ltd, London, UK). Every 12 hours, the sample 
was decanted from the cup in a 30 ml tube containing 8 ml 10% human pooled serum (HPS) 
medium [RPMI 1640 medium supplemented with pyruvate (1 mM), glutamax (2 mM), penicillin 
(100 U/ml), streptomycin (100 mg/ml) (Thermo Fisher Scientific, Waltham, USA), 10% HPS 
(manufactured in-house), and 0.3% sodium citrate (Merck, Darmstadt, Germany)] and stored at 
room temperature. After 1.5 days, three tubes containing different fractions of menstrual blood 
were processed immediately to assess lymphocyte composition. Decidua parietalis, the maternal 
side of the fetal-maternal interface, was obtained from 19 healthy women after uncomplicated 
term pregnancy. Decidual samples were obtained after delivery by planned elective cesarean 
section and processed immediately. The study was approved by the institutional review board 
(Commissie Mensgebonden Onderzoek region Arnhem-Nijmegen, CMO nr. 2009/004) and was 
performed in accordance with the relevant guidelines and regulations. Samples were obtained 
from each participant upon written informed consent.
Isolation of lymphocytes
One ml of peripheral blood was lysed with 25 ml lysis buffer [NH4CL + KHCO3/Na4EDTA 
(Merck, Darmstadt, Germany) diluted in H2O (Versol, Lyon, France)] for 10 min and washed 3x 
times with PBS (Braun, Melsungen, Germany). These cells were used for surface staining. For 
intracellular staining, peripheral blood mononuclear cells (PBMC) were isolated by means of 
density gradient centrifugation (Lymphoprep; Axis-Shield PoC AS, Oslo, Norway). After isolation, 
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cells were washed twice with PBS. Menstrual blood was washed with PBS and passed through 
a 70 µm cell strainer (Falcon, Durham, USA) to remove clots and mucus. Granulocytes were 
depleted by use of a granulocyte depletion kit according to the manufacturer’s instructions 
(STEMCELL Technologies, Vancouver, Canada). After isolation, cells were washed twice with 
PBS containing 2% HPS. Decidua parietalis was collected as described previously (30). Briefly, 
after removing the amnion, the decidua parietalis was carefully scraped from the chorion. The 
obtained tissue was washed thoroughly in PBS before mincing with scissors. The resulting pulp 
was washed again until the supernatant became transparent. The tissue was enzymatically 
incubated with 1% collagenase I (Gibco Life Technologies, Waltham, USA) and 1% DNAse 
(Roche Diagnostics, Risch-Rotkreuz, Switzerland) in a water bath at 370C while shaking for 60 
minutes. After washing with RPMI medium, the suspension was passed through a 70 µm cell 
strainer (Greiner, Frickenhausen, Germany) and washed again with RPMI. Lymphocytes were 
obtained after density gradient centrifugation (Lymphoprep). Analysis was done immediately on 
fresh material to exclude the influence of cryopreservation on the expression of certain markers. 
For optimal analysis of the chemokine receptors CD183 (CXCR3), CD194 (CCR4), and CD196 
(CCR6) on decidual cells, cells were put to rest at 37°C in a humidified 5% CO2 incubator for 16 
hours before staining for flow cytometry. Typically 93%, 95%, and 81% of respectively peripheral, 
menstrual, and decidual lymphocytes were viable cells (Supplementary Figure S1).
Flow cytometry
Samples were phenotypically analyzed using the 10-color NaviosTM flow cytometer (Beckman 
Coulter, Fullerton, CA, USA). Briefly, cells were washed twice with PBS + 0.2% bovine serum 
albumin (BSA; Sigma-Aldrich, St. Louis, USA) and labeled for 20 min at RT in the dark with 
the fluorochrome-conjugated mAbs of interest. Samples were washed twice with PBS + 0.2% 
BSA. For cell surface staining of B cells, monocytes/macrophages, T cells, Treg, NKT cells 
and NK cells, the following conjugated mAbs were used: CD3-PE/ECD/PB (Beckman Coulter; 
UCHT1), CD4-PC5.5/PB (Beckman Coulter; 13B8.2), CD4-AF700 (eBioscience, San Diego, 
USA; RPA-T4), CD8-APC-AF700/APC-AF750 (Beckman Coulter; B9.11), CD14-ECD (Beckman 
Coulter; RMO52), CD16-FITC (Beckman Coulter; 3G8), CD19-APC-AF750 (Beckman Coulter; 
J3-119), CD25-PC7/APC (BD Biosciences, New Jersey, USA; M-A251 and 2A3), CD45-KO 
(Beckman Coulter; J33), CD45RA-FITC/ECD (Beckman Coulter; ALB11 and 2H4LDH11LDB9), 
CD45RO-ECD (Beckman Coulter; UCHL1), CD56-APC (Beckman Coulter; N901), CD62L-FITC/
ECD (eBiosience and Beckman Coulter; DREG-56), CD69-PE (Beckman Coulter; TP1.55.3), 
CD103-FITC (eBioscience; B-Ly7), CD127-APC-AF700 (Beckman Coulter; R34.34), CD183-
PC5.5 (CXCR3; Biolegend, San Diego, USA; G025H7), CD194-PC7 (CXCR4; BD Biosciences; 
1G1), CD196-PE (CCR6; BD Biosciences; 11A9), CD197-BV421 (CCR7; BioLegend; G043H7), 
and Fixable Viability Dye-eFluor780 (eBioscience). For intracellular staining, samples were 
permeabilized and fixed according to manufacturer’s instructions (eBioscience). Cells were 
incubated with the conjugated mAbs of interest for 30 min at 4°C in the dark. The following 
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conjugated mAbs for intracellular staining were used: IFN-γ-PC7 (4S.B3) and IL-17-APC-
AF780 (eBioscience; eBio64DEC17). A minimum of 200.000 cells per staining was applied. 
Fluorescence minus one (FMO) and isotype controls were used for gate settings. The data 
were analyzed using Kaluza V1.1 software (Beckman Coulter). A typical gating strategy used for 
analysis of T cells and NK cells is depicted in Supplementary Figure S1. 
Functional analysis
Peripheral blood (PBMC), menstrual blood (MMC), and decidua parietalis (DPMC) mononuclear 
cells were stimulated with phorbol-12-myristate-13-acetate (PMA), ionomycin and brefeldin A 
(respectively, 12.5 ng/ml, 500 ng/ml and 5 µg/ml; Sigma-Aldrich, St. Louis, USA) for 4 hours 
at 37°C in a humidified 5% CO2 incubator. Functionality was determined by measuring the 
intracellular production of IFN-γ and IL-17 by flow cytometry as described above.
Differentiation assay
MMC were stimulated in vitro with medium as a control, with anti-CD3/anti-CD28 mAb-coated 
microbeads in a 1:10 bead-to-cell ratio (Invitrogen, Bleiswijk, The Netherlands) alone, rhIL-15 
(100 ng/ml; Gibco Life Technologies) alone, and beads together with rhIL-15 in 96-well U-bottom 
plates. The rationale for using IL-15 is because IL-2 is hardly detected in decidua and after 
implantation, endometrial NK cells start to differentiate as a result of local IL-15 production (9). 
After 5 days of culture at 37°C in a humidified 5% CO2 incubator, cells were harvested and the 
presence of T cell subsets and differentiation was measured with flow cytometry. 
Statistical analysis
Statistical analyses were performed using GraphPad Prism 5 (Graphpad software Inc., La Jolla, 
CA, USA). Non-parametric Kruskal-Wallis with Dunns post-hoc test was performed to compare 
PBMC, MMC, and DPMC samples. Statistical significance was denoted as values of P < 0.05. 
All indicated values are mean percentages ± SD.
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SUPPLEMENTAL INFORMATION
Supplementary Table S1. Donor characteristics




(information not available for 3 donors)
Age, median (range) 30 (19-46) 31 (23-37)
Contraceptives 0/17 (100%) NA
Previous pregnancy 9/17 (53%) 15/16 (94%)
Previous miscarriage 6/17 (35%) 4/16 (25%)
Length of menstrual cycle, median (range) 28 (22-35) NA
C-section NA 19/19 (100%)
Duration of pregnancy, median (range) NA 38 weeks (38-40 weeks)
Natural conception NA 15/16 (94%; 1 intrauterine insemination)
Birth weight, median (range) NA 3340 (2948-4325)
NA, not applicable
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Supplementary Table S2. Mean % ± SD is provided for lymphocyte populations in the three study groups 






Lymphocytes 79.1±6.9 62.5±12.1 65.2±9.8
T cells (CD3+CD56-) 80.0±7.3 43.9±15.1 67.1±10.6
CD45RA+ 50.9±7.7 53.4±8.8 17.2±7.4
CD45RO+ 31.2±7.1 28.9±8.0 66.4±11.7
CD4+ T cells 64.6±9.7 64.7±7.4 50.3±7.0
Naive (CD45RA+CCR7+) 54.1±9.4 58.7±8.6 18.6±15.0
Teff (CD45RA+CCR7-) 3.8±1.5 2.6±0.9 2.5±1.6
EM (CD45RA-CCR7-) 23.0±6.5 14.4±5.3 51.6±13.4
CM (CD45RA-CCR7+) 19.1±4.1 24.3±3.8 27.4±7.6
Treg (CD25highCD127-) 5.0±1.4 5.1±1.9 9.5±3.5
Naïve Treg (CD45RA+CD25+) 3.4±2.0 1.9±1.3 1.3±1.2
Differentiated Treg (CD45RA-CD25++) 3.7±2.1 2.4±1.6 8.4±5.9
Th1 (CCR6-CXCR3+CCR4-) 4.8±4.0 11.1±2.7 21.3±8.7
Th2 (CCR6-CXCR3-CCR4+) 8.6±2.7 3.3±1.4 4.9±2.8
Th17 (CCR6+CXCR3-CCR4+) 5.9±2.8 3.9±1.7 4.8±2.3
Th1-like (CCR6-CXCR3+CCR4-) 5.3±3.6 6.6±2.9 9.5±4.1
IL-17+ T cells 2.3±1.3 2.6±1.0 4.4±1.3
IFN-γ+ T cells 7.5±6.7 7.4±3.3 27.8±15.4
CD8+ T cells 28.6±6.9 30.3±6.3 42.5±5.6
Naive (CD45RA+CCR7+) 43.6±11.9 45.3±12.6 15.2±8.0
Teff (CD45RA+CCR7-) 26.6±9.1 25.3±11.5 30.4±11.5
EM (CD45RA-CCR7-) 23.7±7.0 24.5±13.1 45.8±13.2
CM (CD45RA-CCR7+) 6.0±2.2 5.0±1.9 8.7±3.0
NK cells (CD56+CD3-) 8.2±4.8 46.9±16.4 24.3±10.6
CD56+CD16- NK cells 11.4±6.7 92.5±5.8 81.6±6.8
CD56+CD16+ NK cells 88.7±6.7 7.5±5.8 18.5±6.8
MFI CD56 of CD56+CD16- NK cells 52.6±15.5 81.2±19.0 18.1±10.8
NKT cells (CD3+CD56+) 1.6±1.1 1.2±0.9 2.5±1.1
B cells (CD19+) 6.2±2.5 5.6±2.7 3.6±2.8
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Supplementary Figure S1. Representative gating strategy for immunophenotyping of peripheral blood 
(PBMC), menstrual blood (MMC), and term decidua (DPMC). 
Gate settings for PBMC were copied to menstrual and decidual samples. Leukocytes were first gated on CD45 positivity. 
Neutrophils and CD14+ cells were then excluded. The remaining dot plots represent the gating strategy for lymphocytes 
(FS-SS scatter), B cells (CD19+), NK cells (CD3-CD56+), NKT cells (CD3+CD56+), T cells (CD3+CD56-), CD4+ T cells 
(CD3+CD56-CD4+), CD8+ T cells (CD3+CD56-CD8+), and viable lymphocytes (FixViabDye-).
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Supplementary Figure S2. Uterine lymphocytes are of mucosal origin. 
(a) Representative flow cytometry plots for the expression of CD62L, CD69, and CD103 on T cells (CD3+CD56-) from 
peripheral blood (PBMC), menstrual blood (MMC), and decidua (DPMC). (b) Representative flow cytometry plots for the 
expression of CD62L, CD69, and CD103 on NK cells (CD56+CD3-) from PBMC, MMC, and DPMC. (c) Percentage CD62L+, 
CD69+, and CD103+ T cells and NK cells in PBMC (n=2-4), MMC (n=1-4), and DPMC (n=2-3).
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Supplementary Figure S3. CD4+ and CD8+ T cell subsets after in vitro differentiation of endometrial 
lymphocytes towards a decidual-like phenotype (n=4). 
Naive T cell (CD45RA+CCR7+); effector T cell, Teff (CD45RA+CCR7-); effector memory T cell, EM (CD45RA-CCR7-); central 
memory T cell, CM (CD45RA-CCR7+). Lines indicate mean ± SD. 




Three Types of Functional Regulatory T Cells 
Control T Cell Responses at the Human 
Maternal-Fetal Interface
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During pregnancy, maternal regulatory T cells (Tregs) are important in establishing immune 
tolerance to invading fetal extravillous trophoblasts (EVTs). CD25HIFOXP3+ Tregs are found 
at high levels in decidual tissues and have been shown to suppress fetus-specific and non-
specific responses. However, limited data are available on additional decidual Treg types and 
the mechanisms by which they are induced. This study investigated three distinct decidual CD4+ 
Treg types in healthy pregnancies with a regulatory phenotype and the ability to suppress T cell 
responses: CD25HIFOXP3+, PD1HIIL-10+, and TIGIT+ FOXP3dim. Moreover, co-culture of HLA-G+ 
EVTs or decidual macrophages with blood CD4+ T cells directly increased the proportions of 
CD25HIFOXP3+ Tregs compared to T cells cultured alone. EVTs also increased PD1HI Tregs that 
could be inhibited by HLA-C and CD3 antibodies, suggesting an antigen-specific induction. 
The presence of distinct Treg types may allow for the modulation of a variety of inflammatory 
responses in the placenta.
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INTRODUCTION
During pregnancy, CD4+CD25HIFOXP3+ regulatory T cells (Tregs) are found at high levels in 
decidual tissue and have the ability to suppress fetus-specific and non-specific responses (1, 2). 
Most interestingly, HLA-C mismatched pregnancies (where the fetus and extravillous trophoblasts 
(EVTs) express an HLA-C allotype that the mother does not have) had increased levels of functional 
CD4+CD25HI Tregs in decidua, compared to HLA-C matched pregnancies (3). Furthermore, in 
vitro co-culture of naive CD4+ T cells with EVTs directly increased the proportion of CD4+FOXP3+ 
Tregs, compared to CD4+ T cells cultured alone (4-6). This suggests that maternal T cells may 
specifically recognize fetal HLA-C, but its expression on EVTs promotes immune tolerance. 
The importance of maternal immune tolerance for fetal HLA-C is further illustrated by a recent 
study suggesting that HLA-C antibodies may contribute to the etiology of miscar riage (7). The 
proportion of circulating FOXP3+ Tregs was shown to be diminished in maternal blood obtained 
after spontaneous preterm birth (SPTB) (8-10)preeclampsia (PE)(11, 12) and in decidual tissue 
obtained after recurrent spontaneous miscarriage (13, 14). Furthermore, clonally expanded 
CD4+CD25HICD127–CD45RA– Treg populations were observed in healthy term pregnancy 
decidua, and failure of this clonal expansion may be related to development of preeclampsia 
(15). The importance of Tregs was also demonstrated in murine pregnancy models (16-19). 
Depletion of CD25+ Tregs during allogeneic matings, but not syngeneic matings, resulted in an 
increased resorption rate (16). Besides highlighting the role for Tregs, this also demonstrated 
that in the absence of Tregs, effector cells cause immunologic rejection of allogeneic fetal or 
placental tissues. A more recent murine study demonstrated that FOXP3+ Tregs with specificity 
to paternal antigens were generated extrathymically and accumulated in the placenta. In this 
study, females with impaired ability for extrathymic Treg induction showed increased fetal 
resorption rates and had increased influx of immune cells to the placenta in allogeneic matings, 
but not syngeneic matings (20).Other pathways and molecules have been demonstrated to play 
a role in Treg induction during pregnancy, including the blockade of the PD1-PDL1 pathway that 
led to reduced decidual CD25+FOXP3+ Treg numbers and increased embryo resorption in mice, 
which could be abrogated by adoptive CD25+FOXP3+ Treg transfer (21). This demonstrates the 
importance of PD1-PDL1 for decidual Treg induction. However, specific factors that contribute to 
diminished decidual Treg numbers or function during pregnancy complications have not been 
identified in human pregnancy.
Thus far, research on the role of Tregs in human pregnancy has mainly focused on FOXP3+ 
Tregs (2, 8-10, 13-15, 22-24), while other types of FOXP3– Tregs have not been studied in as 
much detail. Most importantly, only a handful of studies provide functional analysis of peripheral 
blood (11, 12) and decidual Tregs (2, 3)during human pregnancy. FOXP3, in combination with 
high expression of CD25 and HELIOS and the absence of CD127 expression, primarily identifies 
natural Tregs (nTregs), although whether HELIOS is a defining marker for human nTregs remains 
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controversial. The nTregs are generated in the thymus, are specific for self-antigens, and are 
responsible for preventing anti-self (autoimmune) responses (25, 26). In contrast, induced 
Tregs (iTregs) are generated in the periphery and can be specific for a large variety of antigens, 
including allo-antigens and viral-antigens (27-29). A well-characterized type of iTregs are Tr1 cells 
that secrete high levels of IL-10; express PD1; co-express CD49b and LAG3, but do not express 
FOXP3; and are important in the control of alloimmune responses (30, 31). Other iTregs include 
TIGIT+ cells that modulate antigen-presenting cells (APC) through interaction with CD155 on 
APCs and Tr35 cells that function through secretion of IL-35, an immune suppressive cytokine 
(32, 33). A large variety of other markers have been used to identify distinct iTreg populations 
(including but not limited to FOXP3, CD25, GITR, TIM3, CD39, LRRC32 (also known as GARP), 
LAP, and CCR8) (34-37). None of these markers are truly specific for iTregs, as they can also 
be expressed on activated T cells. Thus, to identify iTregs, functional assays are required to 
demonstrate their capacity to suppress immune responses such as proliferation, cytokine 
secretion, and cytotoxicity (29, 38). In this study, we provide extensive phenotypic and functional 
characterization of three types of decidual CD4+ Tregs in uncomplicated human pregnancies 
and investigate the ability of HLA-G+ HLA-C+ EVTs and decidual macrophages, the main APCs 
at the maternal-fetal interface, to increase Treg proportions.
RESULTS
Distinct CD4+ T cell types with a regulatory phenotype are present in decidual tissue 
FACS analysis on freshly isolated peripheral blood CD4+ T cells (CD4+ pTs) and decidual CD4+ 
T cells (CD4+ dTs) isolated from first-trimester decidua (gestational age 6–12 weeks) and term 
placenta decidua basalis (d.basalis) and decidua parietalis (d.parietalis) (gestational age > 37 
weeks) was performed to determine cell surface expression of CD45, CD4, CD25, PD1, TIGIT, 
CD127, CD45RA, CD49b, and LAG3 and intracellular expression of FOXP3 and HELIOS. A clear 
population of activated nTregs was identified in all tissues based on the high expression of CD25, 
FOXP3, and HELIOS and the lack of CD45RA and CD127 (Figure 1; Figures S1A-S1D) (25). 
While the percentage of FOXP3+ and HELIOS+ cells within this CD25HI population significantly 
decreased in term pregnancy decidua, the proportion of HELIOS+ cells within CD25HIFOXP3+ 
cells remained relatively stable (Figure 1D, right panel). A second T cell population was identified 
based on the high expression of PD1, the lack of FOXP3 and HELIOS, and low CD25. LAG3 
and CD49b were not expressed by CD4+ dTs. While both CD25HI and PD1HI cells co-expressed 
high levels of TIGIT, a third population of CD4+ dTs also expressed high levels of TIGIT and low 
levels of FOXP3, HELIOS, PD1, and CD25 (Figure 1; Figures S1A S1D). FOXP3 expression in 
TIGIT+ cells was significantly lower than in CD25HI cells (Figure S1E). The t-Distributed Stochastic 
Neighbor Embedding (t-SNE) analysis confirmed the separation of these three T cell populations 
(Figure S2) that hereafter will be named (1) CD25HIFOXP3+, (2) PD1HI, and (3) TIGIT+.
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Figure 1. Three distinct CD4+ T cell populations express Treg-associated markers.
(A and B) Representative FACS plots (A) and percentages (B) of CD25HI, PD1HI, and TIGIT+ cells within CD4+ T 
cells in blood, decidua 6–12 weeks, d.basalis >37 weeks, and d.parietalis >37 weeks. (C and D) Representative FACS 
plots (C) and percentages (D) of FOXP3+ and HELIOS+ cells within the four CD4+ T cell types and HELIOS+ cells within 
CD25HIFOXP3+ cells in blood, decidua 6–12 weeks, d.basalis >37 weeks, and d.parietalis >37 weeks (n = 8–10). Bars 
represent median and interquartile range; *p < 0.05, **p < 0.01 and ***p < 0.001. See also Figures S1-S3.
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These three CD4+ T cell types were purified by FACS sort and analyzed for their ability 
to produce the pro- and anti-inflammatory cytokines IFNɣ, IL-2, and IL-10 upon phorbol 
12-myristate 13-acetate (PMA)/Ionomycin stimulation. PD1HI T cells from all tissues expressed 
the highest levels of IL-10 and coexpressed IFNg (Figure S3), suggesting a resemblance to Tr1 
(30). CD25HIFOXP3+ cells of all tissue compartments expressed the lowest levels of IL-10, 
IFNɣ, and IL-2, whereas TIGIT+ cells expressed high levels of IFNɣ and IL-2 and low levels 
of IL-10. A limitation of this study is the lack of clinical information on the blood and tissues 
used for experiments that may have impacts on Treg phenotypes and contribute to the 
observed variation in Treg proportions. However, a previous report did not find an influence 
of clinical variables such as mode of delivery and fetal sex on the presence of CD4+CD25dim-
activated T cells and CD4+CD25HIFOXP3+ Tregs in decidual tissues of term pregnancy (3).
CD25HIFOXP3+, PD1HI, and TIGIT+ suppress proliferation of CD4+ and CD8+ Teff 
cells
 To determine the capacity of CD25HIFOXP3, PD1HI, and TIGIT+ T cells to suppress proliferation 
of effector T cells (Teffs), carboxyfluorescein succinimidyl ester (CFSE)-labeled CD4+ or CD8+ 
Teffs were stimulated with anti-CD3 and -CD28 beads in the presence or absence of sample-
matched Tregs for 4 days in a 1:2 Treg to Teff ratio. CFSE profiles were analyzed to determine 
the percentage of undivided cell (generation 0) and the average number of divisions per cell 
(division index) within the CD4+ and CD8+ Teffs cultured with and without Tregs (Figure 2A). All 
three CD4+ Treg types in decidual samples of 6–12 weeks suppressed proliferation of CD4+ 
Teffs. This is illustrated by the significant increase in the percentage of undivided cells (Figure 
2B), and a significant decrease of the division index (Figure 2E) upon co-culture of Tregs and 
Teffs, compared to stimulated Teff cultured alone. Additionally, purified PD1dim cells from 6-12 
week decidual tissues did not suppress proliferation of CD4+ T cells (Figure S4A). CD25HI 
FOXP3+ T cells also suppressed proliferation of sample-matched CD8+ Teffs, whereas PD1HI 
and TIGIT+ cells did not consistently reduce CD8+ Teff proliferation (Figures 2C and 2F). Analysis 
of the three T cell populations from term placenta d.parietalis demonstrated that these cells 
had a reduced capacity to suppress CD4+ Teff proliferation, compared to their first-trimester 
counterparts (Figures 2D and 2G), whereas peripheral blood CD25HI and PD1HI, but not TIGIT+ 
cells, suppressed proliferation of CD8+ Teffs (Figures S4B-S4D). To determine if IL-10 secretion 
by PD1HI Tregs is their predominant mechanism to suppress proliferation of CD4+ Teffs, as was 
previously shown for Tr1 cells (30, 31), anti-IL-10R blocking antibodies or immunoglobulin G 
(IgG) control antibodies were added to anti-CD3 and -CD28 stimulated CFSE- labeled CD4+ 
Teffs cultured alone or with sample-matched CD25HI or PD1HI cells. Indeed, addition of IL-10R 
antibodies abrogated the suppressive capacity of PD1HI cells but not of the CD25HI cells that 
were added in parallel control cultures (Figure 2H).
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Figure 2. Decidual Tregs suppress proliferation of Teffs.
(A) CFSE dilution of 6-12-week decidual CD4+ Teffs (upper panel) and CD8+ Teffs (lower panel) stimulated with 
anti-CD3/28 and co-cultured with or without CD25HI, PD1HI, or TIGIT+ Tregs during 4 days in a 1:2, Treg: Teff ratio. 
Percentages of the undivided Teffs are shown. (B–G) Fold change (FC) in the percentage of undivided cells (B–D) and 
in the division index (E–G) after the addition of CD25HI, PD1HI, or TIGIT+ Tregs, compared to CD4+ Teffs 6–12 weeks (B 
and E), CD8+ Teffs 6–12 weeks (C and F), and CD4+ Teffs >37 weeks (D and G) cultured alone. (H) Addition of IL-10R 
blocking antibodies to Teffs +PD1HI but not Teffs + CD25HI cultures inhibit suppression of proliferation, measured by FC 
in percentage of undivided cells, compared to isotype control cultures. Bars represent median and interquartile range; In 
(B)–(G): n = 7–11; (H): n = 3–4; *p < 0.05, **p < 0.01 and ***p < 0.001; values > 1 for FC % undivided cells and 
< 1 for FC division index represent suppression of proliferation. Division index reflects the number of divisions per cell as 
calculated in FlowJO v7.6.5. See also Figure S4.
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Figure 3. Decidual Tregs influence cytokine production by CD4+ and CD8+ Teffs.
(A–F) Graphs depict absolute change (D) in percentage of IFN-ɣ+ (A and D), TNF-α+ (B and E), and IL-10+ (C and F) 
decidual CD4+ Teffs (top panels) and decidual CD8+ Teffs (bottom panels) upon addition of sample-matched CD25HI, 
PD1HI, or TIGIT+ T cells, compared to CD4+ Teffs and CD8+ Teffs cultured alone. Bars represent median and interquartile 
range; n = 4–5; *p < 0.05, **p < 0.01. See also Figure S5.
CD25HIFOXP3+ and PD1HI Tregs influence cytokine production of CD4+ and CD8+ 
Teffs 
Next, the capacity of decidual CD25HIFOXP3+, PD1HI, and TIGIT+ Tregs to influence production of 
pro- and anti-inflammatory cytokines by CD4+ and CD8+ Teffs was investigated. CFSE- labeled 
CD4+ Teffs and CD45-Alexa700 labeled CD8+ Teffs were cultured with or without sample matched 
Tregs in a 1:1:1 CD4 Teff: CD8 Teff: Treg ratio and stimulated with anti-CD3 and -CD28. At day 
three, the cells were restimulated with PMA and Ionomycin for 6h in the presence of GolgiStop for 
the last 4h. CD4+ Teffs, CD8+ Teffs, and Tregs were identified (Fig ure S5A) and analyzed for the 
presence of intracellular cytokines IFNɣ, TNFɑ, and IL-10 (Figure S5B). Addition of CD25HI cells 
significantly decreased the percentage of IFNɣ+ and TNFɑ+ CD4+ and IFNɣ+ CD8+ Teffs (Figures 
3A,3B, and 3D). Addition of PD1HI cells significantly increased the percentage of IL-10+ CD4+ 
and CD8+ Teffs (Figures 3C and 3F) but also increased the percentage of IFNɣ+ CD8+ Teffs 
(Figure 3D). TIGIT+ cells did not consistently change the production of cytokines by CD4+ or 
CD8+ Teffs (Figure 3). Analysis of cytokine production by Tregs themselves confirmed the overall 
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low expression of cytokines by CD25HI cells and high expression of IL-10 by PD1HI cells (Figure 
S5C). Thus, besides suppressing Teff proliferation, both CD25HI and PD1HI Tregs also modulated 
the production of cytokines by Teffs.
CD25HIFOXP3+, PD1HI, and TIGIT+ Tregs from decidua    and blood express distinct 
transcriptional profiles
To further investigate the molecular mechanisms the three Treg types may utilize to modulate 
T cell proliferation and cytokine production, RNA was isolated from CD25HI FOXP3+, PD1HI, 
and TIGIT+ Tregs purified from peripheral blood, first-trimester decidua (6–12 weeks), and term 
pregnancy d.parietalis (>37 weeks). The BioMark Fluidigm 96x96 QPCR chip was used to detect 
gene expression. Sixty-six primer pairs had detectable CT values and melting curves (gene and 
primer list are included in Table S1). CT values were normalized against GAPDH (ΔCT), and the 
fold change (FC) was calculated relative to the median ΔCT of the blood CD4+ Teffs. Expression 
levels of CD25, FOXP3, PD1, and TIGIT confirmed the purity of the Treg fractions (Figure S6A). 
K-means cluster analysis of gene expression in the four T cell populations visualized two separate 
gene clusters in blood and decidua. Cluster I identified a set of genes, including CD25, FOXP3, 
TIGIT, CD39, LRRC32 (GARP), ST2, BATF, and CCR8, which are highly expressed by CD25HI 
FOXP3+, low in PD1HI, and intermediate in TIGIT+Tregs (Figure 4A). Cluster II identified a set 
of genes, including PD1, IFNɣ, IL-10, CCR5, and CXCR3, that are upregulated by PD1HI Tregs 
(Figure 4B). Heatmaps depicting the differentially expressed genes identified in these clusters 
are shown (Figures 4C - 4E). These data further support that CD25HIFOXP3+, PD1HI, and TIGIT+ 
are separate Treg types that may utilize distinct molecular mechanisms of immune modulation. 
Additional K-means cluster analysis revealed several key regulatory genes that differ 
throughout gestation and between decidual and blood Tregs (Figures S6B and S6C). Decidual 
CD25HIFOXP3+ Tregs show increased expression of CCR5, ST2, CD25, BATF, IL10, GITR, LRRC32 
(GARP), and CCR8, compared to blood CD25HIFOXP3+ Tregs, while decidual PD1HI Tregs had 
increased expression of IL-10, IFNɣ, and CCR5, compared to blood PD1HI Tregs. Interestingly, 
first- trimester decidual TIGIT+ Tregs increased expression of IL- 10, IFNɣ, LRRC32, and GZMA, 
while term pregnancy TIGIT+ Tregs had increased expression of, for example, VEGFA, IFNɣ, 
GITR, and CD39 (Figures S6B and S6C). Flow cytometric analysis of freshly isolated Tregs from 
all tissues confirmed differential protein expression of key mRNAs identified here (Figure S7). 
The increased expression of a variety of cytokines (e.g., IL-10, IFNɣ), chemokines (e.g., CCR5, 
CCR8), activation markers (e.g., HLA-DR, GZMA), and co-inhibitory genes and molecules (e.g., 
CD39, TIM3, LRRC32) on decidual Tregs may suggest increased Treg activation and suppressive 
function in decidual tissue to regulate inflammatory responses at the maternal fetal interface.
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Figure 4. Gene expression profiles of CD4+ Tregs and Teffs.
(A and B) K-means clustering identified two clusters of genes (A and B) that significantly correlate their mRNA expression 
pattern among CD25HI, PD1HI, TIGIT+, and Teffs. Blood (left panels), decidua 6–12 weeks (middle panels), and d.parietalis 
>37 weeks (right panels) are depicted. (C–E) Heatmaps depict differentially expressed genes identified in these clusters in 
blood (C), decidua 6–12 weeks (D), and d.parietalis >37 weeks (E). n = 4 for all T cell types. See also Figures S6 and S7.
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EVTs and decidual macrophages increase Treg proportions during co-culture
Previous studies demonstrated that EVTs directly increased FOXP3 levels in CD4+ CD25HI Tregs 
during co-culture (5, 6) and that decidual macrophages favored Treg differentiation (39). To 
investigate the capacity of EVTs and decidual macrophages to increase the three Treg types, 
EVTs and decidual macrophages isolated from first-trimester placental tissue were co- cultured 
with naive CD4+ pTs for 3 days as described previously (6). Co-culture of EVTs or decidual 
macrophages with CD4+ pTs significantly increased the proportion of FOXP3+ and HELIOS+ 
Tregs (Figure 5A). EVTs, but not decidual macrophages, also increased the proportion of PD1HI 
Tregs, while neither EVTs nor decidual macrophages changed the TIGIT+ population (Figure 5A). 
To deter mine whether EVTs and decidual macrophages increased Treg proportions through 
cell-cell contact or by secretion of soluble factors, EVTs or decidual macrophages and CD4+ pTs 
were co-cultured in a transwell system. Separation of EVTs or decidual macrophages from CD4+ 
pTs by a transwell membrane resulted in a small but not significant decrease in the induction of 
FOXP3+ and HELIOS+ cells by EVTs and decidual macrophages (Figures 5B and 5C), suggesting 
that both cell-cell contact and soluble factors may play a role in the induction of FOXP3+ cells 
by EVTs and decidual macrophages. In contrast, when EVTs and CD4+ pTs were separated by a 
transwell mem brane, the increase in the proportion of PD1HI cells was abrogated, demonstrating 
that cell-cell contact is required here (Figure 5B).
To further investigate the mechanisms by which EVTs and decidual macrophages increase Treg 
proportions, additional cell cultures were established where EVTs or decidual macrophages 
were co-incubated with CD4+ pTs in the presence of IgG controls and blocking antibodies for a 
panel of co-inhibitory molecules and anti-inflammatory cytokines. The increase in FOXP3+ cells 
was not reversed by addition of any of the blocking antibodies tested in EVT co-cultures (TCR 
coreceptor CD3; HLA-C; HLA-G receptor ILT2; HLA-G; coinhibitory molecule PDL1; and the 
immune modulatory cytokine TGFβ) (Figure 5D) and decidual macrophage co-cultures (ILT2, 
HLA-DR, PDL1, TGFβ, IL-10 receptor (IL-10R)) (Figure 5E). Interestingly, addition of HLA-C and 
CD3 antibodies signifi cantly inhibited the induction of PD1HI cells by EVTs (Figure 5F), while 
blocking HLA-G interactions resulted in a small but not significant reduction. Blocking ILT2, 
PDL1, and TGFβ in the EVTs and CD4+ T cell co-cultures did not significantly affect induction 
of PD1HI cells by EVTs (Figure 5F). The question of whether placental viral infections alter Treg 
induction or Treg stability and thereby exacerbate placental inflammation is clinically important. 
EVTs were infected with human cytomegaloviruses (HCMVs), the most common pathogen to 
infect the placenta and a major cause of congenital disease (40). Interestingly, no differences 
were observed in the capacity of healthy or HCMV-infected EVTs to increase CD25HIFOXP3+ and 
PD1HI Treg proportions (Figure 5G). Collectively, these results suggest that Tregs can locally be 
induced by EVTs and decidual macrophages and that antigen-specificity may be involved.
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Figure 5. EVTs and Decidual Macrophages Increase Treg Proportions
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(A) CD4+ T cells were cultured alone or in the presence of EVTs or decidual macrophages for 3 days. Cells were analyzed 
for the percentage of FOXP3+, HELIOS+, PD1HI, and TIGIT+ cells as described in Figures S1A and S1B. (B) CD4+ T 
cells were cultured alone, with EVTs, or with EVTs separated by a transwell membrane for 3 days and analyzed for the 
percentage of FOXP3+, HELIOS+, and PD1HI cells. (C) CD4+ T cells were cultured alone, with decidual macrophages, 
or with decidual macrophages separated by a transwell membrane for 3 days and analyzed for the percentage of FOXP3+ 
cells. (D–F) CD4+ T cells were cultured alone or with EVTs or decidual macrophages in the presence of IgG, or blocking 
antibodies for CD3, HLA-C, ILT2, HLA-G, PDL1, TGFb, and IL-10R and analyzed for the percentage of FOXP3+ (D and 
E) and PD1HI (F) cells. (G) CD4+ T cells were cultured alone or with EVTs or HCMV-infected EVTs and analyzed for the 
percentage of FOXP3+ and PD1HI cells. Bars represent median and interquartile range; n = 8–14; *p < 0.05; **p < 0.01; 
***p < 0.005.
DISCUSSION
Modulation of co-inhibitory molecules and Tregs function has exceptional therapeutic potential 
for treatment of a wide variety of inflammatory disorders, including cancer, chronic infection, 
autoimmune disease, and pregnancy complications. This study has refined our view of Treg 
populations at the maternal-fetal interface by presenting phenotypic and functional data of 
three Treg populations, CD25HIFOXP3+, PD1HIFOXP3-IL-10+, and TIGIT+FOXP3dim Tregs, found 
in decidual tissues of human first-trimester and term pregnancy. Functional suppression assays 
confirmed that decidual CD25HIFOXP3+ Tregs suppress prolifer ation and production of IFNɣ and 
TNFα by CD4+ and CD8+ Teffs. Decidual PD1HI Tregs were shown to suppress proliferation of 
CD4+ (but not CD8+) Teffs in an IL-10-dependent manner. PD1HI Tregs also increased expression 
of IL-10 in Teffs, possibly resulting in a positive feedback loop sustaining Teff suppression while 
inducing additional IL-10 secreting Tregs.
Decidual TIGIT+ cells significantly inhibited CD4+ T cell proliferation but did not influence CD8+ 
Teff proliferation or cytokine production, suggesting TIGIT+ Tregs only have limited capacity to 
suppress T cells, but their ability to suppress other cell types (e. g. APCs) was not investigated 
here. Further analysis of gene and protein expression of all Treg types in blood and decidua 
clearly separated the three Treg types and revealed that many immune regulatory molecules (e. 
g. CTLA4, ST2, LRRC32, GITR, IFNɣ, and IL-10) have increased expression in decidua compared 
to blood. Thus, decidual Tregs are highly activated and have the potential to influence immune 
responses through a variety of molecular pathways and cellular targets. Of importance here is 
further investigation into the contribution of decidual Treg types on the modulation of decidual 
CD8+ effector-memory T cells, which were shown to have signatures of T cell activation and 
dysfunction (41).
Most interesting here is the discovery of the role of HLA-C in the induction of PD1HI Tregs by EVT. 
EVTs, but not decidual macrophages, have the capacity to directly increase PD1HI Tregs through 
cell-cell contact. Blocking of the TCR co-receptor CD3 or HLA-C in these EVT and CD4 T cell co-
cultures significantly reduced this increase, suggesting that antigen-specificity may be involved. 
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Although it is well established that CD4+ T cells recognize major histocompatibility complex 
(MHC) class II molecules, MHC class I-restricted CD4+ T cells have been reported (42). Decidual 
PD1HI Tregs somewhat resemble Tr1 cells that have been extensively characterized in murine 
tissues (43) and human peripheral blood (30, 44). Their similarities include the high expression 
of PD1, IL-10, IFNɣ, and granzymes and the lack of FOXP3 expression. In contrast to Tr1 cells that 
were shown to depend on the ILT2-HLA-G pathway for their induction (45), induction of PD1HI 
cells by EVTs was not dependent on the HLA-G receptor ILT2, while directly blocking HLA-G 
during the EVT and CD4 T cell co-culture resulted in a small but not significant decrease of 
PD1HI Tregs induction. Tr1 cells were also shown to be induced by DC-10 through IL-10 secretion 
and interaction of HLA-G and ILT4 (46). Thus, other decidual cell types such as HLA-G+ DC-10, 
that are found in decidual tis sues may contribute to induction of the PD1HI Tregs described 
here (47). The main mechanisms of Tr1-mediated suppression are the secretion of IL-10 and 
killing of APCs by granzyme B (48). The expression of perforin and granzymes in first-trimester 
decidua PD1HI Tregs may suggest they can also diminish APC activity using this pathway. Tr1 
cells were identified in HLA-mismatched fetal liver hematopoietic stem cell transplant (HSCT) 
patients and were shown to suppress allogeneic responses in transplant patients and prevent 
autoimmune responses (31, 49). While the specificity of decidual PD1HI Tregs remains unknown, 
the requirement for direct cell-cell contact with EVTs for their induction, as well as the role for the 
TCR co-receptor CD3, may provoke speculation that decidual PD1HIIL-10 Tregs have specificity 
for fetal allo-antigens expressed by EVTs (e.g., HLA-C). In comparison with decidual PD1HI 
Tregs, decidual CD25HIFOXP3+ Tregs had an increased capacity to suppress proliferation and 
a more potent capacity to suppress IFNɣ and TNFɑ production by CD4+ and CD8+ Teffs. Thus, 
the mechanisms of suppression utilized by CD25HIFOXP3+ Tregs and PD1HI Tregs as well as 
the effects on their cellular targets are inherently different. The increased levels of co-inhibitory 
proteins and/or mRNAs (e.g., CTLA-4, GITR, CD39, ST2, LRRC32) expressed by decidual 
CD25HIFOXP3+ Tregs compared to blood CD25HI FOXP3+ Tregs suggests increased Treg 
activation and suppressive function in decidual tissue to regulate inflammation at the maternal-
fetal interface. Furthermore, it demonstrates that decidual Tregs may utilize distinct molecular 
mechanisms of immune modulation against a variety of cellular targets beyond the inhibition of 
CD4+ and CD8+ Teff responses.
The question of whether decidual Tregs are nTregs generated in the thymus with specificity 
for self-antigens or iTregs generated in the periphery with specificity for paternal antigens is 
immunologically interesting and of clinical relevance. It was previously reported that HELIOS is 
a marker of thymic-derived Tregs, while HELIOS- Tregs were induced from FOXP3- T cells in the 
periphery (50). HELIOS and FOXP3 double-positive Tregs had increased suppressive capacity, 
more stable FOXP3 expression, and dissimilar TCR repertoire compared to HELIOS-FOXP3+ 
Tregs (51, 52). Instability of HELIOS-deficient Tregs was also associated with conversion to a 
T-effector phenotype and enhanced antitumor immunity (53), and HELIOS was shown to control 
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certain aspects of Treg-suppressive function, differentiation, and survival (51). However, the lack 
of HELIOS expression does not exclusively identify human iTregs (54). Here, we demonstrate 
that human decidual CD25HIFOXP3+ Tregs have a high expression of HELIOS, which reduces 
in term pregnancy decidua as well as in cases of miscarriage, as was shown previously (14). 
Furthermore, we demonstrate that co- culture of CD4+ T cells with EVTs or decidual macrophages 
both significantly increased the expression of FOXP3 and HELIOS, advocating for either a local 
expansion of FOXP3+ and HELIOS+ nTregs or a possible de novo induction of FOXP3+ and 
HELIOS+ iTregs. The increased suppressive capacity of first-trimester CD25HI Tregs compared to 
term pregnancy CD25HI cells aligns with the observation that HELIOS expression increases and/
or stabilizes Treg function. Clonally expanded CD4+CD25HICD127–CD45RA– Treg populations 
were observed in term pregnancy decidua (15), and preferential recruitment of fetus-specific 
CD25HIFOXP3+ Tregs from the maternal peripheral blood to the maternal-fetal interface has been 
suggested to occur in human pregnancy (2). Furthermore, CD4+CD25HI Tregs had increased 
suppressive function when they were isolated from decidual tissue with a maternal-fetal HLA-C 
mismatch compared to an HLA-C match (3). In neither of these studies was HELIOS expression 
investigated, but an explanation to align these observations may be that CD25HIFOXP3+ Tregs 
are a mixed population of self-specific nTregs and fetus-specific iTregs. Another explanation may 
suggest that an increased induction of other iTreg types (e.g., PD1HI Tregs) induced in response 
to fetal allo-antigens may indirectly increase or enhance CD25HIFOXP3+ Tregs stability and/or 
function through secretion of immune-suppressive IL-10 and/or other factors. Because of the 
intracellular nature of HELIOS and the lack of other markers to distinguish  CD25HIFOXP3+ nTregs 
from iTregs, it is technically not possible to investigate functional differences between these cells 
from human tissues. A further focus on the mechanisms by which both CD25HI FOXP3+ and 
PD1HIIL-10 Tregs are induced by EVTs and decidual macrophages at the maternal-fetal interface 
as well as the effects of their mutual interactions will contribute to answering burning questions 
on their origin and antigen specificity.
In contrast to our expectations, infection of EVTs with HCMVs did not diminish the ability of EVTs 
to increase CD25HI FOXP3+ and PD1HI Tregs, suggesting that HCMV infection does not alter the 
capacity of EVTs to promote immune tolerance. This is in line with a previous observation that 
decidual natural killer (NK) cells degranulated in response to HCMV-infected maternal decidual 
stromal cells, but not in response to HCMV-infected EVTs, suggesting that immune tolerance 
is maintained at the expense of efficient clearance of HCMV infection (40). Relevance of the 
distinct Treg populations should be addressed by studying their presence and functionality in 
cases of pregnancy complications. Decreased proportions of decidual CD4+CD25HI FOXP3+ 
and HELIOS+ Tregs were associated with spontaneous recurrent miscarriage (13, 14) and 
preeclampsia (11, 12, 55). The detailed phenotypic characterization, combined with gene 
expression and extensive functional analysis of multiple Treg populations as presented here, 
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provides a strong platform for guiding analysis of altered Tregs in clinical conditions for which no 
systematic functional Treg characterization has been performed.
This study provides strong evidence that multiple types of decidual Tregs, including nTregs 
and iTregs, play a key role in maintaining maternal-fetal immune tolerance during pregnancy. 
Moreover, the decidual microenvironment contains cell types, particularly EVTs and decidual 
macrophages, which have mechanisms to stabilize and expand Treg populations. Of importance 
here is the data demonstrating that blocking the TCR co-receptor CD3 as well as HLA-C during 
EVT- CD4 T cell co-cultures inhibited the increase in PD1HI Tregs, suggesting antigen specificity. 
Further, characterization of decidual Tregs and Teffs in placental materials obtained after 
spontaneous preterm birth, preeclampsia, and intrauterine infections will accelerate discovery of 
therapeutic targets to prevent and cure these severe pregnancy complications, as is underway 
for treatment of many types of cancer and autoimmune diseases.
MATERIALS AND METHODS
Discarded human placental and decidual materials (gestational age 6-12 weeks) were obtained 
from women undergoing elective pregnancy termination at a local reproductive health clinic. 
Term placental tissues (gestational age > 37 weeks) were obtained from healthy women after 
uncomplicated pregnancy at term delivered by elective cesarean section or uncomplicated 
spontaneous vaginal delivery at Tufts Medical Center. All tissues were visually inspected for 
signs of excessive inflammation (including discoloration, large infarctions and foul odor) and 
only healthy tissues were used for further processing. Peripheral blood leukocytes were isolated 
from discarded leukopacks from healthy volunteer blood donors at the Massachusetts General 
Hospital in Boston, MA.
All human tissue used for this research was de-identified, discarded clinical material. No 
clinical information including the fetal sex and sex of blood donors was available for analysis. 
The Committee on the Use of Human Subjects (the Harvard IRB) determined that this use of 
placental and decidual material is Not Human Subjects Research. Term placental tissue was 
collected under a protocol approved by Tufts Health Sciences IRB. All procedures to process 
these human blood and tissues materials are described in method details.
Isolation of T cells and decidual macrophages
The procedures to isolate lymphocytes and EVT have recently been described (6) and are also 
described in detail hereafter. To isolate 1st trimester decidual lymphocytes, villous and decidual 
tissues from elective pregnancy terminations were macroscopically identified and separated. 
Decidua parietalis from term pregnancy was collected by removing the amnion and delicately 
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scraping the decidua parietalis from the chorion. Decidua basalis was macroscopically 
dissected from the maternal side of the placenta. Collected decidual tissues were washed with 
PBS, minced and thereafter digested with 0.1% collagenase type IV and 0.01% DNase I (Sigma-
Aldrich) gently shaking in a water bath for 75 min at 37ºC. After digestion, released lymphocytes 
from 1st trimester and term placenta decidua were washed with RPMI 1640 (Life technologies) 
containing 10% FBS (Atlanta Biologicals) for 8 min at 1800 rpm and filtered through 100 mm, 
70 mm and 40 mm sieves (BD, Labware; NJ). Lymphocytes were dissolved in 20 mL 1.023 g/
ml Percoll (GE Healthcare) and layered on a Percoll gradient (10 mL 1.080 g/ml; 15ml 1.053 g/
ml) for density gradient centrifugation (25min, 2000rpm). Decidual lymphocytes were isolated 
from the 1.080 – 1.053 g/ml interface, and decidual macrophages were isolated from the 1.053 – 
1.023 g/ml interface. Cells were washed twice with RPMI and directly stained for flow cytometric 
analysis on a BD LSR-II or for FACS sort on a BD FACS ARIA-II. Peripheral blood CD4+ T cells 
were isolated using a RosetteSep human CD4+ enrichment cocktail (Stem Cell Technologies) 
followed by Ficoll (GE Healthcare) density gradient centrifugation (20 min, 2000 rpm).
Flow Cytometry
Antibodies used for flow cytometry are listed in the Key Resources Table. For surface staining, 
cells were stained for 30 min on ice in PBS 1% NCS. For intracellular staining, cells were fixed 
and permeabilized using the eBioscience FOXP3 staining kit (eBiosciences). For detection 
of intracellular cytokines, CD4+ T cells were stimulated for 6 hours with phorbol 12-myristate 
13-acetate (PMA; 1 mg/ml; Sigma) and Ionomycin (1 mg/ml; Sigma), and Golgistop was added 
for the last 4 hours (1 ml/ml; BD Biosciences). Cells were fixed and permeabilized using the BD 
CytoFix/CytoPerm kit (BV Biosciences). Acquisition and analysis was performed on a LSR-II (BD) 
using FACS Diva software. t-SNE analysis was performed using FlowJo 10 software.
Suppression of T cell proliferation assay
Purified decidual or peripheral blood CD4+ T cells were sorted on a BD FACS Aria into four 
fractions (CD4+CD25HI, CD4+PD1HI, CD4+TIGIT+ and CD4+ Teff) according to the gating strategy 
described in Figure S1. Decidual CD8+ T cells were obtained from the same decidual sample. 
For CFSE labeling CD4+ Teff and CD8+ cells were resuspended in PBS at a concentration of 
0.2 -1.0 x106 cells per ml. CFSE (Invitrogen) was added in a 1:2500 dilution and cells were 
incubated for 5 min in a water bath at 37ºC. Cells were washed with X-VIVO 10 supplemented 
with 50U IL-2 and 5% human AB serum (Corning) for 8 min at 1800 rpm. Cells were resuspended 
at 0.4 x106 cells per ml in X-VIVO 10 supplemented with 50U IL-2 and 5% human AB serum. Treg 
were cultured with the CFSE- labeled Teff in a 1:2 ratio of 20.000 Treg: 40.000 Teff cells, with 
the addition of Dynabeads Human T-Activator CD3/CD28 (1 ml/ml). After four days, cells were 
collected and stained for CD4-PerCP, CD8-Alexa700 and CD45-PacificOrange. CFSE dilution of 
CD4+Teff and CD8+ T cells was analyzed using the proliferation analysis tool of FlowJo v7.6.5 
software. The percentage of undivided cells (generation 0) was calculated based on the total 
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number of cells. The division index was calculated by FlowJo software and reflects the average 
number of divisions per cell. Suppression of T cell cytokine production assay Purified decidual 
CD4+CD25HI, CD4+PD1HI, CD4+TIGIT+, CD4+ Teff and CD8+ T cells were obtained as described 
above (Figure S1). CD4+ Teff cells were labeled with CFSE (Invitrogen) and CD8+ cells were 
labeled with CD45-Alexa700. Treg were cultured with CD4+ and CD8+ Teff in a 1:1:1 ratio (20.000 
Treg: 20.000 CFSE+ CD4+ Teff: 20.000 Alexa 700+ CD8+ Teff). Control cultures without Treg 
contained CD4+ and CD8+ Teff in a 1:1 ratio (30.000 CFSE+ CD4+ Teff: 30.000 Alexa700+ CD8+ 
Teff). CD3/CD28 Dynabeads (1 ml/ml) were added to all cultures and after three days, cells 
were re-stimulated with 2.5 ng/mL PMA in combination with 0.1 mg/mL ionomycin for 6h in the 
presence of 1 mg/mL GolgiStop (BD Bioscience). Cells were collected and stained for cell surface 
expression of CD4-PerCP, CD8-Alexa700, CD45-Pacific Orange and intracellular expression of 
IL-10, IFNg and TNFa upon fixation and permeabilization (CytoFix/Cyto PermTM Plus kit (BD)). 
Acquisition was performed on an LSR-II (BD) using FACS Diva software for analysis following the 
gating strategy shown in (Figure S4).
RNA isolation and QPCR chip analysis
Purified CD4+ T cells from four samples of blood, decidua 6-12wk and d.parietalis >37wk (Figure 
S1A) were resorted into four types CD4+CD25HI, CD4+PD1HI, CD4+TIGIT+ and CD4+ Teff (Figure 
S1B) and collected directly into 600 mL Trizol reagent (Life technologies) supplemented with 0.5 
mL glycogen (20mg/ml; Affymetrix) and stored at 80ºC until RNA isolation. Total RNA was isolated 
using the RNAeasy Micro Kit (QIAGEN) per manufacturer’s instruction. RNA was analyzed on a 
Nanodrop to determine RNA yield and integrity. RNA quality of all samples was further confirmed 
by performing a QPCR analysis for GAPDH and FOXP3 expression. In short: RNA was reverse 
transcribed with Stratagene’s AffinityScript QPCR. cDNA Synthesis Kit and amplification of 
specific PCR products for FOXP3 and GAPDH were detected using the PerfeCTa SYBR Green 
Super Mix with Low ROX (QuantaBio) in duplicates. Subsequently, high quality samples were 
run in duplicate on the BioMark Fluidigm QPCR 96.96 chip. 1.25ml DNA was pre-amplified in a 
96-well plate using the Fluidigm PreAmp Master mix combined with 500nM forward and reverse 
primer of each primer pair (2min at 95ºC, 10 thermal cycles of 15sec at 95ºC and 4min at 60ºC)
(primers are listed in Table S1). Exonuclease treatment to remove unincorporated primers was 
carried out using the Exonuclease I at 40U/ml (New England BioLabs). 2 ml of the Exonuclease I 
dilution was added to each pre-amplification reaction and incubated in a thermal cycler for 30min 
at 37ºC and 15min 80ºC. A 5-fold dilution was prepared in TE buffer (10mM Tris-HCl, 1.0mM 
EDTA, TEKnova, PN T0224). Sample pre-mix for the 48 samples was prepared using 2ml of the 
prepared cDNA with 20X DNA binding dye sample loading reagent (Fluidigm) and 2X SsoFast 
EvaGreen supermix with low ROX (Bio-Rad). The assay mix was prepared in a separate 96-well 
plate consisting of 2X assay loading reagent, 1X DNA suspension buffer and 100mM of mixed 
forward and reverse primers. Chips were primed, loaded with both assay and sample mix and 
run on BioMark readout instruments as described by the manufacturer, at Harvard University’s 
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core facility. Biomark data were processed using Fluidigm Biomark software. Quality control was 
based on EvaGreen reagent allowing for detection of unspecific PCR product and formation 
of primer dimers using the BioMark software. Samples of failed reactions were automatically 
excluded by the software. The resulting values for 66 primers of 48 samples were normalized 
by subtracting CT values for GAPDH (ΔCT) and subsequent conversion into fold-change values 
relative to the median peripheral blood Teff (2ΔΔCT). K-means cluster analysis was performed 
using the fold-change values of the 66 genes in Express Cluster V1.3 in Genepattern https://
cloud. genepattern.org/gp. Differential expression of significantly correlating genes was based 
on K-means with a minimum of a 1.5-fold change.
Isolation of EVT
Isolation of EVT and co-culture with CD4+ T cells was performed as described previously (6) 
and are also described in detail hereafter. 1st trimester villous tissue was gently scraped from 
the basal membrane and the tissue was digested for 8 min at 37ºC with a trypsin (0.2%) EDTA 
(0.02%) solution. Trypsin was quenched with DMEM/F12 medium containing 10% Newborn Calf 
Serum (NCS) and1%Pen/Strep (all from GIBCO) and filtered over a gauze mesh. Filtrate was 
washed once and layered on Ficoll (GE Healthcare) for density gradient centrifugation (20 min, 
2000 rpm). Cells were collected, washed once and incubated for 20 min at 37ºC in a 30mm tissue 
culture dish for removal of macrophages. To establish untouched (free of antibody staining) 
EVT cultures, for each sample the percentage CD45-HLA-G+ EVT was determined by FACS 
analysis for EGFR1, HLA-G and CD45. Samples with > 8% CD45-HLA-G+ cells were stained for 
CD45 and sorted for viable CD45- large trophoblast cells. 50.000 CD45-HLA-G+ EVT (calculated 
based on percentage HLA-G+ cells and total cell number) were plated in 48 well cell culture 
plates (Costar) pre-coated with fibronectin (100 mL 20ng/ml 45min, BD), in DMEM/ F12 (GIBCO) 
supplemented with 10% NCS, pen/strep and glutamine, insulin, transferrin, selenium (GIBCO), 
5ng/ml EGF (Peprotech) and 400 units human gonadotropic hormone (Sigma). Trophoblasts 
were incubated for 2h at 37ºC and thereafter washed 3 times to remove all non-adherent VT. 
Cultures resulted in 50%–80% HLA-G+ EVT.
Co-culture of EVT, decidual macrophages and CD4+ T cells
50.000 EVT or decidual macrophages were co-incubated with 100.000 CD4+ pT from unrelated 
blood donors in X-Vivo10 medium (Lonza), supplemented with 5% human AB serum and 50 
units/ml IL-2 (Biolegend). For blocking experiments, LEAF-purified anti- HLA-G (MoAb 87G; 20 
mg/ml), anti-ILT2 (MoAb GHI/75; 20 mg/ml), anti-PDL1 (MoAb 29E.2A3; 20 mg/ml), anti-TGFβ 
(MoAb 19D8; 25 mg/ml), anti-IL-10R (MoAb 3F9; 20 mg/ml), anti-HLA-DR (MoAb L243; 20 mg/
ml), purified anti-HLA-C (MoAb DT-9; 10 mg/ml) and IgG controls (all from Biolegend), or anti-
CD3 (MoAb SPV-T3b; 25 mg/ml) (ThermoFisher Scientific) were added 30 min before addition 
of CD4+ T cells. For transwell assays, 100.000 EVT or decidual macrophages were plated in 24 
well cell culture plates pre-coated with fibronectin, non-adherent EVT were removed and 200.000 
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CD4+ pT were added directly to the EVT and decidual macrophage cultures or were added on 
top of the membrane after insertion of a 0.4 mM trans well membrane (Costar). CD4+ pT were 
harvested after 60 hours and analyzed by Flow cytometry for CD45, CD4, CD25, PD1, TIGIT and 
intracellular FOXP3 and HELIOS.
HCMV Infection of EVT
High titer virus stocks of HCMV-AD169-GFP (IE-1-GFP) (a gift from Prof. Donald Coen at Harvard 
Medical School) was obtained by infecting Human Foreskin Fibroblasts (HFF) (ATCC) and 
collecting supernatants after 7 days. Supernatants were aliquoted and snap frozen in liquid 
nitrogen until use. Primary EVT were infected with HCMV at an MOI of 2-4 for 12 hours (41). 
Infected cells were imaged in a Nikon EclipseTi fluorescence microscope at 20x magnification. 
HCMV infection of EVT reached > 80% at day 2, and no cytopathic effects on EVT were visible 
after HCMV (41). For co-culture assays, HCMV infected cells were washed twice after 12 hours 
of infection and 100.000 CD4+ pT were added. CD4+ pT were harvested after 48 hours and 
analyzed by Flow cytometry for CD45, CD4, CD25, PD1, TIGIT and intracellular FOXP3.
Quantification and statistical analysis
All data was analyzed using GraphPad Prism version 6.07 software. To determine differences 
between 2 paired groups a non-parametric Wilcoxon Signed Rank test was performed (Figure 
S1E). To determine differences among more than 2 unpaired groups, a nonparametric Kruskal-
Wallis test with Dunn’s multiple comparison post-test was performed (Figure 1, 2, 3, and 5; 
Figure S3, S4, and S7). For the Dunn’s post-test the mean ranks were compared to control 
column A (Figure 2B 2G and 3; Figure S4 and S7), column B (Figure 5D-5F) or with the mean 
rank of every column (Figure 1, 5A-5C, and 5G; Figure S3). P values < 0.05 were considered 
to denote significant differences. *p < 0.05; **p < 0.01; *** p < 0.005 are indicated within 
each figure. Sample size indicates biological replicates of individual placental of blood cell 
isolates and are indicated indicted in each figure  legend. Sample sizes were not determined 
beforehand.
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Supplementary Figure S1. FACS gating strategy. Related to Figure 1. A) CD4+ and CD8+ T cells were
identified by selecting live cells (R1), duplicates were excluded (R2, R3), and CD45+CD56−CD3+CD4+
(CD4+) and CD45+CD56−CD3+CD8+ (CD8+) T cells were selected. B) Based on CD25, PD1 and TIGIT
expression, CD4+ T cells were further separated into CD25HI, PD1HI, TIGIT+ and Teff cells.
Representative FACS plots of C) FOXP3, CD45RA and CD127 expression and D) PD1 and CD25
expression in CD25HI, PD1HI and TIGIT+ cells in a 6-12wk decidual sample. E) Graph depicts the
expression of FOXP3 (MFI) within CD25HI and TIGIT+ cells in blood, decidua 6-12wk, decidua basalis
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Supplementary Figure S1. FACS gating strategy. 
Related to Figure 1. (A) CD4+ and CD8+ T cells were identified by selecting live cells (R1), duplicates were excluded 
(R2, R3), and CD45+CD56−CD3+CD4+ (CD4+) and CD45+CD56−CD3+CD8+ (CD8+) T cells were selected. (B) 
Based on CD25, PD1 and TIGIT expression, CD4+ T cells were further separated into CD25HI, PD1HI, TIGIT+ and Teff cells. 
Representative FACS plots of (C) FOXP3, CD45RA and CD127 expression and (D) PD1 and CD25 expression in CD25HI, 
PD1HI and TIGIT+ cells in a 6-12wk decidual sample. (E) Graph depicts the expression of FOXP3 (MFI) within CD25HI and 
TIGIT+ cells in blood, decidua 6-12wk, decidua basalis >37wk and d.parietalis >37wk. n=8-10. Bars represent median and 
interquartile range; n= 8-10; *P<0.05, **P<0.01, ***P<0.001.
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Supplementary Figure S2. tSNE analysis of decidual CD4+ T cells. Related to Figure 1.
Representative tSNE plots of one decidual CD4+ T cell sample (6-12wk), highlighting CD25, FOXP3,
HELIOS, PD1, CD45RA and TIGIT. Three separate CD4+ T cell populations are identified i)
CD25HIFOXP3+HELIOS+, ii) PD1HI and iii) CD45RA+. TIGIT is co-expressed by CD25HI and PD1HI
cells but not by CD45RA+ cells. TIGIT is also expressed by a large proportion of the remaining CD4+
T cells, these TIGIT+ cells are clearly identified in Fig 1B bottom panels.























Supplementary Figure S2. tSNE analysis of decidual CD4+ T cells.
Related to Figure 1. Representative tSNE plots of one decidual CD4+ T cell sample (6-12wk), highlighting CD25, FOXP3, 
HELIOS, PD1, CD45RA and TIGIT. Three separate CD4+ T cell populations are identifi ed i) CD25HIFOXP3+HELIOS+, 
ii) PD1HI and iii) CD45RA+. TIGIT is co-expressed by C 2 HI and PD1HI cells but not by CD45RA+ cells. TIGIT is also 
expressed y a large proportion of the remaining CD4+ T cells, these TIGIT+ cells are clearly identifi ed in Fig 1B bottom 
panels.
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Supplementary Figure S3. IFNγ+, IL-2+ and IL-10+ expression by Treg. Related to Figure 1.
Representative histograms of A) IFNγ, B) IL-10 and C) IL-2 expression by CD4+ T cells in blood,
decidua 6-12wk and d.parietalis >37wk and in the four T cell subpopulations (CD25HI, PD1HI,
TIGIT+ and Teff) in decidua 6-12wk. Graphs depict percentage of A) IFNγ+, B) IL-10+ and C) IL-2+
cells within CD4+ T cells (left) and the four T cell subtypes (right). Bars represent median and
interquartile range; n= 8-12; *P<0.05, **P<0.01, ***P<0.001. Kruskal-Wallis with Dunn’s post-test
comparing the mean ranks to the mean rank of every other column (column A,B,C) within each of
the T cell populations.
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Supplementary Figure S3. IFNγ+, IL-2+ and IL-10+ expression by Treg. 
Related to Figure 1. Representative histograms of (A) IFNγ, (B) IL-10 and C) IL-2 expression by CD4+ T cells in blood, 
decidua 6-12wk and d.parietalis >37wk and in the four T cell subpopulations (CD25HI, PD1HI, TIGIT+ and Teff) in decidua 
6-12wk. Graphs depict percentage of (A) IFNγ+, B) IL-10+ and (C) IL-2+ cells within CD4+ T cells (left) and the four T cell 
subtypes (right). Bars represent median and interquartile range; n= 8-12; *P<0.05, **P<0.01, ***P<0.001. Kruskal-Wallis 
with Dunn’s post-test comparing the mean ranks to the mean rank of every other column (column A,B,C) within each of the 
T cell populations.
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Supplementary Figure S4. Treg suppression of T cell proliferation. Related to Figure 2. A) CFSE
dilution of 6-12wk decidual CD4+ Teff cells stimulated with anti-CD3/28 and co-cultured with or without
PD1dim, PD1HI or CD25HI cells and B) CFSE dilution of peripheral blood CD4+ Teff cells (upper panels) and
CD8+ Teff cells (bottom panels) stimulated with anti-CD3/28 and co-cultured with or without CD25HI, PD1HI
or TIGIT+ cells. Cells were cultured for four days in a 1:2, Treg:Teff ratio. Percentages of the undivided Teff
cells are shown. C) Fold Change (FC) in percentage undivided peripheral blood Teff cells and D) FC in
division index after addition of CD25HI, PD1HI or TIGIT+ Treg, compared to CD4+ Teff cells (left panels) and
CD8+ Teff cells (right panels) cultured alone. Bars represent median and interquartile range; n=5-7;
*P<0.05, Kruskal-Wallis with Dunn’s post-test comparing columns B-D to column A was performed. Values
>1 for FC %undivided cells and <1 for FC division index represent suppression of proliferation. Division
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Supplementary Figure S4. Treg suppression of T cell proliferation. 
Related to Figure 2. (A) CFSE dilution of 6-12wk decidual CD4+ Teff cells stimulated with anti-CD3/28 and co-cultured with 
or without PD1dim, PD1HI or CD25HI cells and (B) CFSE dilution of peripheral blood CD4+ Teff cells (upper panels) and CD8+ 
Teff cells (bottom panels) stimulated with anti-CD3/28 and co-cultured with or without CD25HI, PD1HI or TIGIT+ cells. Cells 
were cultured for four days in a 1:2, Treg:Teff ratio. Percentages of the undivided Teff cells are shown. (C) Fold Change (FC) 
in percentage undivided peripheral blood Teff cells and (D) FC in division index after addition of CD25HI, PD1HI or TIGIT+ 
Treg, compared to CD4+ Teff cells (left panels) and CD8+ Teff cells (right panels) cultured alone. Bars represent median 
and interquartile range; n=5-7; *P<0.05, Kruskal-Wallis with Dunn’s post-test comparing columns B-D to column A was 
performed. Valu s >1 for FC %undivid d cells and <1 for FC division index represent suppression of proliferation. Division 
index refl ects the number of divisions per cell as calculated in FlowJO v7.6.5.











































































































Supplementary Figure S5. Decidual Treg influence cytokine production by CD4+ and CD8+ Teff cells.
Related to Figure 3. (A) Gating strategy identifies CD45+CFSE+CD4+ T cells (Blue), CD45+CFSE-CD8+ T cells (Red) 
and CD45+CFSE-CD8- Treg (green). (B) Representative FACS plots of IFNɣ, TNFɑ and IL-10 expression in decidual CD4+ 
Teff (Blue) and decidual CD8+ Teff (Red) upon addition of CD25HI, PD1HI or TIGIT+ Treg compared to CD4+ Teff and CD8+ 
Teff cultured alone and IgG controls. (C) Representative FACS plots of IFNɣ, TNFɑ, IL-10 expression in decidual CD25HI, 
PD1HI or TIGIT+ Treg in the same co-cultures.
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Supplementary Figure S6. Gene expression profiles of CD4+ Treg. Related to Figure 4. A) FC
mRNA values of CD25, PD1, TIGIT and FOXP3 (n=4). Bars represent median and interquartile
range. (B and C) K-means clustering identified two clusters of genes that significantly correlate their
mRNA expression pattern in blood, decidua 6-12wk and d.parietalis >37wk. CD25HI (left panels),





















Supplementary Figure S6. Gene expression profiles of CD4+ Treg. 
Related to Figure 4. (A) FC mRNA values of CD25, PD1, TIGIT and FOXP3 (n=4). Bars represent median and interquartile 
range. (B and C) K-means clustering identified two clusters of genes that significantly correlate their mRNA expression 
pattern in blood, decidua 6-12wk and d.parietalis >37wk. CD25HI (left panels), PD1HI (middle panels) and TIGIT+ (right 
panels) are depicted.
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Supplementary Figure S7. Expression of CTLA-4, GITR and CD39 by Treg. Related to Figure 4.
A) Representative histograms of CTLA-4 (top panels), GITR (middle panels) and CD39 (bottom
panels) within CD25HI, PD1HI, TIGIT+ and Teff cells of blood, decidua 6-12wk, d.basalis >37wk and
d.parietalis >37wk. B) Graphs depict percentage of CTLA-4+ (top panels), percentage of GITR+
(middle panels) and Mean Fluorescence Intensity (MFI) of CD39 (bottom panels) within the total
CD4+ cell population and within CD25HI, PD1HI, TIGIT+ and Teff cells of blood, decidua 6-12wk,
d.basalis >37wk and d.parietalis >37wk. (n= 8-12) Bars represent median and interquartile range.
*P<0.05, **P<0.01 and ***P<0.001. Kruskal-Wallis with Dunn’s post-test comparing all decidual
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Supplementary Figure S7. Expression of CTLA-4, GITR and CD39 by Treg. 
Related to Figur  4. (A) Representative histograms of CTLA-4 (top panels), GITR (middle panels) and CD39 (bottom panels) 
within CD25HI, PD1HI, TIGIT+ and Teff cells of blood, decidua 6-12wk, d.basalis >37wk and d.parietalis >37wk. (B) Graphs 
depict percentage of CTLA-4+ (top panels), percentage of GITR+ (middle panels) and Mean Fluorescence Intensity (MFI) 
of CD39 (bottom panels) within the total CD4+ cell population and within CD25HI, PD1HI, TIGIT+ and Teff cells of blood, 
decidua 6-12wk, d.basalis >37wk and d.parietalis >37wk. (n= 8-12) Bars represent median and interquartile range. 
*P<0.05, **P<0.01 and ***P<0.001. Kruskal-Wallis with Dunn’s post-test comparing all decidual fractions (columns B-D) 
to blood (column A) was perf rmed.

CHAPTER 4
Clusters of Tolerogenic B Cells Feature in 
the Dynamic Immunological Landscape 
of the Pregnant Uterus. 
By Marilen Benner, Dorien Feyaerts, Celia Cartagena García, 
Nurcan Inci, Sergi Cedó López, Esther Fasse, Wijs Shadmanfar, 
Olivier W. H. van der Heijden, Mark A. J. Gorris, Irma Joosten, 




Well-timed interaction of correctly functioning maternal immune cells is essential to facilitate 
healthy placenta formation, as the uterine immune environment has to tolerate the semi-
allogeneic fetus, and allow adequate trophoblast invasion. Here, we assess the uterine 
immune signature before and during pregnancy. Extensive supervised and unsupervised flow 
cytometry clustering strategies not only show a general increase in immune memory throughout 
pregnancy, but also reveal a continuous presence of B cells. Contrary to the belief that B cells 
are merely a consequence of uterine pathology, decidual B cells produce IL-10 and are found to 
be localized in clusters, together with Foxp3+ T cells. Our findings therefore suggest a role for B 
cells in healthy pregnancy.
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INTRODUCTION
The uterus is a highly dynamic compartment. Each cycle, in preparation of pregnancy, the 
endometrium undergoes decidualization; a complex process of mucosal differentiation and influx 
of immune cells dictated by changing hormone levels. During the early stages of pregnancy, the 
well-timed presence of correctly functioning maternal immune cells contributing to both correct 
trophoblast invasion of semi-allogeneic fetal cells, and spiral artery remodeling, is essential (1-
4). Impairment in the recruitment, induction, or activation of immune components at the fetal-
maternal interface can be harmful for mother and/or child. Depending on the nature and timing 
of the erroneous interactions, (recurrent) miscarriages, preeclampsia (PE), intra-uterine growth 
restriction or pre-term labor (PTL) may occur (3, 5, 6).
After the initial challenge of implantation, the uterine immune environment faces the task of 
maintaining an anti-inflammatory state (3). Maternal uterine immune cells have to regulate the 
response to local or systemic infections, on the one hand counteracting threats to maternal and 
fetal health while on the other hand preventing a harmful inflammatory cascade. Any disbalance 
in the local immune response during this crucial window of development may affect the unborn 
child, with possible long-term effects on its immunity (7, 8) or cognitive function (9, 10). In 
the last stage of pregnancy, proinflammatory signaling, through infiltration of leucocytes into 
decidua and myometrium, and stimulation of cytokine secretion, facilitates physiologic uterine 
contractions (11). In addition, these adaptations may prepare for wound healing and tissue 
remodeling processes after parturition (12, 13). 
Although knowledge on the chronology of the systemic immune states during pregnancy has 
advanced in recent years, studies on gestational uterine immune cell fluxes are scarce (14, 15). 
Here, we examined local immune cell dynamics throughout human gestation using endometrial 
lymphocytes derived from menstrual blood alongside decidual tissue from 1st and 2nd trimester, 
and term decidua from uncomplicated pregnancies. We provide an overview of lymphocytes 
present within the uterus throughout gestation with a focus on B cells with IL-10 secreting 
capacities. 
RESULTS 
The uterus is a highly dynamic immune compartment
Onset and maintenance of pregnancy elicits both short term, as well as long term adaptations of 
local immunity to facilitate healthy pregnancy. Thus, we assessed the immune cell composition 
in human uterine tissues (menstrual blood and decidua) from the non-pregnant phase, to 1st 
and 2nd trimester, up to term pregnancy by high dimensional immunophenotyping (Figure 1A). 
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Figure 1. The dynamic immune environment of mucosal tissue from menstrual blood to term decidua
(A) Representation of samples chosen and workfl ow to study decidual lymphocytes of varying time points in absence of, and 
during, pregnancy.
(B-D) Frequencies of NK cells (B), T cells (C), and regulatory T cells (D) of single cell suspensions. Gating strategies are 
shown in Figure S1A and B. Peripheral blood (PB) n=20, menstrual blood (MMC) n=20, 1st trimester n=16, 2nd trimester 
n=11, term pregnancy n=9).
(E and F) CD19+ HLA-DR+ B cells could be found in MMC, 1st trimester, 2nd trimester, and term decidua. 
(G and H) Stratifi cation of menstrual blood-derived and lymphocytes based on hierarchical clustering using CD3, CD4, CD8, 
CD14, CD16, CD19, CD25, CD56 and HLA-DR to identify populations of similar marker expression and their abundance 
using the CITRUS tool by Cytobank™. 5000 events (gating strategy Figure S2A) were sampled per fi le and PAM predictive 
clustering was applied to identify clusters contributing to gestational-age dependent, stratifying signatures (model error 
rate is shown in Figure S2B). The color scale illustrates the relative marker expression per cluster while size of each node 
represents event frequency. As an example, CD56 expression is shown (G), super-clusters indicates frequency of each 
marker per cluster (Figure S2C+D). Relative frequency of clusters compared to total lymphocyte count identifi ed as most 
stratifying between menstrual blood, 1st, 2nd trimester and term decidua samples, ordered from A to F decreasing in their 
contribution to stratifi cation (H). Samples <5000 lymphocytes were excluded from analysis (MMC n=20, 1st trimester n=40, 
2nd trimester n=16, term pregnancy n=9).
^ p<0.05, ̂ ^ p<0.01, ̂ ^^ p<0.001 Kruskal-Wallis and post-hoc Dunn’s multiple comparison test to assess difference 
between mucosa and peripheral blood; * p<0.05, ** p<0.01, *** p<0.001 Kruskal-Wallis; to compare menstrual blood 
mononuclear cells, 1st trimester, 2nd trimester and term decidua. Data are represented as mean ± SEM.
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over time, using supervised flowcytometric analysis. For menstrual blood mononuclear cells 
(MMC), we observed that the NK cell abundance (CD45+CD3-CD56+) was relatively higher than 
in peripheral blood (Figure 1B), as previously shown (16, 17). NK cell levels were high in 1st 
trimester decidua, stayed at that level in 2nd trimester and dropped towards term (Figure 1B). 
Independent of the time point of gestation, the majority of the decidual NK cells were negative 
for CD16 and showed high expression of CD56 (NKbright, Figure S1C). Compared to peripheral 
blood, lower T cell (CD45+CD3+CD56-) frequencies were seen in MMC, decreasing further 
in 1st and 2nd trimester decidua (Figure 1C), and increasing again towards term. In MMC, the 
distribution of CD4+ and CD8+ cells within the total CD3+ T cell population was similar to that in 
peripheral blood (Figure S1D). After initiation of pregnancy, within CD3+ T cells, the frequency 
of CD8+ cells increased locally and remained at that level throughout pregnancy. CD4+ T cell 
frequency decreased in 1st trimester decidua (Figure S1D). Overall abundance of CD4+ T cells 
within all CD3+ T cells remained relatively low over the course of pregnancy compared to MMC or 
peripheral blood. Previously, the percentage of naive CD4+ (CD45RA+CCR7+) T cells was shown 
to decrease over the course of pregnancy (Feyaerts et al., 2017). Here, we observed that this 
switch from naive towards a memory/effector phenotype already takes place at the earliest stage 
of pregnancy in 1st trimester decidua (Figure S1E,F). A slight drop in CCR4-CCR6-CXCR3+CD4+ 
T cells (Th1) was observed in 2nd trimester samples (Figure S1G). CCR4+CCR6+CXCR3-CD4+ 
(Th17) decreased from 1st trimester to term (Figure S1G). A prominent role in the delicate balance 
of immunity vs tolerance at the fetal-maternal interface is ascribed to regulatory T cells (Treg (18). 
Compared to peripheral blood, (CD4+Foxp3+Helios+CD25HiCD127low/-, Figure S1H) Treg levels 
in MMC were low. In pregnancy, levels rose gradually from 1st trimester to 2nd trimester, and 
remained at this level up to parturition (Figure 1D). While levels of NKT cells (CD45+CD3+CD56+) 
in MMC were similar to those in peripheral blood, their abundance in decidual tissue was highest 
at term (Fig S1I). Samples of all gestational ages contained a small CD3-CD19+HLA-DR+ B cell 
population (Figure 1E, F). 
To further explore phenotypic features of the different cell populations, we employed an 
unsupervised approach, using the CITRUS (cluster identification, characterization, and 
regression) tool on the Cytobank™ platform. This hierarchical clustering method stratifies cell 
subtypes based on similar descriptive features (i.e. marker expression) that correlate with 
the assigned sample type, in this case, gestational age (19). The six most stratifying clusters 
to predict gestational age are shown in Figure 1G and 1H. Most predictive clusters were 
CD4+ T cells (Cluster A, CD45+CD3+CD4+CD8-), followed by NKbright (Cluster B, CD45+CD3-
CD56+CD16-) cells, CD8+ T cells (Cluster E, CD45+CD3+CD4-CD8+), and regulatory T cells 
(Cluster F, CD45+CD4+CD25HiHLA-DR+). In line with supervised analysis, T cell clusters A, C, 
E, F decreased in frequency of overall lymphocytes from MMC to 1st trimester decidua and 
increased towards term; NK cell clusters (B, D) showed the reverse pattern. Decidual NK cells 
expressing CD25 (Cluster D, CD45+CD3-CD56+CD25+CD16-), an NK cell subtype suspected to 
be upregulated due to trophoblast contact at the fetal-maternal interface (20) was detected. A 
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cluster representing CD45+CD3-CD19+HLA-DR+ B cells was present in both MMC and decidual 
tissue of all gestational ages (Figure 1G). 
Pregnancy is accompanied by a gain in decidual B cell memory
Having established that B cells are present in decidua throughout pregnancy, we investigated 
their phenotype in more detail. Little is known on their phenotype within the uterine mucosa. 
Supervised analysis revealed that similar to peripheral blood, MMC derived B cells were mainly 
naive (IgD+CD27-, Figure 2A). Their frequency was lower upon initiation of pregnancy, and 
further dropped towards the 2nd trimester (Figure 2B). Switched memory B cells (IgD-CD27+) 
increased from MMC throughout gestation (Figure 2C). Abundance of non-switched memory B 
cells (IgD+CD27+) was comparable to peripheral blood and remained steady during gestation 
(Figure 2D). The frequency of plasmablasts (CD27+CD38+/hiIgD-) was low in MMC and 1st 
trimester decidua compared to peripheral blood (Figure 2E). Plasmablast abundance increased 
from MMC to 2nd trimester and term decidua. The overall frequency of B cells positive for CD27, 
a memory marker, increased upon pregnancy (Figure 2F) (21, 22). 














































































































































Figure 2. Differential expression of B cell subsets in samples of decidua 
(A-D) Gating strategy (A) for characterization of naive (B) and switched memory (C) and non-switched memory B cells (D) 
based on IgD and CD27 expression (within B cells, gating strategy Figure S3A) in peripheral blood (PB, n=25), menstrual 
blood (MMC, n=11), 1st (n=39) and 2nd (n=17) trimester as well as term decidua (n=8). 
(E) CD27+IgD- cells were further classified as plasmablasts in case of additional CD38 staining.
(F) CD27 positivity of CD19+ B cells.
^p<0.05, ^^p<0.01, ^^^p<0.001 Kruskal-Wallis and Dunn’s multiple comparison test to assess difference between 
isolated mucosal tissues and peripheral blood; *p<0.05, **p<0.01, ***p<0.001 to compare MMC, 1st trimester, 2nd 
trimester and term decidua. Data are shown as mean±SEM.
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Decidual B cells are distinct from peripheral blood B cells
Recent studies emphasize the diversity in B cell subsets, including populations with regulatory 
capacities (Breg), especially when comparing systemic to tissue-specific immunity (23, 24). To 
gain more in-depth insight in B cell subsets in decidual tissues versus peripheral blood, we 
employed a CITRUS based multidimensional unsupervised clustering analysis. While considered 
a common B cell marker (25), we included CD20 in our clustering analysis for assessment of 
its possible differential expression. The decidual B cell population contained four subsets that 
were absent in peripheral blood (Cluster I-IV, Figure 3A; marker expression 3C,D); cluster I, 
comprising CD24hiCD27+CD38- cells, and cluster II, comprising CD24+CD27+CD38+ cells (cells 
of both clusters were further characterized as IgDlowIgMlowCD20+), cluster III, comprising IgD-
IgMlowCD20-CD24hiCD27-CD38hi cells, and cluster IV, comprising IgD+IgMlowCD20+CD24+CD27-
CD38+ cells (Figure 3A). Cluster III was not observed in term decidua. Two additional clusters 
were more abundant in peripheral blood: cluster V, resembling plasmablasts (IgD-IgMlowCD20-
CD24-CD27hiCD38hi cells) and cluster VI (IgD+IgM+CD20+CD24low CD27lowCD38low cells) (Figure 
3B, marker expression 3C,D). 
Decidual B cells have in vitro IL-10 producing capacity and are found in clusters
Mouse studies revealed a role for regulatory B cells (Breg) in healthy pregnancy (26-28). For 
human B cells, regulatory properties have been ascribed to a number of phenotypically distinct 
B cell subsets, united in their ability to produce IL-10 (29). To examine the presence of possible 
Breg in the different decidual tissues, we performed in vitro stimulation of decidual and peripheral 
blood mononuclear cells (PBMC) in the absence or presence of CpG (TLR9 activation) and 
CD40L (mimicking T cell dependent triggering of CD40) (30, 31). Upon stimulation, higher 
frequencies of decidua derived IL-10 expressing B cells compared to peripheral blood derived 
ones were found (Figure 4 A,B). In the absence of additional CpG and CD40L stimulation, 1st and 
2nd trimester decidua derived B cells already expressed IL-10 (Figure 4C). 
Information on decidual B cell localization is scarce. Immunohistochemical analysis on 1st and 
2nd trimester decidua revealed that B cells were located closely together with T cells (Figure 4D). 
As several studies in humans and mice have pointed out the importance of IL-10 secreting B 
cells for regulatory T cell induction (32-35), we investigated whether these decidual lymphocyte 
clusters also harbored Treg. Additional staining of Foxp3, a key transcription factor of Treg, 
showed the presence of Foxp3+CD3+ T cells in close proximity to the B cells (Figure 4E, S3C). 
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Figure 3. Unsupervised clustering of B cell subsets in decidua
(A and B) Decidual B cells (n=33) were stratifi ed by automatic clustering based on IgD, IgM, CD20, CD24, CD27 and CD38 
expression using the CITRUS tool by Cytobank™ and compared to peripheral blood (PB, n= 25). 246 B cells as gated in 
Figure S3A for each sample were used as input. A minimum cluster size of 2% was handled. Clusters of signifi cantly higher 
(I-IV, A) or lower (V and VI, B) expression in decidua compared to peripheral blood are shown and abundance was separated 
into the individual gestational time points. Abundance depicts number of cells within a cluster divided by the total number 
of cells per sample. Samples of <200 B cells were excluded (1st trimester n=16, 2nd trimester n=13, and term n=4). Data 
are represented as mean±SEM.
(C) Clustering tree depicting relation of identifi ed clusters. The color scale illustrates relative marker expression per cluster 
while size of each node represents event frequency. As an example, CD38 expression is shown (remaining markers Figure 
S3B). 
(D) Marker expression of each subset in relation to overall expression. 
^p<0.05, ^^p<0.01, ^^^p<0.001 Kruskal-Wallis and Dunn’s multiple comparison test; *p<0.05, **p<0.01 to 
compare 1st trimester, 2nd trimester and term decidua. Data are represented as mean±SEM.
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Figure 4. B cells in decidua secrete IL-10 
(A) Representative gating strategy for assessment of intracellular IL-10 in peripheral blood and decidual B cells. Live, CD19+
events were selected. For each IL-10 assessment, a fl uorescent minus one (FMO) strategy (using a staining mix excluding IL-
10) was applied to cells subjected to the identical conditions for correct positioning of the gate selecting IL-10 positive cells. 
(B) 50.000 mononuclear cells were stimulated for 24h with 5µg/ml CpG and 1µg/ml CD40L, or (C) in absence of stimulation 
(peripheral blood, PB n= 7, 1st trim. n=15, 2nd trim. n=9). 
(D) Representative immunohistochemistry of 10 week decidua stained for CD19 (brown) and CD3 (red) of decidual 
lymphocyte clusters (n=8 in 3 biological replicates, 9wk-14.5wk). Original magnifi cation x40, scale bar (black) indicating 
200µm. 
(E) Representative 4-color multiplex staining of 10 week decidua. Original magnifi cation x20, scale bar (white) indicating 
50µm.
(F) Schematic representation summarizing co-localization of B and T cells. Decidual B cells are able to secrete IL-10, with 
possible impact on regulatory T cell maintenance and thus healthy pregnancy. 
PIB, PMA+ionomycin+Brefeldin A. Treg, regulatory T cell. **p<0.01 Kruskal-Wallis and Dunn’s multiple comparison test for 
comparison of PB, 1st trimester and 2nd trimester decidua. Data are shown as mean±SEM.
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DISCUSSION
Pregnancy poses an immunological challenge as semi-allogeneic fetal cells have to invade 
maternal tissue for correct placenta formation. Here, we provide an overview of the dynamic 
changes in lymphocyte subsets, shaping the gestational immune environment. We highlight 
a possible role for decidual B cells, whose potential contribution to healthy pregnancy is just 
starting to be considered. Our data reveal that B cells undergo phenotypic adaptations in the 
decidual tissues over time, which may be regarded as a physiologic component of healthy 
pregnancy. 
The possible relevance of B cells for healthy pregnancy is gaining attention (36). In mice, it was 
shown that the lack of mature B cells is associated with reduced litter size, decreased size of the 
embryos and higher susceptibility to prenatal infections (35). In women with common variable 
immunodeficiency, a condition associated with reduced frequencies of switched memory B cells 
in peripheral blood (37), an elevated risk for preterm birth or other pregnancy complications, 
such as PE, stillbirth or vaginal bleeding was observed (38). Recurrent miscarriage (39, 40) 
and PE (41) was also linked to alterations in the induction of B cell memory. Although there is 
no consensus regarding frequencies of systemic B cell subsets in pregnant women, healthy 
pregnancy, especially in its final stages, was consistently shown to be marked by a decrease in 
absolute numbers of circulating B cells (42-46). This may be explained by a decrease in B cell 
lymphopoiesis, as was shown in mice during gestation (47, 48), but it may also be due to a (re)
distribution to local sites. Our observation that naive B cells in early decidual tissues increase in 
abundance and switch to a memory phenotype could be an indication that redistribution occurs.
The question is, what purpose do these decidual B cells serve? Although there are indications 
that B cells may contribute to the inflammation required for the onset of labor (49), decidual 
B cells may well serve an additional purpose. By supervised and unsupervised analysis, we 
observed high frequencies of CD24hiCD27+ (cluster I) and CD24hiCD38hi (cluster III) B cells in 
1st and 2nd trimester decidua, cell types associated with IL-10 producing capacity, a cytokine 
involved in immune regulation (24). In our hands, decidual B cells produced IL-10, more than 
peripheral blood B cells, and even without prior in vitro stimulation. The latter may suggest 
that decidual B cells already received the necessary activation in utero. Unsupervised analysis 
revealed that these cell clusters, together with two additional clusters expressing CD24 and CD38 
(clusters II and IV) are unique for decidua and not present in peripheral blood. These cells might 
represent a specialized tissue-resident B cell subset or they may be induced de novo through 
local interaction with fetal cells. Indeed, recent in vitro experiments point out that trophoblast cells 
have the capacity to upregulate IL-10 in B cells, underlining the impact of fetal cells on B cell 
stimulation during the peri-implantation period (50). Likewise, upon in vitro stimulation, especially 
B cells derived from 1st trimester decidua produced IL-10. This might support the notion that B 
cell mediated IL-10 production is induced relatively early on in gestation, shortly after primary 
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encounter with invading fetal trophoblast cells. So far, there is only scant availability of data 
regarding decidual IL-10 expression in vivo (51). Also, in our hands, using immunohistochemistry, 
in vivo IL-10 producing B cells were not readily detectable. Indeed, IL-10 staining in tissues poses 
a technical challenge; IL-10 has a short half-life, it is rapidly secreted, and in vivo secreted levels 
in the local micro-environment, although functionally relevant, may likely be too low to yield 
positive staining results (52). While unsupervised clustering of decidual B cells did not show 
significant differences in subsets between 1st and 2nd trimester, less IL-10 production upon in vitro 
stimulation of decidual immune cells was observed in 2nd trimester. It may be possible that the 
potency of IL-10 production declines independent from the unchanged phenotype. 
CD20 is a well-known marker expressed by multiple B cell subsets, amongst which are B cells 
with regulatory function (53). Of note, unsupervised analysis showed that the most abundantly 
expressed B cell populations lacked CD20. Hasan and colleagues showed the diverse 
heterogeneity of marker expression by Breg, but unfortunately, they did not include CD20 in 
their study (24). While the biological function of CD20 remains poorly understood, future studies 
might benefit from considering CD20 as differentially expressed marker. 
We found that decidual B cells colocalized with T cells, similar to what has been described for 
non-pregnant endometrium (Yeaman et al., 1997). This colocalization supports the possibility 
of a functional interaction that may go both ways: T cell derived cytokines may facilitate the 
induction of Breg (Rosser et al., 2014), whereas in turn, through the production of IL-10, Breg 
may contribute to the induction of Foxp3+ Treg (34, 53, 54). In decidua, we detected Foxp3+ 
T cells in clusters of lymphocytes, closely located to B cells. In healthy individuals, peripheral 
blood Breg convert effector T cells to Treg through IL-10 production, and inhibit development of 
naive T cells towards Th1 or Th17 cells (34), thereby mediating suppression in case of a local 
inflammatory reaction (54). It is thus tempting to speculate that the IL-10 secreted by nearby 
B cells contributes to placental Treg induction and maintenance; these latter cells are well 
recognized for their contribution to successful pregnancy (55, 56). So, besides the idea that 
colocalization of decidual T and B cells is a phenomenon exclusive to pathologies (57), the 
interaction between Breg and T cells may just as well contribute to the required homeostasis and 
the tight regulation needed for healthy placentation, while preserving immune competence at the 
fetal-maternal interface. Unfortunately, the low amount of B cells that can be isolated per sample 
restricts experimental possibilities to assess their suppressive capacity on T cells. Even though 
their contribution in numbers within decidual lymphocytes is small, we propose that their effect 
might be amplified through close proximity and effect on T cells and possible Treg induction 
(Figure 4E). 
In conclusion, the current study highlights the complex dynamics of the human uterine immune 
landscape, including B cells with the potential to contribute to the immune-regulatory environment 
of the uterus during pregnancy. 
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MATERIALS AND METHODS 
Experimental model and subject details 
Peripheral blood was collected from 36 healthy female volunteers (mean age 22.8 years ± 3.4 
years). Exclusion criteria were smoking, chronic disease, medication, carrier of an infectious 
disease and pregnancy. Menstrual blood was provided by 28 healthy women (exclusion 
criteria: known fertility disorder, potential carrier of an infectious disease, auto-immune disease, 
drug abuse, or use of hormonal or intra-uterine device contraceptives) with regular menstrual 
cycle. First and 2nd trimester material was obtained from discarded placental and decidual 
tissue upon elective pregnancy termination of healthy women at a local reproductive health 
clinic. No additional data other than gestational age at time point of termination was acquired. 
Exclusion criteria were carrier of an infectious disease (active systemic infection), suspected 
to be a potential carrier of an infectious disease or an increased risk for infection (HIV, Hep 
B/C, HTLV or similar), auto-immune diseases, drug abuse, intoxication with heavy metals or 
pesticides. Term placental tissue (>37weeks gestation) was collected from planned cesarean 
section following uncomplicated pregnancy. Exclusion criteria were gestational age <37 weeks, 
use of immunosuppressive drugs, biological or antidepressants, HIV positivity, active infection 
during caesarean section, signs of infection (maternal fever or signs of intrauterine infection), 
use of antibiotics prior to caesarean section. All gestational samples were assessed visually 
and excluded for processing in case of signs of infection (discoloration) or excessive blood 
clots. Written informed consent was obtained for all volunteers donating blood or tissue for this 
study in accordance with the Dutch Medical Research Involving Human Subject Act (WMO). The 
study was approved by the local review board (Commissie Mensgebonden Onderzoek region 
Arnhem-Nijmegen, 42561.091.12, 2017-3253, 2014-232, 2009/004). An overview of all study 
participants is given in Supplemental Table S1. The amount of individual participants included 
per experiment is indicated in the according legend as the amount of cells isolated per sample 
limited the number of experiments carried out simultaneously. 
METHOD DETAILS
Sample collection 
Peripheral blood was collected using EDTA tubes. For menstrual blood, women were asked 
to use a menstrual cup (Femmecup Ltd, London, UK) and collect its content every 12h during 
the first 36h after initiation of menstruation. Contents of the cup were poured in a 30 ml tube 
containing 10 ml of supplemented RPMI 1640 medium (1 mM pyruvate, 2 mM glutamax, 100 
U/ml penicillin, 100 µg/ml streptomycin (all Thermo Fisher Scientific Waltham, USA) 0.3% v/v 
sodium citrate (Merck Darmstadt, Germany) 10% v/v human pooled serum; HPS, manufactured 
in-house) for storage at room temperature until processing. After collection, menstrual blood 
samples were transferred to the lab immediately to undergo processing within max. 24h. First 
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and second trimester tissue was transported to the lab at room temperature and processed 
immediately upon arrival. 
Cell isolation 
Flow cytometry staining was performed on either whole blood or, for Treg staining, on isolated 
mononuclear cell populations. Peripheral blood mononuclear cells were isolated from whole 
blood based on density gradient separation (1.077 ± 0.001 g/ml, 290 ± 15mOsm, Lymphoprep, 
Axis-Shield, Oslo, Norway). Menstrual blood mononuclear cells were isolated following an 
established protocol (58, 59). This protocol typically results in cell viability of ~96%. In brief, 
menstrual blood was washed with PBS (Braun, Melsungen, Germany) and filtered (70µm cell 
strainer Falcon®, Corning Inc., NY, USA) to remove clots or excess mucus. A granulocyte depletion 
cocktail RosetteSep™ (Stemcell technologies Inc, Vancouver, Canada) was used according 
to manufacturer’s instructions. After sterile density gradient centrifugation (Lymphoprep™), 
menstrual blood mononuclear cells (MMC) were collected. First and 2nd trimester decidual 
leucocytes were isolated from maternal mucosal tissue that was carefully selected during 
visual assessment of the individual tissue pieces. Villous tissue, blood clots, glands and areas 
of blood infiltration were discarded. At these early stages of gestation, the selected pieces of 
membrane do not contain fused fetal membranes yet. Tissue pieces were minced mechanically 
using scissors and washed in PBS until the supernatant became transparent. For cells used for 
phenotyping, tissue was transferred to c-tubes (gentleMACS system) for additional mechanic 
processing using a MACS dissociator (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) 
prior to incubation with Accutase (Stempro, Gibco Life Technologies, Waltham, USA) in a 1:2 
tissue to enzyme ratio; a gentle dissociation method to preserve marker expression (60). For 
B cell assays, washed tissue was digested using 0.2% collagenase (Gibco Life Technologies, 
Waltham, USA) and 0.04% DNAse (Roche Diagnostics, Risch-Rotkreuz, Switzerland). Tissue 
digestion was performed in a shaking water bath at 37 °C for 45 minutes. After digestion, the 
solution was filtered through 100µm, 70µm and 40µm cell strainers consecutively. Lymphocytes 
were obtained through density gradient centrifugation by diluting the washed filtrate in 20 mL 
1.023 g/ml Percoll (GE Healthcare, Little Chalfont, UK) to be layered on gradient of 10 mL 
1.080 g/ml and 15ml 1.053 g/ml Percoll (centrifugation for 25min at 2000rpm). Large cells 
accumulating at the 1.053 – 1.023 g/ml interface were discarded and decidual leucocytes were 
isolated from the 1.080 – 1.053 g/ml interface. Leucocytes were washed twice in RPMI before 
further use. For term decidua, decidua parietalis was separated from the two fetal layers. The 
amnion was removed prior to scraping decidua parietalis from the chorionic membrane. After 
this, the isolation procedure was identical to that of 1st and 2nd trimester.
Flow cytometry staining and analysis 
For whole blood staining, 25ml red blood cell lysis buffer [NH4CL + KHCO3/ Na4EDTA (Merck, 
Darmstadt, Germany) diluted in H2O (Versol, Lyon, France)] was added to 1ml of peripheral blood 
for 10 min, and washed 3times with PBS. A minimum of 200.000 cells was used for staining with 
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fluorochrome-conjugated monoclonal antibodies (moAbs) of interest for 20 min at RT in the dark. 
For Treg subset characterization and chemokine markers assessment a minimum of 500.000 
mononuclear cells were used; 50.000 for intracellular cytokine assessment. For intracellular 
staining, fixation and permeabilization was carried out according to manufacturer’s instructions 
(eBioscience, San Diego, USA). IL-10 detection was preceded by incubation with Fixable Viability 
Dye-eFluor 780/Krome Orange (eBioscience) in PBS for 30min at 4 °C in the dark. Samples were 
measured using a 10-color NaviosTM flow cytometer (Beckman Coulter, Fullerton, CA, USA). For 
manual gating, data were analyzed using Kaluza V2.1 (Beckman Coulter). Gates were set based 
on isotype controls and a fluorescent-minus-one strategy. Locations of gates were fixed except 
for CD3/CD56 based selection of NK cells as shown in Supplemental Figure S1. A detailed 
gating strategy for the various cell subsets and tissue types is shown in Figure S1B. 
CITRUS clustering
For unsupervised analysis, manually gated lymphocytes (Figure 1) or CD3 negative lymphocytes 
(for B cell analysis in Figure 3) were extracted (plug in provided by Beckman Coulter) before 
further processing using the web-based analysis platform Cytobank (http://cytobank.org/)
(61). Lymphocytes and CD19+ B cells, respectively, were chosen as input population. Files 
were assigned to the appropriate gestational-age group, i.e. menstrual blood, 1st trimester, 2nd 
trimester and term. Unsupervised clustering of lymphocyte and B cell frequencies was performed 
using the CITRUS tool. Clustering was performed based on abundance with a minimum cluster 
size of 2% of total cells and a false discovery rate of 1%. For B cell clustering, samples of less 
than 200 B cell events were excluded from analysis (lowest amount of events included was 246). 
Clustering was analyzed with prediction analysis for microarrays (PAM), a predictive model to 
identify features determining gestational age-dependent variation.
B cell stimulation assays 
50.000 peripheral blood mononuclear cells or decidual lymphocytes were cultured in the 
presence or absence of CpG (5µg/ml) and CD40L (1µg/ml) stimulation, in 10% HPS culture 
media (RPMI 1640 medium supplemented with 1 mM pyruvate, 2 mM glutamax, 100 U/ml 
penicillin, and 100 µg/ml streptomycin) in a 96-well U-bottom plate for 24h at 37°C in a humidified 
5% CO2 incubator. Phorbol-12-myristate-13-acetate (PMA, 50 ng/ml) and ionomycin (1 ug/ml) 
were added for the final 5h and brefeldin A (5µg/ml; Sigma-Aldrich, St. Louis, USA) for the final 2h 
of incubation. IL-10 expression of viable B cells was measured by flow cytometry as described. 
Immunohistochemistry 
Tissue samples were fixed in neutral buffered 4% formalin (Mallinckrodt Baker Inc, Deventer, The 
Netherlands) for 4h, transferred to 70% ethanol before preparation in a Tissue-Tek VIP tissue 
processor for embedding in paraffin. Slides were deparaffinized in xylene before rehydration, 
washing in tap water and boiling in Tris-EDTA buffer (pH 9, Klinipath). 6 µm sections were stained 
for either IHC or IF staining. For IHC staining, antibody binding was visualized by diaminobenzidine 
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(Thermo Scientific) or Poly-HRP-goat-anti-mouse/rabbit/rat IgG (BrightVision, Duiven, the 
Netherlands) with permanent red. IHC staining was assessed microscopically (AxioImager M2; 
Zeiss, Sliedrecht, the Netherlands) and sections were photographed using a high resolution color 
camera for bright field microscopy (AxioCam 105 color, Zeiss). Images were assessed using 
ZEN blue edition version 2.3 (Zeiss). For IF staining, visualization was performed using the Opal 
seven-color IHC Kit (Akoya Biosciences) on the BOND RX IHC & ISH Research Platform (Leica 
Biosystems). All staining cycles contained heating steps in between cycles. Tissue sections were 
counterstained with DAPI and mounted in Fluoromount-G (SouthernBiotech). Images of stained 
slides were acquired using the Vectra (Vectra 3.0.4, PerkinElmer) and exported with inForm 
software (Version 2.4.8, Akoya Biosciences). All staining Abs are listed in order of application in 
Supplemental Table S2. 
Quantification and statistical analysis
All statistical analysis was performed using GraphPad Prism 5 (La Jolla, CA, USA). All values 
represent mean percentages ± SEM (error bars). Kruskal-Wallis and post-hoc Dunn’s multiple 
comparison test (non-parametric) were performed to assess differences between mucosal 
isolates compared to peripheral blood as well as when assessing differences between mucosal 
tissues. Details on sample size and statistical outcomes can be found in the respective figure 
legends. 
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Supplemental Figure S1. Gating strategies and frequencies of menstrual blood and decidual tissue 
derived lymphocyte frequencies assessed by manual analysis. Related to Figure 1. 
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(A) Gating strategy to select lymphocytes as starting population of all samples used. 
(B) Representative flow cytometry plots to assess general lymphocyte composition of single cell suspensions based on 
CD3/CD56 expression resulting in frequencies of total NK cells, T cells, and NKT cells. 
(C) NK cells separated in NKbright and NKdim subsets based on CD16 expression. 
(D) CD4/CD8 expression within all CD45+CD3+ lymphocytes. 
(E +F) Naive and effector memory (EM) cells of all CD4+ lymphocytes. 
(G) T cells with CCR4-CCR6-CXCR3+, CCR4+CCR6-CXCR3+ and CCR4+CCR6+CXCR3- profile. representing respectively T 
helper 1, T helper 2 and T helper 17 cells 
(H) Gating strategy to assess regulatory T cells. 
(I) Frequencies of NKT cells. 
Except for the depicted gates of CD3/CD56 expression, gate settings across tissues were identical and representative plots 
show cell distribution within these gates as frequency of parent population. PB, peripheral blood; MMC, menstrual blood 
mononuclear cells; 1st, first trimester decidual lymphocytes; ^ p < 0.05, ^^ p < 0.01, ^^^ p < 0.001 Kruskal-Wallis 
and post-hoc Dunn’s multiple comparison test (non-parametric) to assess difference between isolated mucosal tissues and 
peripheral blood; * p < 0.05, *** p<0.001 Kruskal-Wallis and post-hoc Dunn’s multiple comparison test (non-parametric) 
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Supplemental Figure S2. CITRUS modelling of general decidual lymphocyte assessment. Related to 
Figure 1. 
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(A) Gating strategy preceding unsupervised clustering. 
(B) Cross-validation error rate of the nearest shrunken centroid predictive association model. Predictive group  assignment 
based on automatic feature generation using CD3, CD4, CD8, CD14, CD16, CD19, CD25, CD56 and HLA-DR expression 
data of menstrual blood mononuclear cells (n=18), first trimester (n=18), second trimester (n=10), and term (n=12) 
decidua. 5686 events were clustered at a minimum cluster size of 2% of all events. 
(C) Clustering tree illustrating the relationship between nodes after hierarchical clustering. The color scale shows marker 
expression per cluster while size of each node represents event frequency. 
(D) Cluster-specific expression of the individual markers. 
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Supplemental Figure S3. Details of decidual B cell analysis. Related to Figure 3 + 4. 
(A) Flow cytometry gating strategy to select B cell population within all samples. Gate positions were not changed except 
for stringent selection of CD3- and CD19+ events only. 
(B) Unsupervised analysis of peripheral blood vs decidual B cells Marker expression of clusters identified by unsupervised 
analysis of IgD, IgM, CD20, CD24, CD27 and CD38. Color scales illustrates the relative marker expression per cluster while 
size of each node represents event frequency.
(C) Single components of multiplex assay. Representative example of individual components of CD3 (red), CD19 (yellow), 
and Foxp3(green). Original magnification x20, scale bar indicates 100µm. 
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Total subjects (n)4 36 28 69 27 12
Age at delivery (years)
Mean (SD) 22.7 (3.4) 29.5 (6.9) Anonym. Anonym. 32 (3.6)
Range 19 - 32 19 - 44 Anonym. Anonym. 28 - 39
Duration gestation (weeks)
Mean (SD) NA NA 7.7 (2.0) 14.8 (1.1) >37
Range NA NA 4.7 - 12.9 13.0 - 17.3 NA
1includes 6 anonymous donors, 2includes 7 anonymous donors, 3includes 4 anonymous donors, 4samples used per 
experiment listed in according figure legends as not all samples could be used for multiple stainings




A combination of immune cell types 
identified through ensemble 
machine learning strategy 
detects altered profile 
in recurrent pregnancy loss
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The underlying cause of recurrent pregnancy loss (RPL) remains largely unknown. As successful 
implantation and placentation depends on a tightly regulated immune response to facilitate 
adequate interaction with trophoblast cells, dysregulation of immunity might account for idiopathic 
RPL. So far, studies focusing on single parameter analysis did not allow for clear classification 
of immunity in women with RPL versus healthy pregnancies. We here defined immune profiles 
in peripheral blood (PB) as well as menstrual blood (MB), a source of endometrial cells, of 
RPL patients and compared them to those of women with healthy pregnancies. Frequencies 
of 63 immune cell types defined by flow cytometry were included in the analysis, next to age 
and CMV status. By harnessing the combined value of 8 machine learning classifiers in an 
ensemble strategy and recursive feature selection, we were able to determine a combination 
of immune parameters that separated RPL from controls. In PB, the combination of four cell 
types (non-switched memory B cells, CD8+CD4-T cells, CD56bright CD16- Natural Killer (NKbright) 
cells, CD4+ effector T cells) classified samples correctly to their respective cohort. The identified 
classifying cell types in PB differed from the results observed in MB, where a combination of 6 
cell types (Ki67+CD8+ T cells, (HLA-DR+) regulatory T cells, CD27+ B cells, NKbright cells, Treg 
cells, CD24HiCD38Hi B cells) plus age allowed for assigning samples correctly to their respective 
cohort. This unbiased phenotyping approach focusing on immune profiles rather than single 
parameters might be of promising diagnostic value and deserves further large-scale validation. 
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INTRODUCTION
Only 30% of recognized pregnancies progress from conception to live birth (1). Spontaneous 
pregnancy loss poses a great medical and emotional burden. One to 2% of women suffer from 
recurrent pregnancy loss (RPL), defined as the consecutive loss of two or more pregnancies 
before 20 weeks gestation (2, 3). In absence of embryonal chromosome abnormalities, fractions 
of RPL can be attributed to genetic (2-5%), anatomic (10-15%) endocrine (17-20%) or autoimmune 
related factors (20%), but over 40% of cases remain unexplained (4, 5). These unexplained 
cases may be linked to an inadequate maternal immune response during key processes of 
implantation and placentation at the fetal-maternal interface (6-8). As the mechanisms behind 
this dysregulation are unknown, it is unclear whether they are contained to the uterus or manifest 
systemically. 
Most investigations to identify dysregulation of immunity in RPL have focused on specific immune 
cell populations isolated from peripheral blood (PB). This sample source is readily available to 
study large populations and, due to its limited invasiveness, allows inclusion of large control 
cohorts. Altered levels of circulating T (helper) cell profiles, regulatory T cells (Treg) and ratios of 
Natural Killer (NK) cell subsets were observed in RPL patients but none of these cell types were 
observed individually at levels that allowed robust distinction from women without pregnancy 
complications (9-13). Large variance, due to inter-populational differences, the time point of 
sampling or the measurement itself, and the complexity of relationships between immunological 
parameters hamper detection of cohort differences by commonly applied univariate approaches 
(14). Furthermore, it has to be considered that endometrial and decidual immune cells are 
highly specialized to enable adequate interaction with trophoblast cells, through mechanisms 
independent from PB derived cells (15-19). Consequently, PB cannot serve to detect dysregulation 
of uterine immunity (20). Menstrual blood (MB) offers non-invasive access to uterine immune 
cells that display tissues-specific markers and NK cell profiles characteristic to decidua (21-26). 
This non-invasive sample source is only limitedly investigated until now, yet allows large scale 
studies to understand reproductive disorders. 
Here, we assessed immunophenotypic profiles of peripheral and menstrual blood using an 
ensemble machine-learning strategy. This approach enabled unbiased multivariate detection of 
immunological differences in women suffering from RPL. 
CHAPTER 5112
RESULTS
As immune responses are never limited to a single cell type, minor changes in frequency of a 
specific subset can affect neighboring cells through cell contact or secretion of soluble factors. 
While a subtle change in numbers or characteristics of a given immune cell population might fall 
within a physiological range, hampering its detection, machine learning can identify a change in 
overall patterns and the underlying cell types involved. To collect a dataset suited for multivariate 
analysis, we established a phenotypic flow cytometry-based overview of immune cell frequencies 
(Figure 1A) of PB and MB (n=15, n=18, respectively) of women who suffered from at least two 
consecutive unexplained miscarriages (patient characteristics, Table 1). The analysis covered 
total leucocyte populations, T, B, and NK cell subsets using five established staining panels 
(27)(Supplementary Table 1). In total, 63 immune subsets, age and CMV status were assessed, 
which results in 65 features that are taken into account for further analysis (Supplementary 
Figure S1, Supplementary Table 2). Data were compared to a control cohort, of women with 
uncomplicated pregnancies (PB, n=13; MB n=14). We used machine-learning based cohort 
classification to identify immune cell subsets that discriminate RPL from control, based on either 
MB or PB profiles. To achieve this, we employed an ensemble strategy as it allows for robust 
feature selection in a low sample size setting (28). Through combining 8 distinct classification 
algorithms, the ensemble overcomes any possible bias of its individual classification algorithms 
(Lopez-Rincon et al. 2019; Lopez-Rincon et al. 2020). The outcome of the individual algorithms 
were weighted and combined into a single ensemble ranking (29). The 80% top features of this 
list were then used to run the individual algorithms, including 10-fold cross-validation to ensure 
generality of the results, and the average classification accuracy is calculated. By repeatedly 
reducing the list of top-contributing features by 20%, the optimal number of features to achieve 
robust classification was determined (Figure 1B). With this approach, we identified that a 
combination of 4 cell types for PB (non-switched memory B cells, CD8+CD4-T cells, NKbright 
cells, CD4+ effector T cells; Figure 1C left panel, Supplementary Figure 3), and 6 cell types for 
MB (Ki67+CD8+ T cells, HLA-DR+ Treg, CD27+ B cells, NKbright cells, Treg cells, CD24HiCD38Hi 
B cells; Figure 1C right panel, Supplementary Figure 3), together with age, allowed for optimal 
classification as RPL versus control. After determination of the features used for classification, 
the individual classifying algorithms were run using the respective immunological parameters. 
This resulted in a maximum average area under the curve (AUC) of 0.82 ± 0.23 for PB, and 0.90 
± 0.17 for MB when analyzed by PassiveAgressive Classifier (Figure 1D), with an accuracy of 
0.87 ± 0.16 and 0.84 ± 0.14, respectively (Supplementary Table 3). 
Reducing the number of features included in a multivariate approach allows for more robust 
outcomes as features of high variance, with minor distinctive value, can be excluded. However, this 
approach might mask notable differences of an individual feature, as only the most contributing 
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node in a network of related variables is considered. Thus, we additionally assessed all studied 
features by classical bivariate analysis. No differences in total leucocyte populations or frequently 
studied T helper cell subsets were detected (Supplementary Figure S3). Whereas no altered NK 
cell subset frequencies were observed in PB of RPL patients, MB revealed decreased fractions 
of NKbright cells, and an increased percentage of CD16+CD56+ NKdim cells (Figure 2 A,B). 
Table 1. Cohort characteristics. 
Control RPL
PB n 13 15










MB n 14 18










^Information NA for one donor, ^^ three, or ^^^ four donors. RPL: Recurrent pregnancy loss. PB: peripheral blood, 
MB: Menstrual blood.
Latent cytomegalovirus (CMV) infection is known to selectively affect expansion of leucocyte 
subsets, especially regarding subsets of NK cells, T cells and B cells (30-33). Of all assessed 
features, a difference based on CMV status was only observed for CD27+ B cells in MB of RPL 
patients (Figure 2C). RPL patients who were CMV seropositive showed highest frequencies of 
CD27 expressing B cells. 
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Peripheral blood Menstrual blood
Figure 1. Machine learning approach using ensemble strategy to determine immune features that identify 
patients of recurrent pregnancy loss (RPL).
(A) Schematic representation of study design. A flow cytometry based dataset was established to describe the immune 
profile of systemic or uterine immunity, through leucocyte isolation from peripheral blood (PB) or menstrual blood (MB), 
respectively. (B) Number of feature combinations yielding optimal classification accuracy. Eight machine learning classifiers 
were used to established a ranked list of top features that were recursively reduced. Accuracy is depicted as average and 
standard deviation of 10 runs. (C) Heatmap of the features allowing for optimal accuracy regarding data from PB (left panel) 
or MB (right panel). (D) Receiver operating characteristics (ROC) curve showing the average area under the curve (AUC) 
using PassiveAgressive classifier of PB (left panel) and MB derived immune features (right panel) after stratified 10-fold 
cross-validation. ROC curves of the remaining classifiers are depicted in Supplementary Figure S2. 
























































































Figure 2. Univariate analysis of immune profi ling shows uterine-specifi c deviations in RM patients. 
(A+B) NK cell profi les of peripheral blood (PB) and menstrual blood derived cells (MB). (C) Cytomegalovirus (CMV) 
seropositivity of CD27+ B cells. Additional results of univariate analysis are depicted in Supplementary Figure S3. Data 
were compared by Mann-Whitney/Wilcoxon tests (non-parametric), * p < 0.05, ns= non-signifi cant. Ctrl, control; RPL, 
recurrent pregnancy loss. 
DISCUSSION
Adaptations of the maternal immune system during pregnancy occur not only systemically, but 
also locally, where immune cells and soluble factors contribute to the contact of trophoblast 
cells and the maternal mucosa. Subtle changes in immunological profi les of both compartments 
may contribute to the etiology of recurrent pregnancy loss. To create a better understanding of 
dysregulated immunity in RPL, we assessed in how far the joint assessment of leucocyte subsets 
might reveal differences in PB or MB of affected women. By using an ensemble machine learning 
strategy and recursive feature selection, we were able to identify 4 cell subsets of PB and 6 cell 
subsets and age for MB, which, when combined, robustly allowed for cohort classifi cation for 
either PB or MB. Based on general defi nitions describing the discriminative power of a diagnostic 
test, both PB and MB had “excellent” distinctive value (34, 35). Thus, RPL is associated with 
immune adaptations that can be traced back systemically and in the uterus. 
Classic univariate approaches often do not suffi ce when studying immunological data (14). 
Large overlap between frequencies in RPL and control cohort measured in PB and MB hampers 
the individual discriminative value of a cell type. Furthermore, differences in cell types of low 
CHAPTER 5116
abundance and high variation are challenging to detect through univariate analysis but could 
be revealed using the presented approach. As the differences in AUC of the different individual 
classifiers show, algorithms of multivariate approaches also present with varying power to 
classify a sample to its cohort. The ensemble machine learning strategy overcomes the bias 
associated with choosing a single machine learning algorithm. 
The power of combining classifiers, even in this low sample size setting, allowed to detect the 
discriminative value of low frequency cell types in MB that have a possible regulatory phenotype. 
CD8+ T cells positive for Ki67 (indicating proliferation) were identified as most classifying feature in 
MB samples. In healthy pregnancy, decidual CD8+ T cells are known to take longer than systemic 
cells to initiate proliferation upon stimulation, possibly through interaction of their coinhibitory 
molecules with the decidual microenvironment (36). Also involved in local regulation (19, 37-39), 
altered levels of Treg (overall cell population and HLA-DR+), and CD24HiCD38Hi B cells contributed 
to robust RPL classification, fitting with the theory that pregnancy is negatively affected when 
local mechanisms of tolerance fail (40, 41). This focus on immune regulatory subsets was not 
observed in PB, except for NKbright cells, which contribute to cohort classification in both PB and 
uterine samples. Of note, age contributed as risk factor in uterine, but not systemic, immunity. 
The observed differences in classifying leucocyte subsets, depending on the sample source, 
affirm that systemic and local immunity of reproduction demand independent consideration. 
Circulatory non-switched memory B cells contributed strongly to cohort classification of PB, 
which is in line with previously shown higher levels of circulatory non-switched memory B cells of 
RPL patients (13, 42). The presented data highlight that B cells deserve consideration in context 
of RPL. Memory B cells are altered in many autoimmune diseases such as systemic lupus 
erythematosus, systemic sclerosis, and antiphospholipid syndrome, known to be associated 
with poor reproductive outcome (43). B cell-related pregnancy complications might also result 
from incorrect activation through soluble factors that regulate B cell activity, as serum from 
women suffering from spontaneous abortion failed to induce normal levels of IL-10 production 
by B cells (44). Of note, we observed higher levels of CD27+ B cells in CMV seropositive RPL 
patients. It has previously been shown that CMV affects frequencies of CD27+ memory B cells 
in women, but not men (45). Thus, CMV status is important to include in similar approaches 
studying leucocytes due to its known effect of selectively expanding specific subsets (30, 33). 
RPL is a multifactorial condition (46). Small sample size is a limitation of the current study, as 
we cannot take into account subgroups of different in disease etiologies. Nevertheless, we were 
able to show that investigating a immunity by multivariate approach in RPL is worthwhile. The 
applied flow cytometry-based profiling of MB holds the possibility to detect locally involved 
rare cell types (47-50). Compared to the trending, high-dimensional approaches using mass 
spectrometry or single-cell sequencing, flow cytometry is relatively cheap to perform and thus 
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allows analysis of large cohorts. More women suffering from RPL have to be enrolled to account 
for the heterogeneity of this cohort. Combined with inclusion of a validation cohort, this will ensure 
generality of results to enable translation towards diagnostic tests. This is of special interest 
for RPL, a condition that not only needs proper diagnosis, but would benefit from repeated 
sampling in order to assess the success of intervention strategies. To both ends, classification 
needs to be robust and accurate, and deserves further assessment. 
Taken together, RPL patients present with a dysregulated immune environment, systemically 
and within the uterus. Cohort classification of possible diagnostic value cannot rely on individual 
immune cell frequencies but rather depends on a combination of immune cell subsets. The non-
invasive source of menstrual blood, allowing to investigate important regulatory mechanisms, 
holds many opportunities for the assessment and monitoring of reproductive health. 
MATERIALS AND METHODS 
Sample collection 
Peripheral and menstrual blood was collected from women without known disorders of 
reproduction, with regular menstrual cycles, and women suffering from recurrent pregnancy loss 
(RPL). Characteristics of women included in this study are documented in Table 1. Exclusion 
criteria were autoimmune diseases, smoking and current use of an intra-uterine device or 
hormonal contraceptives. 10 ml of PB was collected in ACD-A tubes. Women used a menstrual 
cup (Femmecup Ltd, London, UK) for 3 12h intervals during the first 36h of menstruation. 
Menstrual effluent was collected in supplemented RPMI 1640 media (pyruvate (1 mM), glutamax 
(2 mM), penicillin (100 U/ml), streptomycin (100 µg/ml) (all Thermo Fisher Scientific, Waltham, 
USA), 10% human pooled serum (HPS, manufactured in-house), and 0.3% sodium citrate (Merck, 
Darmstadt, Germany) for storage at room temperate until processing. Samples were transferred 
to the lab for immediate processing, within max. 24h after the last collection. Written informed 
consent was obtained for all volunteers in accordance with the Dutch Medical Research Involving 
Human Subject Act (Commissie Mensgebonden Onderzoek Arnhem-Nijmegen, Nr 2017-3256). 
Leucocyte isolation
Leucocytes from PB were isolated through density gradient centrifugation (Lymphoprep, Axis-
Shield PoC AS, Oslo, Norway). MB was processed as described previously (25, 37). Briefly, 
menstrual blood derived cells were obtained after granulocyte depletion using RosetteSep 




For surface staining, a minimum of 250.000 PB or MB was stained using fluorochrome-
conjugated monoclonal antibodies (moAbs) for 20min at room temperature in the dark. An 
overview of all moAbs used is shown in Supplementary Table 2. Staining of intracellular moAbs 
was performed with a minimum of 500.000 cells. Samples were fixed and permeabilized 
according to manufacturer’s instructions (eBioscience, San Diego, USA). Flow cytometry data 
were analyzed using Kaluza (Beckman Coulter, v2.1). Gate settings (Supplementary Figure S1) 
were based on a fluorescence minus one strategy. Isotype controls were applied. 
Data analysis
Data were processed using R v.4.0.2 and the ggpubr, ggplot2, ggsignif, tidyr packages. Non-
parametric Mann-Whitney test was used. Values of p <0.05 were considered statistically 
significant. An ensemble feature selection was used to detect of features allowing for cohort 
classification. This strategy was previously designed and validated to overcome the bias of using 
a single machine-learning algorithm, thus allowing for a more robust selection of classifying 
features (29, 51). Eight classifiers (Bagging, Gradient Boosting, Logistic Regression, Passive- 
Aggressive regression, Random Forest, Ridge regression, SGD (Stochastic Gradient Descent 
on linear models), SVC (Support Vector Machines Classifier with a linear kernel) classifier) were 
run in 10-fold and used to score features on their importance for classification. Scoring of the 
individual algorithms was combined in an ensemble ranking: for Bagging, Gradient Boosting 
and Random Forest analysis that work with classification trees, features of the trees’ splits were 
counted and ranked by frequency; for PassiveAggressive, Logistic, and Ridge regression, SGD, 
and SVC classifier feature importance was assigned by the coefficients’ value associated with 
each feature. The ranking of each classifier was scored based on times it appeared within the 
top classifying features. A detailed description of the ranking used for the ensemble strategy 
has previously been presented (29). To reduce the number of features to the ones that allow for 
optimal classification, classifiers were run repeatedly with the top 80% features in a recursive 
feature selection approach. All classifiers were subjected to stratified 5-and 10-fold cross-
validation. Having determined which features allow for the most robust classification, the set of 
parameters was used to run the individual classifying algorithms, combined with 10-fold cross-
validation. 
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Supplementary Figure 1. Flow cytometry gate settings for features included in analysis. 
(A) Overall leucocyte subsets. (B) B cell subsets and (C) T cells subsets are shown on the following pages. An overview of 
all included leucocyte subsets is shown in Supplementary Table 2. 
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B
IMMUNE PROFILES IDENTIFY RECURRENT PREGNANCY LOSS 125
5
C
Supplementary Figure 1. Continued
CHAPTER 5126
A 
Supplementary Figure S2| Receiver operating characteristic curve of the individual classifiers based on features 
selected by the ensemble approach. (A) Results for peripheral blood derived mononuclear cells (PBMC), (B) 
menstrual blood derived mononuclear cells (MBC) on next page. 
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Supplementary Figure S2. Receiver operating characteristic curve of the individual classifiers based on 
features selected by the ensemble approach. 
(A) Results for peripheral blood derived mononuclear cells (PBMC), (B) menstrual blood derived mononuclear cells (MBC) 
on next page. 
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Supplementary Figure S2 continued| Receiver operating characteristic curve of the individual classifiers based on 
features selected by the ensemble approach. 
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Supplementary Figure S3. Univariate analysis of immune cell subsets of leucocytes isolated from 
peripheral blood (PB) and menstrual blood (MB). 
Continued on following pages. Data were compared by Mann-Whitney/Wilcoxon tests (non-parametric), * p < 0.05, ns= 
non-signifi cant. Ctrl, control; RPL, recurrent pregnancy loss.  
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Supplementary Figure S3. Continued
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Supplementary Table 1. List of monoclonal antibodies used in 5 panels.  
Antibody Producer Catalogue #
CD3-ECD Beckman Coulter A07748
CD3-PB Beckman Coulter B49204
CD45-KO Beckman Coulter B36294
CD45RA-ECD Beckman Coulter B49193
CD45RA-FITC Beckman Coulter A07786
CD4-AF700 eBioscience 56-0049-42
CD4-PE-Cy.5.5 Beckman Coulter B16491
CD56-APC Beckman Coulter IM2474
CD5APCAF700 Beckman Coulter A78835
CD8-APCAF700 Beckman Coulter B49181
CD8-APCAF750 Beckman Coulter A94683
CD8-ECD Beckman Coulter 737659
CD14-ECD Beckman Coulter B92391
CD16- FITC Beckman Coulter B49215
CD19-APCAF750 Beckman Coulter A94681
CD20-PB Beckman Coulter B49208




CD27-PE-Cy5.5 Beckman Coulter B21444
CD38-PC7 Beckman Coulter B49198









HLA-DR- PE Beckman Coulter IM1639
HLA-DR-PE Beckman Coulter IM1639
IFN-y-PC7 eBioscience 25-7319-82
IgD-FITC Southern Biotech 2032-02
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Supplementary Table 3. Average accuracy of individual classifiers, upon 10-fold cross-validation.
Peripheral Blood Menstrual Blood
Average SD Average SD
SGDClassifier 0,9 0,15 0,84 0,11
SVC(linear) 0,83 0,22 0,9 0,08
LogisticRegression 0,83 0,22 0,85 0,09
PassiveAggressive Classifier 0,87 0,16 0,84 0,14
GradientBoosting Classifier (n_estimators=300) 0,72 0,21 0,62 0,08
RandomForest Classifier (n_estimators=300) 0,75 0,17 0,64 0,21
RidgeClassifier 0,87 0,22 0,81 0,19









How uterine microbiota might be responsible 
for a receptive, fertile endometrium 
By Marilen Benner, Gerben Ferwerda, Irma Joosten, 
and Renate G. van der Molen. 




Fertility depends on a receptive state of the endometrium, influenced by hormonal and anatomical 
adaptations, as well as the immune system. Local and systemic immunity is greatly influenced by 
microbiota. Recent discoveries of 16S rRNA in the endometrium and the ability to detect low-biomass 
microbiota fueled the notion that the uterus may be indeed a non-sterile compartment. To date, the 
concept of the “sterile womb” focuses on in utero effects of microbiota on offspring and neonatal 
immunity. However, little awareness has been raised regarding the importance of uterine microbiota 
for endometrial physiology in reproductive health; manifested in fertility and placentation.
Objective and rationale
Commensal colonization of the uterus has been widely discussed in the literature. The objective 
of this review is to outline the possible importance of this uterine colonization for a healthy, 
fertile uterus. We present the available evidence regarding uterine microbiota, focusing on recent 
findings based on 16S rRNA, and depict the possible importance of uterine colonization for a 
receptive endometrium. We highlight a possible role of uterine microbiota for host immunity and 
tissue adaptation, as well as conferring protection against pathogens. Based on knowledge of 
the interaction of the mucosal immune cells of the gut with the local microbiome, we want to 
investigate the potential implications of commensal colonization for uterine health. 
Methods
PubMed and Google Scholar were searched for articles in English indexed from January 1st, 
2008 to March 1st, 2018 for “16S rRNA”, “uterus” and related search terms to assess available 
evidence on uterine microbiome analysis. A manual search of the references within the resulting 
articles was performed. To investigate possible functional contributions of uterine microbiota to 
health, studies on microbiota of other body sites were additionally assessed. 
Outcomes
Challenging the view of a sterile uterus is in its infancy and, to date, no conclusions on a “core 
uterine microbiome” can be drawn. Nevertheless, evidence for certain microbiota and/or associated 
compounds in the uterus accumulates. The presence of microbiota or their constituent molecules, 
such as polysaccharide A of the Bacteroides fragilis capsule, go together with healthy physiological 
function. Lessons learned from the gut microbiome suggest that the microbiota of the uterus may 
potentially modulate immune cell subsets needed for implantation and have implications for tissue 
morphology. Microbiota can also be crucial in protection against uterine infections by defending their 
niche and competing with pathogens. Our review highlights the need for well-designed studies on 
a “baseline” microbial state of the uterus representing the optimal starting point for implantation and 
subsequent placenta formation. 
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Wider implications
The complex interplay of processes and cells involved in healthy pregnancy is still poorly 
understood. The correct receptive endometrial state, including the local immune environment, 
is crucial not only for fertility but also placenta formation since initiation of placentation highly 
depends on interaction with immune cells. Implantation failure, recurrent pregnancy loss, and 
other pathologies of endometrium and placenta, such as pre-eclampsia, represent an increasing 
societal burden. More robust studies are needed to investigate uterine colonization. Based on 
current data, future research needs to include the uterine microbiome as a relevant factor in 
order to understand the players needed for healthy pregnancy. 
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INTRODUCTION 
Maternal microbial colonization contributes to development of the unborn child by micronutrient 
provision, xenobiotic metabolism and enhancing maternal energy conversion (1). Currently, the 
concept of the “sterile womb”, the paradigm that the fetus grows up in a sterile environment, 
is highly debated (2). If bacteria (or their compounds) were naturally present in the uterus, their 
role even before pregnancy, in maintenance of the uterus deserves attention. Various recent 
reviews focused on correlations between commensal uterine colonization, fertility problems and 
pregnancy complications (3-6).
Bacteria are known to affect immunity (7, 8). If they already impact the immune environment of the 
uterus before pregnancy, this would greatly impact the receptive potential of the endometrium, as 
well as the ability to correctly initialize placenta formation. Successful embryo implantation requires 
both a synchronous development and an intricate interplay between the hatched blastocyst and 
endometrium. This depends on a receptive state of the endometrium. In the first week after 
fertilization, the blastocyst makes initial contact with the highly specialized endometrium. During 
the female cycle, if the endometrium fails to undergo the proper adaptations to acquire this 
receptive state, infertility and impaired placentation may be the consequence. Since bacteria can 
play a role in morphological changes of, for example, mucosal cells, implications of microbiota 
in decidualization can be envisioned. At the same time, commensal microbiota may convey 
protection towards pathogenic species contributing to uterine health. 
Studies evaluating the endometrial microbiome and its role in fertility are limited and therefore we 
depend on extrapolating knowledge from other colonized body sites. A vast number of studies 
focusing on the gut microbiota have pointed out the contribution of microbes to immunity and 
development, and the necessity of commensal colonization to achieve a basal, healthy immune 
state (7, 9, 10). We hypothesize that, if indeed present, the endometrial microbiome or its 
compounds can have implications for (pre-) decidualization, and therefore fertility. The objective 
of this review is to outline the available evidence regarding uterine microbiota, focusing on recent 
findings based on 16S rRNA, and to depict the possible importance of uterine colonization for a 
receptive endometrium. We aim to highlight a possible role of uterine microbiota in host immunity 
and tissue adaptation, as well as conferring protection against pathogens. 
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THE NON-STERILE UTERUS? 
Microbiota and mammals depend on their symbiotic relationship. While microbes receive a 
steady nutrient supply through the host, the host benefits from vital contributions of the microbe 
to physiological processes such as epithelial homeostasis, and is supplied with a natural barrier 
against colonization by pathogenic species (11, 12). Bacterial colonization also plays a crucial 
role in modulation of host immunity. Metagenomic analysis has propelled research on natural 
colonization of the human body forward, revealing microbiota at body sites that were previously 
considered to be sterile. This includes the upper reproductive tract and placenta, challenging 
the classic dogma of a ‘sterile womb’ as coined by Henry Tissier more than a century ago (13). 
Due to the earlier limitations in microbial characterization and challenges in sample acquisition, 
the significance of endometrial bacteria may have been missed or overlooked (14). Now, 
increasing evidence in favour of an endometrial microbiome (15-23) and a placental commensal 
colonization (24, 25) indicates the need for a paradigm shift. 
The endometrium: An immunologically suited niche for microbiota 
In the gut, the intestinal immune system needs to be highly adapted to withstand the continuous 
threat posed by colonization of the large mucosal surface, separated from host tissue by only a 
single layer of epithelial cells (26). In a symbiotic colonization, bacterial growth is safe for the host 
as long as it is contained within an assigned compartment. Therefore, tissue invasion must be 
limited, thus preventing potentially harmful inflammation or disruption of the niche for the necessary 
symbiotic relationship. Hooper and Macpherson (26) described three types of immunological 
barriers needed for intestinal microbial homeostasis: anatomically limiting exposure of resident 
bacteria to the systemic immune system; immune mediators restricting direct contact between 
epithelia and microbes; and rapid detection and killing of bacteria upon barrier breach. All three 
pre-requisites are met by the endometrial mucosa. In the uterus, the single layer of columnar 
epithelial cells that proliferate to form glandular cells in the secretory phase of the menstrual 
cycle forms a strong barrier through tight junctions (27). The uterine mucosal surface and the 
endometrial fluid (EF) contain infection-controlling molecules, known as antimicrobial peptides 
(AMPs), with fluctuating levels during the menstrual cycle (28). AMPs are known to contribute 
to the health of the female reproductive tract with implications for fertility and pregnancy (29). 
An example of an AMP found in the uterus is the secretory leukocyte protease inhibitor, which 
has antiviral and antifungal properties, and also acts as a bactericidal against gram-negative 
as well as gram-positive bacteria such as Escherichia coli and Staphylococcus aureus (30). 
Furthermore, the endometrial lymphocytes in the mucosal layer are present throughout all stages 
of the menstrual cycle, ready to act upon pathogen invasion (31). Therefore, according to the 
required properties, the uterus could offer a safe niche for symbiotic colonization. 
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Assessing commensal uterine colonization
Not only theoretically does the endometrium offer an environment suited for co-existence with 
bacteria but also, in accordance with earlier hypotheses, such as Viniker’s theory of the “bacteria 
endometrialis” inhabiting the uterine cavity (14), various approaches have now provided evidence 
for uterine colonization, as outlined below. Initial assessment of endometrial colonization was 
based on observations of cells in culture. It has long been thought that the few observed 
growing species from endometrial cultures after hysterectomy resulted from the sterile character 
of the uterus, and the bacteria that were found were ascribed to a pathogenic condition (32, 
33). However, women with no sign of infection also showed some bacterial growth in samples 
maintained in vitro. Species such as Lactobacillus (34, 35), Gardnerella vaginalis, Enterobacter, 
and Streptococcus agalactiae (33), Escherichia coli and Enterococcus faecalis were typically 
found in patients with uterine pathologies, such as endometritis (36). Other studies used catheter 
tips that were used in embryo transfer for microbial assessment based on culturing. Bacterial 
growth was associated with outcomes of IVF treatment, with varying results. If bacterial growth 
was observed upon culturing the catheter tips used for embryo transfer during IVF, live birth 
rates were found to be either decreased (37-40), increased or not affected at all, depending on 
the study or bacterial species cultured (41, 42). This underlines the need to carefully assess the 
outcomes and limitations of such an approach, as discussed below. However, even if smears 
led to growing cultures, pregnancy was possible (e.g. clinical pregnancy rate 28% versus 17% 
in the positive culture group, n= 279) (38). Also, using isolates other than from catheter tips, 
endometrial colonization could be shown for asymptomatic as well as symptomatic women (43-
45). Taken together, microbial presence could not be ascribed to a certain pregnancy outcome 
based on culture-dependent methods.
 
As we now know, culture-dependent characterization of microbial communities is associated 
with limitations (Supplementary Table I). In culture-based approaches, rapidly growing, aerobic 
species dominate, leaving rare species that demand specific culture conditions undetected 
(e.g. (46, 47). Molecular approaches allow detection of species that will not be revealed by 
culture-dependent techniques. Mitchell and colleagues examined uterine swabs and EF from 
hysterectomies by quantitative PCR (qPCR) for 12 bacterial species, including Atopobium 
vaginae, Prevotella spp., Lactobacillus crispatus, Lactobacillus iners, G. vaginalis, and bacterial 
vaginosis-associated bacterium 1 (BVAB1) (48). All of the selected species could be detected in 
vaginal samples and to a varying extent in the endometrium. Clear differences could be found 
between vaginal and endometrial samples. While A. vaginae was more commonly detected in 
vagina, L. iners and BVAB1 were more likely to be detected in endometrial samples. Of note, 
95% of hysterectomy samples showed the presence of bacterial DNA. Also based on selected 
targets, Swidsinski and colleagues used fluorescent in-situ hybridization probes for G. vaginalis, 
A. vaginae, Lactobacillus, Bacteroides, Prevotella, Enterobacteriaceae, and Eubacteria (49). 
Again, the endometrial microbiotic environment was shown to be different than that of the 
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vagina. However, the need of these studies to select specific probes targeting a certain species 
is intrinsically biased. 
Rather than evaluating the presence and/or abundance of a certain species, amplicon 
sequencing of the hypervariable 16S region of the ribosomal RNA makes it possible to identify 
species present in a sample (50). The metagenomic molecular approach of high-throughput 16S 
rRNA sequencing allows for a more complete view, reflecting the diversity and relative abundance 
of microbiota. However, also this technique comes with its limitations as outlined below. While 
shotgun whole genome sequencing (WGS) offers advantages to amplicon 16S sequencing (51, 
52), as yet this approach has not been employed to study endometrial microbiota. 
Evidence of endometrial microbiota by 16S sequencing 
In the Human Microbiome Project (HMP), efforts are made to understand more about the natural 
colonization of various body sites, its physiological importance and implications for disease 
(53). In the context of the HMP, data on gut and vaginal colonization increase, but the upper 
reproductive tract has not been characterized extensively yet (54). However, the importance of 
microbiota for human reproduction is increasingly acknowledged (55). Recently, several studies 
targeted a putative endometrial microbiome through 16S rRNA sequencing, and each of the 
studies documented the presence of uterine microbiota (15-23). An overview of these recent 
studies assessing human uterine microbial composition based on 16S rRNA sequencing is 
given in Table I. Tips used for embryo transfer, swabs, biopsies or aspirates were employed 
to obtain endometrial samples. The studies used next-generation sequencing and assigned 
the sequence reads to different operational taxonomic units (OTUs). Phylotypes or, depending 
on the fit against the database used for taxonomic annotation, genotype or species could be 
assigned to the 16S rRNA gene amplicon sequence. Depending on the study, varying 16S rRNA 
regions were targeted simultaneously, since depending on which hypervariable V1 to V9 region 
is targeted, more differentiation at genus or species level is possible (56). Alpha (within a subject) 
and beta (between different subjects) diversity were assessed using different diversity indices 
(Hugerth and Andersson,2017). One of the classifications often used to express alpha diversity 
and species richness (i.e. how different species are sequenced in total) is the Shannon Diversity 
Index. Another often-used index is Chao1, using rare classes of OTUs (e.g. Franasiak et al.,2016; 
Moreno et al., 2016). Beta diversity is often expressed through the Bray-Curtis dissimilarity (e.g. 
Walther-Antonio, et al.,2016). Taxonomic distribution profiles of identified genera or species are 
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Franasiak and colleagues characterized the endometrial microbiome of 33 women by collecting 
material from the tip of the catheter used for embryo transfer (ET) during ART (57). Both in 
the group of non-ongoing and ongoing pregnancies, Lactobacillus and Flavobacterium were 
identified as the most abundant genera. However, in this initial study only women undergoing 
ART for unspecified reasons were included. Therefore, it is unclear to what extent these findings 
represent the colonization of a healthy, fertile endometrium. The same holds true for the study 
by Tao and colleagues (22) assessing the microbiota obtained from catheter tips during ET 
of 70 women. Lactobacillus was abundantly detected (>90% of OTUs in 33 women, >70% in 
50 women). Samples also frequently contained Corynebacterium (40 women), Staphylococcus 
(38 women), Streptococcus (38 women) and Bifidobacterium (15 women). To achieve reliable 
sequencing results, particular attention was given to sample preparation, as sampling using 
remaining tissue from catheter tips only yields ultra-low bacterial cell counts. The authors were 
able to reliably determine bacterial abundance when more than 60 bacterial cells were present 
per sample, although no estimation was given of how many cells the catheter tips likely contain. 
Verstraelen and colleagues identified Bacteroides as the dominant genus, present in >90% of 
the women that were included. All women underwent hysteroscopy in the absence of uterine 
anomalies (16). Again, the cohort of women employed sought medical help due to recurrent 
implantation failure (RIF) or recurrent pregnancy loss. Twelve of the 19 women included showed 
75% similarity in bacterial composition (Bray-Curtis dissimilarity of 24.6%, range 13.2 – 34.3%) 
due to general high abundance of Bacteroidetes and Proteobacteria taxa. Next to this core 
of Bacteroidetes and Proteobacteria, five women also presented with L. iners (n=2) , P. amnii 
(n=1) or L. crispatus (n=1) as the most abundant species. Large dissimilarities were observed 
in two women (79.0 and 90.7% Bray-Curtis dissimilarity) showing Prevotella spp. or L. crispatus 
dominance, which the authors ascribe to possible contamination from the vagina. Control swabs 
from the vagina could have given an indication if the distinctive microbial profile of these women 
indeed reflected an artifact from the transcervical sampling approach but no such data are 
available. 
In a study focusing on the relation of endometrial polyps to local microbiota, Fang et al. 
included 10 fertile women as a control population in their 16S analysis of transcervical uterine 
swabs. Proteobacteria, Firmicutes, and Actinobacteria were consistently found at phylum level; 
Enterobacter, Pseudomonas, and Lactobacillus at genus level. Moreno and colleagues (2016) 
were also able to include fertile women (n=13 for comparison of vaginal aspirates and EF, n=22 
for compositional differences between pre-receptive and receptive phase) of reproductive age 
(19). Lactobacillus (71.1%), Gardnerella (12.6%), Bifidobacterium (3.7%), Streptococcus (3.2%), 
and Prevotella (0.9%) were the most identified genera. Endometrial microbial composition 
was categorized into either Lactobacillus-dominated (>90% Lactobacillus spp.) versus non-
Lactobacillus dominated (>10% bacteria other than Lactobacillus, such as A. vaginae, G. vaginalis, 
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species of the genera Clostridium, Megasphaera, Parvimonas, Prevotella, Sphingomonas or 
Sneathia). Eighteen of the 22 women presented with stable microbiota profiles when comparing 
pre-receptive and receptive phase, of which 12 women were continuously categorized in the 
Lactobacillus-dominated group, and six women categorized in the non-Lactobacillus group 
independent from sampling time point. This indicates that bacterial community composition was 
relatively stable in most women. Contradictory to the results by Franasiak et al. (2006), Moreno 
et al. (2016) found an association between Lactobacillus abundance and pregnancy outcome. 
Implantation was decreased (23.1% versus 60.7%), and pregnancy rates declined (13.3% versus 
58.8%) when the women showed a non-Lactobacillus dominated endometrial phenotype at 
the time of ET. An especially negative impact on reproductive outcome was observed when 
G. vaginalis and Streptococcus species were present in abundance. These results were 
independent of pH of the sample, known to be affected by Lactobacillus species (58). 
Unlike the other transcervical sampling approaches, Walther-Antonio et al. (2016) studied 
samples taken from the uterus, Fallopian tubes, and ovaries removed during hysterectomy 
(n=31), in addition to pre-operative vaginal and cervical swabs and scrapes. Their results 
showed Shigella and Barnesiella as dominant species of the endometrial microbiome in 
accordance with earlier culture-based observations (36). High abundance of Staphylococcus, 
Blautia and Parabacteroides was found in benign uterine conditions (n=10), and Bacteroides, 
and Faecalibacterium were associated with women who presented with cancer as reason for 
hysterectomy (n=17). Miles and colleagues (2017) also took samples from various tissue types 
obtained during hysterectomy. Their data on 10 women, comprising a wide range of uterine 
pathologies, shows high variability. Species such as Lactobacillus, Acinetobacter, Blautia, 
Corynebacterium and Staphylococcus were abundantly found in some of the women. The 
authors also note that even after various attempts, no sequencing data could be obtained 
for endometrium from a patient with atrophic endometrium. Similarly, Chen and colleagues 
investigated the microbiota of different sites of the female reproductive tract accessed through 
surgery (23). Tissue was obtained during laparoscopy or laparotomy, therefore not reflecting 
healthy, fertile women of reproductive age but the patients enrolled had conditions known not to 
involve infection. In these conditions, Lactobacillus, Pseudomonas, Acinetobacter, Vagococcus, 
and Sphingobium were frequently detected. 
When evaluating the results of the recent 16S endometrial studies, certain species were found 
in more than one study (Table I). Some of the described findings are addressed in two recent 
reviews (4, 59), neither including a concluding summary of the species found in the different 
studies, nor a meta-analysis. 
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MICROBIOTA IN THE UTERUS - REAL OR ARTIFACT? 
Until now, available 16S data on uterine microbiota do not allow conclusions on a “core uterine 
microbiome” due to a number of limitations. When investigating the questioned low-biomass 
microbiome, studies need to be designed with a special focus on possible contamination. In the 
following paragraph, we outline the pitfalls of the presented studies. 
Contamination acquired during sample acquisition and processing 
It is currently highly debated whether microbiota found to be involved in reproduction, such 
as in the placenta, are in fact merely the result of contamination and an artifact of the study 
design (60). Contamination always has to be a concern when studying 16S data. Especially 
when investigating a suspected low-biomass microbiome, as found within the uterus, the impact 
of various (contaminating) handling steps makes it hard to detect low-abundance microbes 
originating only from the sampling site (61-63). To overcome the hurdles associated with the need 
for highly sensitive detection, the 16S studies on endometrial colonization employed different 
controls (Table I). To examine the possible contribution of contamination when studying the 
placenta, Lauder and colleagues examined the results from “air swabs” waved in the laboratory 
space, as well as unused sterile swabs, in comparison to placental tissue samples (64). They 
could not distinguish between contamination controls and placental samples. Compositions of 
microbiota in negative controls are known to be associated with the DNA extraction kits (65). 
Misrepresentation of data needs to be minimized by using special DNA isolation kits for low 
microbial biomass samples and committing to one kit type for all samples (65). 
Low-biomass microbial communities are sensitive to contamination and 
misinterpretation 
Lauder et al. suggest the presence of a placental microbiome below their level of detection as a 
reason for not being able to distinguish between air swabs and sampled material (64). Detection 
of a low-biomass microbiome (where for 1g of placental tissue only 20 – 2000 ng of bacterial 
DNA is estimated to be extracted) is a major issue when assessing endometrial microbiota (66). 
Chen et al. included an assessment of the bacterial biomass in their approach. Copy numbers, 
as calculated from qPCR on vaginal typical Lactobacillus species, were related to the relative 
abundance of the species as found in 16S rRNA sequencing, showing that microbial numbers 
decrease from vagina (1010 – 1020copies/sample) through the cervix (108 – 1010copies/sample) 
to the uterus (102 – 103copies/sample) (23). As the authors point out, this still represents higher 
numbers than those that can potentially be detected in background noise (62) or in their controls 
of sterile PBS, sterile saline, and ultrapure water. Accordingly, even though the detected biomass 
is small, the detected species are not an artifact or contamination.
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Another source of misinterpretation that is gaining attention is the approach in which species 
distribution is related to the obtained sequencing library. Disease-associated changes in 
Prevotella and Bacteroides abundances found in Crohn’s disease were found to be rooted 
in proportional profiling and had to be ascribed to a general decrease in microbiota richness 
in Crohn’s disease (67). If abundance is interpreted as a relative proportion, a change in the 
presence of a certain species presents as increase or decrease of a possibly unrelated species. 
Low-biomass microbiota, as detected in the uterus, are highly sensitive to this misrepresentation 
of data. A quantitative assessment of genus abundance proportional to cell counts and microbial 
load of the sample would allow a more precise representation of data (67).
Vaginal microbiota as a source of contamination
Due to its high biomass relative to the uterine microbiome and the high abundance of Lactobacillus 
in the vagina, misrepresentation of species distribution cannot be excluded. Especially when 
using a transcervical approach, contamination by vaginal bacteria needs to be controlled for. 
Moreno and colleagues compared endometrial and vaginal samples, and only two of the 26 
sample pairs (two pairs per woman) of EF and vaginal aspirate showed the same microbial 
profile (19). While in some samples only minor differences were observed, six paired samples 
exhibited totally different profiles when women belonged to the group of non-Lactobacilli 
dominated subjects. In nine of the 13 women, Lactobacillus consistently reflected the dominant 
genus with more than 90% colonization in the pre-receptive and receptive phase of endometrium 
and vagina. Notably, some common species, such as A. vaginae, G. vaginalis, Prevotella, and 
Sneathia, of both endometrium and vagina were identified. Also, the study that circumvented this 
risk, by sampling from uteri obtained during hysterectomy, showed a correlation between the 
vaginal and uterine microbiomes (20). However, it is unclear how the uterine microenvironment 
is contaminated by transfer of cervicovaginal bacteria into the excised uterus. As manipulation 
of the uterus during surgery might enable passage of bacteria from the lower reproductive tract, 
it cannot be excluded that the correlation of vaginal and uterine microbiota is just an artifact. 
This correlation was also seen by Verstraelen et al. (2016), who detected endometrial phylotypes 
known to be associated with the vagina. L. crispatus was present in 12 of the 19 women, and most 
abundant in five of 19 individuals (range from 17.1% to 79.1% of the total number of sequence 
reads). Also, species associated with vaginal microbiota imbalance, such as Prevotella (P. amnii, 
Prevotella sp., P. timonensis, P. disiens), were abundantly expressed in two subjects (18.4% and 
55.4% of total sequence reads) (47, 68, 69). Likewise, G. vaginalis was present in six women, 
but at an abundance of less than 1%. While trying to avoid vaginal contamination through the 
use of a sheath-protected sampling surface and trying to prevent cervicovaginal contact of the 
sampling tool, it cannot be excluded that insertion or extraction of the device facilitates bacterial 
carry-over. Verstraelen et al. pointed out that, even though a certain degree of species overlap 
exists, it is not to be assumed that endometrial samples reflect vaginal colonization, since the 
diversity found in endometrial samples is higher than in the vagina (16). 
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While we believe that it is unlikely that the distribution profiles from endometrial swabs are merely 
a representation of vaginal colonization, the possibility of carrying over traces from vaginal 
microbiota onto the sample cannot be neglected. Likewise, insertion of a sampling device 
or speculum could carry over bacteria from the lower reproductive tract into the uterus. It is 
also unclear how surgical access of the uterus coincided with disruption of the cervical barrier 
allowing passage of bacteria that would normally not reside in the uterus as a result of the pre-
operative preparation. 
Live bacteria?
It cannot be ignored that, without further measures, sequencing of 16S rRNA does not differentiate 
between living bacteria or (dead) bacterial fragments. Chen et al. studied cultures of freshly 
collected peritoneal fluid samples from the Pouch of Douglas (the lowest part of the abdominal 
cavity, between uterus and rectum), a site shown to be similar in microbial diversity, and even 
lower in terms of microbial abundance, as compared to the endometrium (23). Eight different 
isolates were cultured belonging to seven genera, such as Lactobacillus, Staphylococcus, 
and Actinomyces, in five out of 15 samples, whereas various negative controls did not lead to 
bacterial growth when cultured. These results indicate that the detected 16S reads do not solely 
reflect dead bacterial fragments. 
Conclusions on the validity of the current evidence
Based on the current study designs, no information on bacterial detection and distributions of 
a “core uterine microbiome” can be extracted. Contamination during sampling by surrounding 
microbiota and reagent kits have not been addressed systematically on a large cohort of healthy, 
fertile women yet, in order to allow any conclusions on the continuous baseline colonization of the 
uterus independent of pathologies. Future studies also need to address the question of whether 
detected 16S results from bacterial fragments rather than live organisms by using a more robust 
approach than culture in vitro since (even though proving that culture is not impossible) often 
no growth can be established in cases of these ultra-low biomass samples. The variability in 
culturing success probably also results from variation between women in species composition 
and biomass of live bacteria. Aside from this, even 16S rRNA data, reflecting a proportion of the 
overall community that is dead or fragmented, represent ligands for the host cells to recognize 
and act upon. Thereby, these inactive bacterial fragments can still contribute to a physiologic 
interaction with host cells.
We conclude that well-setup large cohort studies are needed to define a healthy uterine 
microbiome. We want to stress that even though no uterus-typical bacterial profile can be 
established yet, existing data are not to be underrated as evidence towards a natural microbial 
presence within the uterus. A number of the presented studies do employ negative controls 
and/or additional vaginal swabs. Since species abundance of these controls was not identical 
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to the results from endometrial material, we should consider a physiological importance of local 
microbiota. 
ENDOMETRIUM – STARTING POINT FOR DECIDUALIZATION, 
IMPLANTATION AND PLACENTATION 
To understand how microbiota could play a role in the uterine interplay of cells involved in the 
per-implantation period, we first need to understand how the endometrium forms the basis for 
successful implantation and placentation. Despite the growing interest from both clinicians and 
scientists in the process of implantation, the mechanisms underlying human implantation remain 
poorly understood. Each month, before the presence of a developing embryo, the stage for 
formation of the placenta is set. During the mid-to-late luteal phase spontaneous decidualization 
occurs; i.e. the transformation of the endometrium into a receptive state, independent of the 
presence or absence of a conceptus. Six to 10 days after ovulation (during day 19-24 of the 
menstrual cycle) the receptive state of the endometrium is shaped. This is referred to as ‘the window 
of implantation’ (WOI), lasting for 2-4 days (70, 71). The substantial physiological adaptations 
needed for correct cyclical changes of the endometrium are orchestrated by fluctuations of 
progesterone and oestrogen (72, 73), as well as by immune cells and their products (74, 75). 
Endometrial stromal fibroblasts differentiate to become larger, rounded fibroblast-like stromal 
cells. To achieve this, the cytoskeleton and plasma membrane undergo modifications (76-78). 
The luminal epithelium must be able to interact with the blastocyst. Interactions also involve 
adhesion molecules, such as integrins, L-selectin ligands (e.g. L-selectin ligands expressed by 
the luminal epithelium and L-selectin receptors of the blastocyst), and oligosaccharides (79-82). 
We summarized key endometrial adaptations in the peri-implantation period (Figure 1) to show 
the importance of enabling the correct interaction of endometrium and blastocyst. 
Already at this stage, irreversible shortcomings in placental vascularization pose an origin 
for diseases such as pre-eclampsia or intra-uterine growth restriction (83). On the maternal 
side, the underlying mechanisms regulating correct migration of the trophoblast and vascular 
remodeling may be rooted in the endometrium. Due to its importance for correct placentation, 
the endometrium is crucial for developing a healthy placenta, and therefore a healthy pregnancy 
(84). If microbial compounds constitute another physiologic player in the complex uterine 
environment, its natural impact will likely also contribute to implantation and placentation. 
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Possible impact of microbiota on various levels?
Figure 1. Illustration of key elements in blastocyst-endometrium interaction needed for a receptive 
endometrium. 
Due to its important contributions during early placentation, the endometrium is key to healthy pregnancy. During the window 
of opportunity, day 19-24 of the menstrual cycle, the endometrium resides in a receptive state that allows selection, apposition 
and attachment of a healthy blastocyst. Implantation is marked by invasive growth and differentiation of trophoblast cells. 
Proper interaction of invading trophoblast and local immunity is needed to achieve correct villi development and a healthy 
placenta. All these highly regulated properties of the endometrium needed in the initial phase of pregnancy are possibly 
affected by uterine microbiota. IVS , intervillous space; uNK, uterine natural killer cell.
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UTERINE IMMUNITY DURING IMPLANTATION AND PLACENTATION AS A 
POSSIBLE INTERACTION PARTNER OF LOCAL MICROBIOTA 
Local immune cells belong to the factors known to influence extravillous trophoblast migration, 
and are therefore instrumental to maternal spiral artery remodeling (85). The immune system 
is intimately involved in all aspects of the reproductive process, particularly around the time 
of conception, and in the peri-implantation period (86). Different stages during the initiation of 
pregnancy hold specific immunologic challenges: to enable a healthy pregnancy, the maternal 
immune system must support the introduction of semen to allow fertilization, the initial contact of 
blastocyst and endometrium, and correct formation of the placenta (87). All of these processes 
are subjects of extensive study, and a comprehensive overview is beyond the scope of a single 
review. Natural killer (NK) cells, T cells and antigen presenting cells (APCs) are a common focus 
when investigating the immunology of pregnancy (88-95). 
We wish to highlight the importance of a tightly-regulated uterine immune environment that could 
potentially be affected by microbiota-induced factors. Recent discoveries on the interplay of 
the intestinal microbiome, their metabolites, and host immunity, give an impression of the vast 
impact that the endometrial microbiome could have (96-98). We outline here the implications of 
gut microbiota affecting cell types known to be important within the uterus. 
Lymphocytes involved in the peri-implantation period 
NK cells are the most abundant of immune cells in the endometrium representing ~ 70% of 
all hematopoietic cells present (99, 100). The term endometrial NK cells (eNK; or uterine NK 
cells; uNK cells) refers to NK cells in the non-pregnant endometrium, and decidual NK (dNK) 
cells residing in the placental membrane are phenotypically and functionally different from eNK 
cells or peripheral blood NK (pbNK) cells (100, 101). In the endometrium, the non-cytolytic and 
potent cytokine secretors, CD56brightCD16- NK cells, dominate. Only a small fraction of eNK cells 
belongs to the CD56+CD16+NK population specialized in killing infected cells (94, 102), contrary 
to the NK cell division in peripheral blood where the majority are CD56+CD16+. Throughout 
the female cycle, eNK cells continue to accumulate until the first half of gestation. Abnormal 
levels of NK cells, measured 20 days after ET, were shown to be associated with RIF (103). 
Direct involvement of eNK cells in implantation remains unclear, as successful implantation 
is possible in NK cell deficient mice (104). More evidence points towards an involvement of 
dNK cells in placenta-formation processes after initial implantation. However, an indirect role of 
the human CD56brightCD16- eNK cells already during implantation cannot be neglected due to 
their high abundance and ability to secrete large amounts of cytokines, such as IFN-γ, tumor 
necrosis factor alpha (TNFα), granulocyte-macrophage colony-stimulating factor (GM-CSF) and 
interleukin 10 (IL-10) (102). 
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Just as eNK and dNK cells are distinct from pbNK cells, the mucosal NK cells of the gut that 
are continuously exposed to the gut microbiome are distinct from pbNK cells. This distinction 
is characterized by limited IFN-γ production and an absence of cytotoxic effector perforin, 
granzymes, FasL and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in 
mucosal NK cells of the gut (105). Of note, germ-free mice lacked these IL-22+NKp46+ cells 
(106). Hence, the specialized intestinal NK cells might be the result of an adaptation to the 
microbiota-rich environment. It needs to be evaluated whether the reduced cytotoxic capacity of 
uNK cells (107) has any relation to the uterine microbiota. 
APCs, such as macrophages (Mɸ) and dendritic cells (DCs), constitute 10-20% of uterine 
leukocytes, expressing major histocompatibility complex class II molecules (108, 109). Through 
integrating microbial, environmental, and self-derived stimuli, APCs are key to the successful 
initiation of an appropriate immune response (110, 111). Throughout the menstrual cycle, 
mature CD83+ DCs and CD68+ Mɸ increase, peaking in the late secretory phase (112). Mɸ are, 
together with NK cells, the main cytokine producers in the human endometrium (113). Through 
secreting leukemia inhibitory factor (LIF) and IL1B, Mɸ play a known role in the establishment of 
endometrial receptivity by increasing cell surface fucosylated structures, allowing trophectoderm 
attachment (87). 
Even more pronounced than seen for NK cells, monocytes of the heavily colonized gut mucosa 
are markedly different in phenotype and function compared to blood-derived monocytes. Even 
though they reside in close proximity to bacteria colonizing the intestinal lumen, the ability of 
the local macrophages to mount a pro-inflammatory response seems to be tuned down. Their 
expression of, for example, lipopolysaccharide (LPS)-binding protein CD14 receptor (114), 
CD89, implicated in IgA-enhanced phagocytosis is decreased (115). Also, various FCγ receptors 
(CD16, CD32, CD64), integrins (CD11a, CD11b, CD11c, CD18) and the IL-2 receptor CD25 are, 
amongst others, downregulated on intestinal macrophages. Their ability to produce cytokines 
(IL-1, IL-6, TNFα) is diminished (116). It needs to be investigated whether this Smad-induced 
IκBα expression and NF-κB inactivation-mediated phenotype, termed “inflammation anergy”, is 
paralleled at the fetal-maternal interface (117). 
T cells represent the third largest fraction of immune cells found in human endometrium (118-120). 
Since, in the absence of pregnancy, T cells mostly reside in the deeper layers of the endometrium, 
their relation to fertility disorders more likely reflects a role in early placenta formation after 
implantation, rather than a contribution to the pre-implantation period. Experimental evidence on 
the functional importance of T cells in the WOI is scarce. It has been suggested that a switch in 
the ratio of Th1 and Th2 cells (Th1/Th2 paradigm) within the endometrium is needed to prepare 
for implantation, as a pronounced decrease in Th1 was accompanied by an increase in Th2 cells 
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seen from the secretory phase towards early pregnancy (121). More recently, regulatory T (Treg) 
cells and Th17 cells have been included in the discussion (122, 123). 
Increasing evidence on the shaping of T cell subsets by microbiota based on studies of the gut 
is emerging (124). Like in the endometrium, mucosal immunity of the intestines depends on an 
interplay of IFN-γ producing Th1 cells, Th17 cells that secrete IL-17 and IL-22, and innate lymphoid 
cells with Th2-cytokine secreting functions, and suppressive Foxp3+ Treg cells. Differentiation of 
various T cell subsets is impaired in mice with disrupted gut microbiota (125, 126). Commensal 
segmented filamentous bacteria were shown to be important for Th17-mediated mucosal 
protection (127). A detailed understanding of the mechanisms underlying bacteria-mediated T 
cell induction is not yet available. One of the few examples in which the link between microbe 
and host is known, is polysaccharide A (PSA) originating from the capsule of Bacteroides fragilis 
(127). Bacteroides, found in a number of the endometrial studies analyzing 16S rRNA, tunes the 
Th17 response of intestinal T cells, and causes a systemic increase of circulating CD4+ T and 
Th1 cells (128-130). 
Other microbiota are known to induce and cause accumulation of Treg cells, essential in 
maintaining tolerance and known to be important for pregnancy (131). In the gut, Treg mediated 
IL-10 production is thought to be critical to maintain intestinal microbial homeostasis by limiting 
continuous activation of Th1 and Th17 cells. Commensal microbiota promote de novo generation 
and activation of mucosal Treg cells (132) as shown by mice colonized with altered Schaedler flora 
species (Lactobaillus, Bacteroides, species of Flexistipes phylum and gram-positive bacteria of 
the Firmicutes, Bacillus-Clostridium group) (132, 133). Focusing on specific strains, colonization 
of mice with Clostridia strains was shown to induce expansion of Treg cells locally in the lamina 
propria and systemically, resulting in increased resistance to colitis and IgE responses in adult 
mice (134). These intestinally induced Treg were shown to express a T-cell receptor repertoire 
specific for bacteria of the luminal content of colonized mice, allowing tolerance towards 
individual species (135). Similar generation and activation of immune cell types by endometrial 
microbiota could be essential for correct homeostasis regarding maintenance of a microbiome 
and programming the local immunity within the uterus. The majority of work on microbiota and 
immunity focuses on T cell homeostasis, but especially cells of the innate arm of the immune 
system are involved in the peri-implantation period. 
Cytokines and chemokines belong to the soluble factors known to be associated with reproductive 
health. Induced by either endometrial cells or immune cells recruited upon blastocyst encounter, 
the implantation period is characterized by an increase in pro-inflammatory Th1 cytokines, 
such as IL-6, IL-8, LIF, and TNF-α, with implications for immune cell recruitment and activation 
of the endometrium, as reviewed previously (136, 137). Throughout the female cycle, healthy 
endometrial stromal cells constitutively secrete the chemokine CCL2, also known as monocyte 
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chemoattractant protein 1 involved in directing monocytes, T cells and DCs to inflammatory 
or tumor tissue (138) (139, 140). Also, decidual stromal cells obtained during first trimester 
(~8 weeks in both studies) secrete CCL2, which was shown to attract Th2 and Th17 cells, 
thereby influencing the local T cell balance (141, 142). In addition, macrophage recruitment 
and polarization (143), and plasmacytoid DCs were affected by CCL2. It was recently shown 
that microbiota are important in establishing baseline CCL2 secretion controlling homeostatic 
trafficking of plasmacytoid DCs (144). As no functional contribution of endometrial microbiota 
has been shown yet, the physiologically closest possible microbiome, as indicated by Chen et 
al. (2017), is probably the cervicovaginal microbiome. Cytokine concentrations were shown to be 
affected depending on the microbial profiles of 16S rRNA analysis of cervicovaginal lavage. This 
was reflected in lower IL-1beta, IL-8 and IL-10 levels in bacterial vaginosis (BV) (145). 
Also other cytokines, such as LIF, GM-CSF, colony-stimulating factor-1, heparin binding EGF 
like growth factor, insulin-like growth factor Iand II, contribute to fertility through their role in 
supporting blastocyst development in the pre-implantation phase (87). Decreased LIF expression 
of endometrial epithelial cells was shown to be associated with infertility (146). Cervicovaginal 
levels of cytokines were affected by the bacterial flora found (147) and a probiotic supplement 
was shown to affect vaginal interleukin changes (148). It remains to be seen if different uterine 
microbial profiles could be associated with altered chemokine/cytokine profiles and effects on 
reproductive success. 
LESSONS LEARNED FROM THE GUT MICROBIOME: POSSIBLE 
INTERACTIONS BETWEEN LOCAL MICROBIOME AND ENDOMETRIUM 
Besides influence on systemic and tissue resident lymphocytes, the microbiota and host interact 
on various levels. The relation between microbes and host is not a black and white phenomenon; 
and thus surpasses the simplified view of commensal versus pathogen. The immune system 
shapes a homeostatic co-existence, i.e. by eliminating species that might not only be harmful 
but also disturb the balance (12). Two different types of battles are continuously fought when 
hosting a microbial community: one that is responsible for facing the daily challenge posed 
by containment of symbiotic microbes, and one for defense against pathogenic microbes that 
breach containment (12, 149). Although our understanding of the microbiome – host interaction 
is still rudimentary, its functional importance, especially on various arms of innate and adaptive 
immunity, is evident (7, 150). Below, we give an overview of the different mechanisms of how 
endometrial colonization might have implications for the uterine immune-environment, and thus 
for fertility.
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Pattern recognition receptors 
To detect viral, fungal and bacterial pathogens, the innate immune system senses pathogen-
associated molecular patterns (PAMPs) through pattern recognition receptors (PRRs), such 
as toll-like receptors (TLRs), RIG-I-like receptors, NOD-like receptors (NLRs) and C-type lectin 
receptors, such as collectins, selectins, endocytic receptors and proteoglycans (151-153). PAMPs 
include, for example, cell wall mannans (yeast), formylated or lipo-peptides, peptidoglycans, 
teichoic acids and bacterial cell-wall components such as LPS (154). Activation of TLR induces 
Nuclear factor-kappa B (NFкB), which initiates an inflammatory cascade including upregulation 
of markers to mount an adaptive immune response (155). PRRs form the first line of defense 
against sexually transmitted disease or any other pathogens that can access the female 
reproductive tract through the vagina (156). For example, decidual and uterine stromal and 
epithelial cells express various TLRs and other PRRs, and the cells mount a potent inflammatory 
response upon receptor recognition (157-162). An overview of TLRs of the endometrium is given 
in Table II. The expression of TLR mRNA and protein changes throughout the menstrual cycle, as 
shown by different groups (163-167). Receptor expression on endometrial cells was found to be 
low in the proliferative phase and increased in the secretory phase for TLRs 1 – 10. Together with 
intracellular receptors, there is a constitutively high expression of pathogenicity sensors lining 
the female reproductive tract (160). All of these receptors can sense their specific PAMP and 
react by inducing signaling cascades. 
Evidence accumulates that PRRs are one way for microbiota and host to communicate. Round 
and colleagues examined how B. fragilis induces symbiosis via TLR2 of CD4+ T cells. PSA of 
B. fragilis induces Foxp3+ regulatory cells that are needed to counteract the otherwise Th17-
mediated killing of Bacteroides (168). Nod2-deficient mice were more susceptible to pathogenic 
infection (169). Nod2 was shown to control dysregulated commensal colonization, and 
commensal resident bacteria are in turn needed to induce Nod2 expression. TLRs and NLRs 
are suspected to play a role in the periconceptual regulation as they are major players in the 
cascade of cytokine induction (86, 170). 
Protection against pathogens 
Maintaining colonization of commensal bacteria protects the host against pathogens. 
Residential microbiota successfully compete for the niche by exhibiting better adaptation than 
an occasionally invading pathogenic species, termed the “colonization resistance” concept 
(171, 172). Commensal microbiota are specialized in nutrient usage of their habitat, and deplete 
the environment of nutrients needed for pathogenic species. Consumption of a limited resource 
can starve the pathogenic invader (173). E. coli, for example, competes in consumption of 
sugars, amino acids and other nutrients with the pathogenic enterohaemorrhagic E. coli (EHEC) 
(174, 175). Symbionts also defend their niche (176). An example is the commensal Clostridium 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































bile acids (177). Another contribution by commensals is continuous receptor stimulation leading 
to TLR upregulation; needed to sense potentially dangerous bacteria (178). Mice and humans 
treated with antibiotics, diminishing the intestinal microbiota, are highly susceptible to antibiotic-
resistant strains because of a reduced expression of antimicrobial defense mechanisms (179). 
In the female reproductive tract, inhibition of gonococci (Neisseria gonorrhoeae) adherence is 
observed in the presence of Lactobacilli when using an in vitro model of endometrial epithelial 
cells (180). In an endocervical epithelial cell model, TLR agonists, as a surrogate for microbial 
products, were shown to stimulate antimicrobial products and mucins (181). Maintaining 
commensal colonization within the endometrium may likely offer a similar means of effective 
protection against uterine infections. 
Tissue adaptation 
In addition to lymphocytes, epithelial cells play a crucial role in co-existence with commensal 
colonization. An intact epithelium allows for safe colonization without extensive (pathogenic) 
barrier breach, through a physical barrier and reaction of the epithelial cells towards bacterial 
ligands. On the other hand, bacteria also contribute to a healthy barrier development. Increasing 
evidence highlights the importance of microbiota for gut development and morphogenesis. 
Known adaptations of microbiota-implicated tissue adaptations include intestinal epithelial cell 
differentiation (182), support of epithelial cell regeneration (183), modulation of epithelial cell 
permeability (184), and vascularization (185). In the uterus, commensal bacteria might contribute 
to the remodeling needed for a receptive state of the endometrium. The genus Bacteroides, 
constituting 30% of the endometrial community in 90% of women, is known to be tightly involved 
in intestinal tissue development by influencing epithelial cell maturation and maintenance (186, 
187). Hooper and colleagues showed that B. thetaiotaomicron induced gene expression of 
proteins involved in nutrient absorption, angiogenesis, intestinal maturation, and mucosal barrier 
reinforcement (188). Bacteroides was shown to be essential for intestinal vascularization through 
signaling mediated by Paneth cells, the main type of epithelial cell in the intestine secreting anti-
microbial compounds (189). Further studies using endometrial epithelial cells are warranted to 
ascribe similar physiological functions to the uterine microbiome during endometrial remodeling. 
The continuous reparative processes following the secretory phase might benefit from microbial 
support mechanisms. Dysbiosis in this critical period of preparing for blastocyst invasion might 
be one of the unrevealed causes leading to recurrent implantation failure due to failed remodeling.
Another interesting tissue adaptation involved in the peri-implantation period is the change in 
barrier function of the endometrial epithelium. Features of tight junctions, such as area of whole 
junction and the area enclosed by junctional strands, decrease from day 13 to day 22 of the 
menstrual cycle, which could be beneficial for implantation (190). Redistribution of adherens 
junctions and desmosomes during the WOI may also prepare for trophoblast invasion (191). 
The tight junctional barrier function is regulated by nutrients and cytokines (192). As a side effect 
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of increased barrier permeability, more barrier breach of the uterine microbiota can occur. This 
in turn can lead to a more pro-inflammatory immune environment with mucosal immune cells 
stimulated to secrete the cytokines that are beneficial for the peri-implantation period. 
DISCUSSION
Conclusions on the possible presence of uterine colonization 
Even before the era of 16S RNA analysis, it was put forward that “it is difficult to envision that a 
mucosa that is continuously exposed to microorganisms present in the lower genital tract and 
that is regularly invaded by sperm that can carry microorganisms into the endometrial cavity, 
may be free of bacteria and its products such as endotoxin” (193). We also agree that, based on 
the various lines of evidence for the existence of an endometrial microbiota, the era of the sterile 
uterus, free of any microbial compounds, has to come to an end. 
Taken together, this variety of immunological adaptations due to microbial presence contributes 
to establishing the right balance of tolerance versus reactivity towards bacterial ligands, and 
likely has a physiological impact on pregnancy (Figure 2). Following the suggestion by Espinoza 
and colleagues, it can be envisioned that as long as no pathologic pro-inflammatory response 
against the microorganisms of the endometrial mucosa is started, the presence of a certain 
microbial coexistence does not harm the conceptus (194), and might well contribute to vital 
processes in the peri-implantation period and pregnancy. 
Additional studies required to define the core microbiome
Sample cohort 
Even though several studies have evaluated the microbiome of the endometrium, a “baseline” 
or “core” microbiome of this healthy endometrium has not been defined. The studies presented 
here on 16S rRNA evaluation of endometrial microbiota vary to a large extent in experimental 
approach. Differences in sample population, sample acquisition method, 16S region, controls, 
and bacterial genotyping make it impossible to combine the data in a more powerful meta-
analysis. Of note, all studies enrolled small and highly selected cohorts. Except for the studies 
by Fang and colleagues (2017) assessing 10 healthy women, and Moreno and colleagues 
(2016) including 22 healthy women, all studies enrolled subjects seeking treatment because of 
reproductive complications or uterine abnormalities (18, 19). Therefore, the majority of data does 
not reflect a putative steady-state healthy endometrial microbiome. Only recruitment of healthy, 
fertile women would provide insight into the microbiome of a fertile, receptive endometrium. 
However, without underlying medical reasons, sampling in healthy women is unethical and 
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Figure 2. Uterine microbiota may contribute to healthy endometrium physiology. 
Upon pathogen recognition receptor (PRR) stimulation, epithelial cells release soluble factors such as cytokines affecting local 
lymphocyte populations. If bacteria are naturally present in the uterus, similar interaction with host cells as seen in mucosa 
of the gut can be envisioned. Local lymphocytes e.g. antigen presenting cells (APCs) could sense microbes by probing 
through the epithelia or upon barrier breach initiating a signaling cascade. Presence of commensals might alter the mucosal 
T cell balance and the involved cytokines can have an effect on the local immune environment. Cells important for healthy 
implantation and placentation such as uterine natural killer (NK) cells are potentially affected. Therefore colonization might 
have an impact on important initial steps of endometrial physiology. APC, antigen presenting cell; IL-10, interleukin 10; NK cell, 
natural killer cell; PSA, Polysaccharide A; PRR, pattern recognition receptor; Th17, T helper 17 cells; Treg, regulatory T cell.
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Controlling for vaginal and environmental contamination 
A transvaginal approach carries the risk of contamination by the cervicovaginal microbiome. Due 
to the high biomass of the vaginal relative to the uterine microbiome and the high abundance 
of Lactobacillus, misrepresentation of species distribution cannot be excluded. To achieve more 
conclusive results in the near future, transvaginal studies on endometrial microbiota need to 
strictly incorporate control samples from vagina and cervix. 
Additionally, contamination by reagents needs to be controlled for by including controls of all 
extraction kits used, a common source for misleading data (195). Also, air swabs and swabs of 
other environmental sources of microbial exposure need to be taken into account when trying to 
establish conclusive results on the low-biomass microbiome of the uterus. 
Standardized sample processing 
In the presented studies, major differences in the processing of material, data collection and 
analyses are all sources of variation (196). The choice of hypervariable region (V1-V9) of the 16S 
rRNA, containing species-specific sequences used for assessing microbial diversity, influences 
the detection results. V1 for example was found to be well suited to distinguish between S. 
aureus species, whereas V2 was more successful in Mycobacterium species differentiation (56). 
Depending on the variable region of the 16S rRNA, different species are preferentially detected. A 
standardized approach in which study design, sampling method, DNA extraction with generation 
of 16S amplicons and sequencing, assigning of OTUs to genus/species, and reporting of the 
findings is needed (197) to achieve conclusive results for endometrial and placental microbiome 
studies. Without these standardized, well-controlled study designs the uterine microbiome will 
still not come into its own in the future. 
Points of interest 
Timing of intervention 
Owing to the dynamic fluctuations of microbiota in the uterus, the timing of microbial influence(s) 
on a healthy pregnancy needs attention. Depending on when the pregnant (or soon-to-be 
pregnant) woman undergoes any external microbial (pro-/pre or antibiotic) intervention, this might 
alter the physiologic processes of implantation, placenta formation or placenta maintenance if 
microbiota are involved. There is increasing evidence that BV is associated with infertility and 
pregnancy complications (198). Interestingly, the risk of delivering preterm because of BV is 
not reduced after clearance of infection by antibiotics (199). This might be explained by the fact 
that the effects of BV have already taken place and the initiated cascade of changes induced 
by the bacterial imbalance cannot be reversed. Accordingly, treatment of BV before 20 weeks 
of gestation might decrease the risk of BV-associated preterm birth, suggesting that the early 
phase of pregnancy in particular is sensitive to microbial impact (200). Systematic reviews on 
other conditions of bacterial imbalance associated with pregnancy and their treatment might 
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narrow down the window in which a certain microbe-associated effect on pregnancy takes 
place. In the future, robust evidence for a uterine microbiome might also fuel novel options for 
intervention concerning fertility and prevention of preterm birth risk in women with a history of BV. 
Chicken or egg 
It is possible that the state of inflammation is a sign of dysregulated immunity, rather than only a 
result of the presence of pathogenic, bacterial colonization. Chronic endometritis, the persistent 
inflammation of the endometrial lining, is associated with RIF (201) and successful antibiotic 
treatment of endometritis could clear the condition (as characterized by accumulation of plasma 
cells in biopsy samples), but clearance did not improve the chance of implantation. In this case, a 
certain microbial profile might not represent the cause but, instead, the effect of an immune state 
that is unfavorable for pregnancy. Interestingly, bacteria found in the endometrium causing the 
inflammation were not found in the vagina, suggesting that they are commensals in a dysbiotic 
state, rather than pathogenic intruders (36). 
 
However, at present, we cannot exclude an active effect of microbiota on the physiological 
changes needed for a receptive endometrium. Functional studies are needed to understand the 
host-microbe interaction in the uterus. More robust information on the species involved in uterine 
colonization will allow further functional assessment using in vitro endometrial models (202). Next 
to this, the association of bacterial metabolites as a cause or consequence of certain microbial 
colonization and the state of fertility needs to be examined. Yeoman et al. (2013) evaluated 
metabolomic profiling as a fast and cost-effective diagnostic tool for BV (203). It remains to be 
elucidated whether uterine metabolites can be a proxy for the infertility related to dysbiosis. Also, 
since naturally occurring microbes continuously breach the endothelial barrier and are a part of 
homeostasis, microbes will continuously shape the immune environment. How this impacts the 
tightly regulated immunological processes involved from endometrium preparation towards a 
healthy pregnancy is yet to be discovered. 
Dynamic bugs
Recently, the importance of the microbiome for regulation of rhythmic biological changes has 
been stated (204). Fluctuating microbial community structures might direct hormonal changes 
(205). It is tempting to speculate that similar dynamics are involved in the female cycle. Moreno 
and colleagues observed differences in the microbiota detected in the pre-receptive versus 
receptive phase in the endometrium (19). The extent of this effect varied. However, also for the 
vaginal microbiota it was shown that while in some women low constancy and high species 
turnover is observed, the extent of these changes can be very small for others (206). Until 
now, sample size prohibits conclusions on putative characteristic changes of the endometrial 
microbiota associated with the induction of the WOI. More in-depth studies on changes in the 
endometrial microbiome are needed to assess whether microbiota play a role in orchestrating 
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the cyclic endometrial changes and establishing a receptive endometrium. Studies examining 
16S rRNA from endometrium alongside first trimester and term placental samples are needed 
to show if, and how far, the microbes of the fetal-maternal interface relate to the pre-pregnancy 
state. 
Origin 
The origin of the endometrial, and especially the placental, microbiome is highly discussed. 
Different routes of colonization have been suggested, including the gut, vagina, or oral cavity. 
We believe that with placental development originating from decidualized endometrium, it would 
be highly unlikely that the endometrial and placental microbiome are completely independent. 
In the intimate relationship of endometrium/decidua and placenta, the trophoblast cells invading 
the uterine mucosal tissue have to be in contact with the residential microbiota. Systematically 
comparing the healthy, pre-pregnancy endometrium to placental samples will help to elucidate 
whether the placental colonization results from the bacteria already present in the uterus. A vaginal 
origin is one of the suggested routes of uterine colonization, as a number of species seem to be 
residents of both body sites. Transfer of labeled macrospheres by a “uterine peristaltic pump” 
activity from vagina to uterus has been shown (207, 208). Evidence from mouse studies points 
out that a change in TLRs and antimicrobial peptide expression and function allows the passage 
of vaginal bacteria through the cervix into the uterus upon cervical infection. Remarkably, in 
nonpregnant mice, bacteria could travel from the lower reproductive tract into the uterus, but 
this was prohibited during pregnancy. These findings suggest that a healthy, uninfected cervix, 
regulates the ascents of vaginal bacteria (209). This theory is supported by earlier findings of 
differences in biochemical and chemical properties of the cervix depending on the pregnancy 
state (210, 211). 
In line with theories on oral transmission of bacteria into the uterus, an association of 
periodontal disease and pregnancy complications is highly discussed (212). Indeed, bacteria 
such as Lactobacillus or A.vaginae that were found in the 16S assessment of the endometrial 
microbiome, are associated with caries, but not healthy plaques (213, 214). Interestingly, the 
placental microbiome resembles that of the oral cavity more than that of gut or even vagina (24). 
Several studies also show an association of cytokines and bacteria from amniotic fluid with oral 
microbiota (215, 216). It remains to be seen whether bacteria of the oral cavity can indeed travel 
via the circulatory system to selectively colonize the uterus before or during pregnancy (217). 
Jimenez and colleagues elegantly showed that in utero bacterial colonization of the fetus takes 
place, which can be influenced by maternal oral uptake of microbiota (218). Pregnant mice were 
fed with a genetically labeled E. fecium strain isolated from human breast milk, and the bacteria 
could be detected in pups delivered by C-section. The authors point out that next to the possible 
oral route, APCs of the gut might sense and actively harvest intestinal bacteria, facilitating their 
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spread to other body sites. This sampling of luminal bacteria by DCs has been shown for the 
gut (219). A similar way of harvesting might already take place before pregnancy to prepare the 
uterus for placentation. If and how microbiota of gut and uterus might interact remains to be 
established. The study by Jimenez et al. (2008) fits with the “in utero colonization hypothesis”, 
which in itself is heavily debated. Recently, Perez-Muños and colleagues have pointed out the 
shortcomings of published data surrounding the theory that newborns acquire first microbial 
colonization in utero (2). Studies on in utero colonization and microbial colonization of the non-
pregnant uterus share the same methodological and technical limitations that have not been 
addressed sufficiently to allow any conclusions to be drawn about a core uterine microbiome. 
We wish to point that even though possibly not determining colonization of the pup in utero, as 
highlighted by the authors, maternal fertility or uterine health might have still have been affected 
by the microbial status. Importantly, a role in establishing protection against pathogenic invasion 
can be envisioned, a threat that mice in protected breeding facilities are a lot less exposed to 
than humans. Therefore, the fact that germ-free mice are fertile does not rule out a possible 
impact of uterine microbiota on normal physiology of the human endometrium.
CONCLUSION
Microbiota might be another piece in the complex mechanism contributing to the cogwheels 
of hormones, immune cells and physiological adaptations that are needed for successful 
pregnancy. As described in this review, a vast number of possible physiological contributions of 
the uterine microbiota can be inferred from other body sites. We highlight that the assessment of 
uterine microbiota still suffers from many limitations. Nevertheless, the available evidence shows 
that the presence of uterine 16S rRNA is not solely the result of sampling or analysis errors and 
deserves to be acknowledged. We conclude that the concept of the sterile endometrium, and the 
uterine compartment in general, is outworn, although the true core uterine microbiome still needs 
to be assessed. Functional studies are needed to elucidate the physiological importance of the 
microbiome in fertility. The challenge of studying reproductive immunology and the microbiota 
involved is that research on all of the different aspects is still in its infancy; microbiome, immunity, 
endocrinology in pregnancy, and placental and fetal development need to be studied together 
to obtain a more comprehensive overview. Thus, experts in various fields, such as microbiology 
and immunology, need to co-operate. Without this, such a basal process as pregnancy, needed 
for healthy offspring, will continue to be a mystery. 
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METHODS
PubMed and Google Scholar were searched for articles in English indexed from January 1st, 2008 
to March 1st, 2018 for “16S rRNA”, “uterus” and related search terms (Supplementary Figure I) to 
assess available evidence on uterine microbiome analysis. Studies on the upper female genital 
tract were investigated regarding data on specifically the uterine compartment. A manual search 
of the references within the resulting articles was performed. Studies on microbiota of other body 




1. Macpherson AJ, de Aguero MG, Ganal-Vonarburg SC. How nutrition and the maternal microbiota shape 
the neonatal immune system. Nature reviews Immunology. 2017;10(3):508-17.
2. Perez-Munoz ME, Arrieta MC, Ramer-Tait AE, Walter J. A critical assessment of the “sterile womb” 
and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. 
Microbiome. 2017;5(1):48.
3. Moreno I, Franasiak JM. Endometrial microbiota—new player in town. Fertil Steril.
4. Franasiak JM, Scott RT. Endometrial microbiome. Curr Opin Obstet Gynecol. 2017;29(3):146-52.
5. Power ML, Quaglieri C, Schulkin J. Reproductive Microbiomes. Reproductive sciences (Thousand 
Oaks, Calif). 2017:1933719117698577.
6. Prince AL, Antony KM, Chu DM, Aagaard KM. The Microbiome, Parturition, and Timing of Birth: More 
questions than answers. Journal of reproductive immunology. 2014;0:12-9.
7. Littman Dan R, Pamer Eric G. Role of the Commensal Microbiota in Normal and Pathogenic Host 
Immune Responses. Cell Host Microbe. 2011;10(4):311-23.
8. Hooper LV, Littman DR, Macpherson AJ. Interactions Between the Microbiota and the Immune System. 
Science. 2012;336(6086):1268.
9. Geva-Zatorsky N, Sefik E, Kua L, Pasman L, Tan TG, Ortiz-Lopez A, et al. Mining the Human Gut 
Microbiota for Immunomodulatory Organisms. Cell.
10. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nature reviews 
Genetics. 2012;13(4):260-70.
11. Buchon N, Broderick NA, Chakrabarti S, Lemaitre B. Invasive and indigenous microbiota impact intestinal 
stem cell activity through multiple pathways in Drosophila. Genes & development. 2009;23(19):2333-44.
12. Eberl G. A new vision of immunity: homeostasis of the superorganism. Mucosal Immunol. 2010;3(5):450-60.
13. Tissier H. Recherches sur la flore intestinale normale et pathologique du nourrisson. Doctoral dissertation 
University of Paris. 1900.
14. Viniker DA. Hypothesis on the role of sub-clinical bacteria of the endometrium (bacteria endometrialis) 
in gynaecological and obstetric enigmas. Human reproduction update. 1999;5(4):373-85.
15. Franasiak JM, Scott Jr RT. Reproductive tract microbiome in assisted reproductive technologies. Fertil 
Steril. 2015;104(6):1364-71.
16. Verstraelen H, Vilchez-Vargas R, Desimpel F, Jauregui R, Vankeirsbilck N, Weyers S, et al. Characterisation 
of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region 
of the 16S rRNA gene. PeerJ. 2016;4:e1602.
17. Khan KN, Fujishita A, Masumoto H, Muto H, Kitajima M, Masuzaki H, et al. Molecular detection of 
intrauterine microbial colonization in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 
2016;199:69-75.
18. Fang R-L, Chen L-X, Shu W-S, Yao S-Z, Wang S-W, Chen Y-Q. Barcoded sequencing reveals diverse 
intrauterine microbiomes in patients suffering with endometrial polyps. Am J Transl Res. 2016;8(3):1581-92.
MICROBIOTA AND ENDOMETRIAL HEALTH 171
6
19. Moreno I, Codoner FM, Vilella F, Valbuena D, Martinez-Blanch JF, Jimenez-Almazan J, et al. Evidence 
that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 
2016;215(6):684-703.
20. Walther-Antonio MR, Chen J, Multinu F, Hokenstad A, Distad TJ, Cheek EH, et al. Potential contribution 
of the uterine microbiome in the development of endometrial cancer. Genome medicine. 2016;8(1):122.
21. Miles SM, Hardy BL, Merrell DS. Investigation of the microbiota of the reproductive tract in women undergoing 
a total hysterectomy and bilateral salpingo-oopherectomy. Fertil Steril. 2017;107(3):813-20.e1.
22. Tao X, Franasiak JM, Zhan Y, Scott RT, Rajchel J, Bedard J, et al. Characterizing the endometrial 
microbiome by analyzing the ultra-low bacteria from embryo transfer catheter tips in IVF cycles: 
Next generation sequencing (NGS) analysis of the 16S ribosomal gene. Hum Microbiome J. 
2017;3(Supplement C):15-21.
23. Chen C, Song X, Wei W, Zhong H, Dai J, Lan Z, et al. The microbiota continuum along the female 
reproductive tract and its relation to uterine-related diseases. Nature communications. 2017;8(1):875.
24. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique 
microbiome. Science translational medicine. 2014;6(237):237ra65.
25. Prince AL, Ma J, Kannan PS, Alvarez M, Gisslen T, Harris RA, et al. The placental membrane microbiome 
is altered among subjects with spontaneous preterm birth with and without chorioamnionitis. Am J 
Obstet Gynecol. 2016;214(5):627.e1-.e16.
26. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal 
microbiota. Nature reviews Immunology. 2010;10(3):159-69.
27. Wira CR, Rodriguez-Garcia M, Patel MV. The role of sex hormones in immune protection of the female 
reproductive tract. Nature reviews Immunology. 2015;15(4):217-30.
28. Wira CR, Fahey JV, Rodriguez-Garcia M, Shen Z, Patel MV. Regulation of mucosal immunity in the 
female reproductive tract: the role of sex hormones in immune protection against sexually transmitted 
pathogens. Am J Reprod Immunol. 2014;72(2):236-58.
29. Frew L, Stock SJ. Antimicrobial peptides and pregnancy. Reproduction (Cambridge, England). 
2011;141(6):725-35.
30. King AE, Critchley HO, Kelly RW. Presence of secretory leukocyte protease inhibitor in human 
endometrium and first trimester decidua suggests an antibacterial protective role. Molecular human 
reproduction. 2000;6(2):191-6.
31. Givan AL, White HD, Stern JE, Colby E, Gosselin EJ, Guyre PM, et al. Flow cytometric analysis of 
leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and 
vagina. Am J Reprod Immunol. 1997;38(5):350-9.
32. Ansbacher R, Boyson WA, Morris JA. Sterility of the uterine cavity. Am J Obstet Gynecol. 1967;99(3):394-6.
33. Moller BR, Kristiansen FV, Thorsen P, Frost L, Mogensen SC. Sterility of the uterine cavity. Acta Obstet 
Gynecol Scand. 1995;74(3):216-9.
34. Duff P, Gibbs RS, Blanco JD, Clair PJS. Endometrial Culture Techniques in Puerperal Patients. Obstetrics 
and gynecology. 1983;61(2):217-22.
CHAPTER 6172
35. Cowling P, McCoy DR, Marshall RJ, Padfield CJ, Reeves DS. Bacterial colonization of the non-pregnant 
uterus: a study of pre-menopausal abdominal hysterectomy specimens. Eur J Clin Microbiol Infect Dis. 
1992;11(2):204-5.
36. Cicinelli E, De Ziegler D, Nicoletti R, Colafiglio G, Saliani N, Resta L, et al. Chronic endometritis: 
correlation among hysteroscopic, histologic, and bacteriologic findings in a prospective trial with 2190 
consecutive office hysteroscopies. Fertil Steril. 2008;89(3):677-84.
37. Egbase PE, al-Sharhan M, al-Othman S, al-Mutawa M, Udo EE, Grudzinskas JG. Incidence of microbial 
growth from the tip of the embryo transfer catheter after embryo transfer in relation to clinical pregnancy 
rate following in-vitro fertilization and embryo transfer. Human reproduction (Oxford, England). 
1996;11(8):1687-9.
38. Fanchin R, Harmas A, Benaoudia F, Lundkvist U, Olivennes F, Frydman R. Microbial flora of the cervix 
assessed at the time of embryo transfer adversely affects in vitro fertilization outcome. Fertil Steril. 
1998;70(5):866-70.
39. Egbase PE, Udo EE, Al-Sharhan M, Grudzinskas JG. Prophylactic antibiotics and endocervical microbial 
inoculation of the endometrium at embryo transfer. Lancet (London, England). 1999;354(9179):651-2.
40. Salim R, Ben-Shlomo I, Colodner R, Keness Y, Shalev E. Bacterial colonization of the uterine cervix and 
success rate in assisted reproduction: results of a prospective survey. Human reproduction (Oxford, 
England). 2002;17(2):337-40.
41. Moore DE, Soules MR, Klein NA, Fujimoto VY, Agnew KJ, Eschenbach DA. Bacteria in the transfer 
catheter tip influence the live-birth rate after in vitro fertilization. Fertil Steril. 2000;74(6):1118-24.
42. Selman H, Mariani M, Barnocchi N, Mencacci A, Bistoni F, Arena S, et al. Examination of bacterial 
contamination at the time of embryo transfer, and its impact on the IVF/pregnancy outcome. J Assist 
Reprod Genet. 2007;24(9):395-9.
43. Koren Z, Spigland I. Irrigation technique for detection of Mycoplasma intrauterine infection in infertile 
patients. Obstetrics and gynecology. 1978;52(5):588-90.
44. Stray-Pedersen B, Bruu AL, Molne K. Infertility and uterine colonization with Ureaplasma urealyticum. 
Acta Obstet Gynecol Scand. 1982;61(1):21-4.
45. Naessens A, Foulon W, Cammu H, Goossens A, Lauwers S. Epidemiology and pathogenesis of 
ureaplasma urealyticum in spontaneous abortion and early preterm labor. Acta Obstet Gynecol Scand. 
1987;66(6):513-6.
46. Relman DA. New technologies, human-microbe interactions, and the search for previously unrecognized 
pathogens. The Journal of infectious diseases. 2002;186 Suppl 2:S254-8.
47. Verstraelen H, Verhelst R, Claeys G, Temmerman M, Vaneechoutte M. Culture-independent analysis of 
vaginal microflora: The unrecognized association of Atopobium vaginae with bacterial vaginosis. Am J 
Obstet Gynecol. 2004;191(4):1130-2.
48. Mitchell CM, Haick A, Nkwopara E, Garcia R, Rendi M, Agnew K, et al. Colonization of the upper genital 
tract by vaginal bacterial species in nonpregnant women. Am J Obstet Gynecol. 2015;212(5):611.e1-9.
49. Swidsinski A, Verstraelen H, Loening-Baucke V, Swidsinski S, Mendling W, Halwani Z. Presence of a 
Polymicrobial Endometrial Biofilm in Patients with Bacterial Vaginosis. PloS one. 2013;8(1):e53997.
MICROBIOTA AND ENDOMETRIAL HEALTH 173
6
50. Clarridge JE. Impact of 16S rRNA Gene Sequence Analysis for Identification of Bacteria on Clinical 
Microbiology and Infectious Diseases. Clin Microbiol Rev. 2004;17(4):840-62.
51. Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. Analysis of the microbiome: Advantages of whole 
genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun. 2016;469(4):967-77.
52. Tessler M, Neumann JS, Afshinnekoo E, Pineda M, Hersch R, Velho LFM, et al. Large-scale differences 
in microbial biodiversity discovery between 16S amplicon and shotgun sequencing. Scientific reports. 
2017;7(1):6589.
53. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, et al. The NIH Human Microbiome 
Project. Genome research. 2009;19(12):2317-23.
54. Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, et al. The Human Microbiome 
Project: A Community Resource for the Healthy Human Microbiome. PLoS Biol. 2012;10(8):e1001377.
55. Younes JA, Lievens E, Hummelen R, van der Westen R, Reid G, Petrova MI. Women and Their Microbes: 
The Unexpected Friendship. Trends in microbiology. 2017.
56. Chakravorty S, Helb D, Burday M, Connell N, Alland D. A detailed analysis of 16S ribosomal RNA gene 
segments for the diagnosis of pathogenic bacteria. J Microbiol Meth. 2007;69(2):330-9.
57. Franasiak JM, Werner MD, Juneau CR, Tao X, Landis J, Zhan Y, et al. Endometrial microbiome at the 
time of embryo transfer: next-generation sequencing of the 16S ribosomal subunit. J Assist Reprod 
Genet. 2016;33(1):129-36.
58. Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic 
Lactobacillus species in vaginal health. Res Microbiol. 2017;168(9):782-92.
59. Moreno I, Franasiak JM. Endometrial microbiota-new player in town. Fertil Steril. 2017;108(1):32-9.
60. Kliman HJ. Comment on “The placenta harbors a unique microbiome”. Science translational medicine. 
2014;6(254):254le4.
61. van der Horst J, Buijs MJ, Laine ML, Wismeijer D, Loos BG, Crielaard W, et al. Sterile paper points as 
a bacterial DNA-contamination source in microbiome profiles of clinical samples. Journal of dentistry. 
2013;41(12):1297-301.
62. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. Reagent and laboratory 
contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12:87.
63. Laurence M, Hatzis C, Brash DE. Common contaminants in next-generation sequencing that hinder 
discovery of low-abundance microbes. PloS one. 2014;9(5):e97876.
64. Lauder AP, Roche AM, Sherrill-Mix S, Bailey A, Laughlin AL, Bittinger K, et al. Comparison of placenta 
samples with contamination controls does not provide evidence for a distinct placenta microbiota. 
Microbiome. 2016;4(1):29.
65. Kim D, Hofstaedter CE, Zhao C, Mattei L, Tanes C, Clarke E, et al. Optimizing methods and dodging 
pitfalls in microbiome research. Microbiome. 2017;5(1):52.
66. Antony KM, Ma J, Mitchell KB, Racusin DA, Versalovic J, Aagaard K. The preterm placental 
microbiome varies in association with excess maternal gestational weight gain. Am J Obstet Gynecol. 
2015;212(5):653.e1-16.
CHAPTER 6174
67. Vandeputte D, Kathagen G, D’Hoe K, Vieira-Silva S, Valles-Colomer M, Sabino J, et al. Quantitative 
microbiome profiling links gut community variation to microbial load. Nature. 2017;551(7681):507-11.
68. Onderdonk AB, Delaney ML, Fichorova RN. The Human Microbiome during Bacterial Vaginosis. Clin 
Microbiol Rev. 2016;29(2):223-38.
69. Martin DH, Marrazzo JM. The Vaginal Microbiome: Current Understanding and Future Directions. The 
Journal of infectious diseases. 2016;214(Suppl 1):S36-41.
70. Navot D, Bergh PA, Williams M, Garrisi GJ, Guzman I, Sandler B, et al. An insight into early reproductive 
processes through the in vivo model of ovum donation. The Journal of clinical endocrinology and 
metabolism. 1991;72(2):408-14.
71. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. The 
New England journal of medicine. 1999;340(23):1796-9.
72. Jabbour HN, Kelly RW, Fraser HM, Critchley HO. Endocrine regulation of menstruation. Endocr Rev. 
2006;27(1):17-46.
73. Henriet P, Gaide Chevronnay HP, Marbaix E. The endocrine and paracrine control of menstruation. 
Molecular and cellular endocrinology. 2012;358(2):197-207.
74. Salamonsen LA, Zhang J, Brasted M. Leukocyte networks and human endometrial remodelling. Journal 
of reproductive immunology. 2002;57(1):95-108.
75. Singh M, Chaudhry P, Asselin E. Bridging endometrial receptivity and implantation: network of hormones, 
cytokines, and growth factors. The Journal of endocrinology. 2011;210(1):5-14.
76. Murphy CR. The plasma membrane transformation of uterine epithelial cells during pregnancy. Journal 
of reproduction and fertility Supplement. 2000;55:23-8.
77. Martin JC, Jasper MJ, Valbuena D, Meseguer M, Remohi J, Pellicer A, et al. Increased adhesiveness 
in cultured endometrial-derived cells is related to the absence of moesin expression. Biol Reprod. 
2000;63(5):1370-6.
78. Thie M, Harrach-Ruprecht B, Sauer H, Fuchs P, Albers A, Denker HW. Cell adhesion to the apical pole 
of epithelium: a function of cell polarity. Eur J Cell Biol. 1995;66(2):180-91.
79. Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. Nature 
medicine. 2012;18(12):1754-67.
80. Prakobphol A, Genbacev O, Gormley M, Kapidzic M, Fisher SJ. A role for the L-selectin adhesion system 
in mediating cytotrophoblast emigration from the placenta. Dev Biol. 2006;298(1):107-17.
81. Kang YJ, Forbes K, Carver J, Aplin JD. The role of the osteopontin-integrin alphavbeta3 interaction at 
implantation: functional analysis using three different in vitro models. Human reproduction (Oxford, 
England). 2014;29(4):739-49.
82. Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the development puzzle. 
Science. 1994;266(5190):1508-18.
83. Conrad KP, Rabaglino MB, Post Uiterweer ED. Emerging role for dysregulated decidualization in the 
genesis of preeclampsia. Placenta. 2017.
84. Burton GJ, Jauniaux E, Charnock-Jones DS. The influence of the intrauterine environment on human 
placental development. The International journal of developmental biology. 2010;54(2-3):303-12.
MICROBIOTA AND ENDOMETRIAL HEALTH 175
6
85. Moffett A, Hiby SE, Sharkey AM. The role of the maternal immune system in the regulation of human 
birthweight. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 
2015;370(1663):20140071.
86. Robertson SA, Chin PY, Glynn DJ, Thompson JG. Peri-conceptual cytokines--setting the trajectory for 
embryo implantation, pregnancy and beyond. Am J Reprod Immunol. 2011;66 Suppl 1:2-10.
87. Robertson SA, Moldenhauer LM. Immunological determinants of implantation success. The International 
journal of developmental biology. 2014;58(2-4):205-17.
88. Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I. Peripheral natural killer 
cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of 
recurrent spontaneous abortion. Human reproduction (Oxford, England). 2000;15(5):1163-9.
89. Moffett A, Regan L, Braude P. Natural killer cells, miscarriage, and infertility. Bmj. 2004;329(7477):1283-5.
90. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM, et al. Differential 
distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during 
human pregnancy. Placenta. 2006;27 Suppl A:S47-53.
91. Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens. 2004;63(1):1-12.
92. Plaks V, Birnberg T, Berkutzki T, Sela S, BenYashar A, Kalchenko V, et al. Uterine DCs are crucial for 
decidua formation during embryo implantation in mice. J Clin Invest. 2008;118(12):3954-65.
93. Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Voort-Maarschalk MV-v, Roelen DL, et al. 
Fetal–maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional 
T regulatory cells. Journal of reproductive immunology. 2009;82(2):148-57.
94. van der Meer A, Lukassen HG, van Lierop MJ, Wijnands F, Mosselman S, Braat DD, et al. Membrane-
bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells. 
Molecular human reproduction. 2004;10(3):189-95.
95. Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest. 
2014;124(5):1872-9.
96. Round JL, Mazmanian SK. The gut microbiome shapes intestinal immune responses during health and 
disease. Nature reviews Immunology. 2009;9(5):313-23.
97. Hooper LV, Littman DR, Macpherson AJ. Interactions Between the Microbiota and the Immune System. 
Science. 2012;336(6086):1268-73.
98. Postler TS, Ghosh S. Understanding the Holobiont: How Microbial Metabolites Affect Human Health 
and Shape the Immune System. Cell Metab. 2017;26(1):110-30.
99. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human 
endometrium: histochemical and immunohistochemical studies. Human reproduction (Oxford, 
England). 1991;6(6):791-8.
100. Moffett-King A. Natural killer cells and pregnancy. Nature reviews Immunology. 2002;2(9):656-63.
101. Male V, Sharkey A, Masters L, Kennedy PR, Farrell LE, Moffett A. The effect of pregnancy on the uterine 
NK cell KIR repertoire. Eur J Immunol. 2011;41(10):3017-27.
102. Hanna J, Mandelboim O. When killers become helpers. Trends in immunology. 2007;28(5):201-6.
CHAPTER 6176
103. Ledee-Bataille N, Dubanchet S, Coulomb-L’hermine A, Durand-Gasselin I, Frydman R, Chaouat G. A 
new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro 
fertilization. Fertil Steril. 2004;81(1):59-65.
104. Le Bouteiller P, Piccinni MP. Human NK cells in pregnant uterus: why there? Am J Reprod Immunol. 
2008;59(5):401-6.
105. Satoh-Takayama N, Vosshenrich CAJ, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, et al. Microbial 
Flora Drives Interleukin 22 Production in Intestinal NKp46+ Cells that Provide Innate Mucosal Immune 
Defense. Immunity. 2008;29(6):958-70.
106. Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, et al. RORgammat and commensal 
microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat 
Immunol. 2009;10(1):83-91.
107. Manaster I, Mandelboim O. The Unique Properties of Uterine NK Cells. Am J Reprod Immunol. 
2010;63(6):434-44.
108. Dekel N, Gnainsky Y, Granot I, Mor G. Inflammation and Implantation. Am J Reprod Immunol. 
2010;63(1):17-21.
109. Mori M, Bogdan A, Balassa T, Csabai T, Szekeres-Bartho J. The decidua-the maternal bed embracing 
the embryo-maintains the pregnancy. Semin Immunopathol. 2016;38(6):635-49.
110. Medzhitov R, Janeway CA. Innate immunity: impact on the adaptive immune response. Curr Opin 
Immunol. 1997;9(1):4-9.
111. Swiatczak B, Rescigno M. How the interplay between antigen presenting cells and microbiota tunes 
host immune responses in the gut. Semin Immunol. 2012;24(1):43-9.
112. Rieger L, Honig A, Sutterlin M, Kapp M, Dietl J, Ruck P, et al. Antigen-presenting cells in human 
endometrium during the menstrual cycle compared to early pregnancy. Journal of the Society for 
Gynecologic Investigation. 2004;11(7):488-93.
113. Kämmerer U, von Wolff M, Markert UR. Immunology of human endometrium. Immunobiology. 
2004;209(7):569-74.
114. Smith PD, Janoff EN, Mosteller-Barnum M, Merger M, Orenstein JM, Kearney JF, et al. Isolation and 
purification of CD14-negative mucosal macrophages from normal human small intestine. Journal of 
immunological methods. 1997;202(1):1-11.
115. Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, Merger M, et al. Intestinal 
macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated 
activities. Journal of immunology (Baltimore, Md : 1950). 2001;167(5):2651-6.
116. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, et al. Human 
intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal 
activity. J Clin Invest. 2005;115(1):66-75.
117. Smythies LE, Shen R, Bimczok D, Novak L, Clements RH, Eckhoff DE, et al. Inflammation Anergy in 
Human Intestinal Macrophages Is Due to Smad-induced IB Expression and NF-B Inactivation. The 
Journal of biological chemistry. 2010;285(25):19593-604.
MICROBIOTA AND ENDOMETRIAL HEALTH 177
6
118. van der Molen RG, Schutten JH, van Cranenbroek B, ter Meer M, Donckers J, Scholten RR, et al. 
Menstrual blood closely resembles the uterine immune micro-environment and is clearly distinct from 
peripheral blood. Human reproduction (Oxford, England). 2014;29(2):303-14.
119. Shanmugasundaram U, Hilton JF, Critchfield JW, Greenblatt RM, Giudice LC, Averbach S, et al. Effects 
of the levonorgestrel-releasing intrauterine device on the immune microenvironment of the human 
cervix and endometrium. Am J Reprod Immunol. 2016;76(2):137-48.
120. Feyaerts D, Benner M, van Cranenbroek B, van der Heijden OWH, Joosten I, van der Molen RG. 
Human uterine lymphocytes acquire a more experienced and tolerogenic phenotype during pregnancy. 
Scientific reports. 2017;7(1):2884.
121. Saito S, Tsukaguchi N, Hasegawa T, Michimata T, Tsuda H, Narita N. Distribution of Th1, Th2, and Th0 
and the Th1/Th2 Cell Ratios in Human Peripheral and Endometrial T Cells. Am J Reprod Immunol. 
1999;42(4):240-5.
122. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J 
Reprod Immunol. 2010;63(6):601-10.
123. Figueiredo AS, Schumacher A. The T helper type 17/regulatory T cell paradigm in pregnancy. 
Immunology. 2016;148(1):13-21.
124. Omenetti S, Pizarro TT. The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome. 
Frontiers in immunology. 2015;6:639.
125. Ivanov, II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, et al. Specific microbiota direct the 
differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 
2008;4(4):337-49.
126. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C, et al. The key role of 
segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 
2009;31(4):677-89.
127. Ivanov, II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by 
segmented filamentous bacteria. Cell. 2009;139(3):485-98.
128. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic 
bacteria directs maturation of the host immune system. Cell. 2005;122(1):107-18.
129. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory 
disease. Nature. 2008;453(7195):620-5.
130. Johnson JL, Jones MB, Cobb BA. Polysaccharide A from the capsule of Bacteroides fragilis induces 
clonal CD4+ T cell expansion. The Journal of biological chemistry. 2015;290(8):5007-14.
131. Saito S, Sasaki Y, Sakai M. CD4+CD25high regulatory T cells in human pregnancy. Journal of 
reproductive immunology. 2005;65(2):111-20.
132. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, et al. Intestinal bacterial 
colonization induces mutualistic regulatory T cell responses. Immunity. 2011;34(5):794-806.
133. Dewhirst FE, Chien CC, Paster BJ, Ericson RL, Orcutt RP, Schauer DB, et al. Phylogeny of the defined 
murine microbiota: altered Schaedler flora. Appl Environ Microbiol. 1999;65(8):3287-92.
CHAPTER 6178
134. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of Colonic Regulatory 
T Cells by Indigenous Clostridium Species. Science. 2011;331(6015):337-41.
135. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, Santacruz N, et al. Peripheral education of the 
immune system by colonic commensal microbiota. Nature. 2011;478(7368):250-4.
136. van Mourik MS, Macklon NS, Heijnen CJ. Embryonic implantation: cytokines, adhesion molecules, and 
immune cells in establishing an implantation environment. Journal of leukocyte biology. 2009;85(1):4-19.
137. Dominguez F, Gadea B, Mercader A, Esteban FJ, Pellicer A, Simon C. Embryologic outcome and 
secretome profile of implanted blastocysts obtained after coculture in human endometrial epithelial 
cells versus the sequential system. Fertil Steril. 2010;93(3):774-82.e1.
138. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a 
T-lymphocyte chemoattractant. Proc Natl Acad Sci USA. 1994;91(9):3652-6.
139. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 
2011;11(11):762-74.
140. Li M-Q, Li H-P, Meng Y-H, Wang X-Q, Zhu X-Y, Mei J, et al. Chemokine CCL2 enhances survival and 
invasiveness of endometrial stromal cells in an autocrine manner by activating Akt and MAPK/Erk1/2 
signal pathway. Fertil Steril. 2012;97(4):919-29.e1.
141. He YY, He XJ, Guo PF, Du MR, Shao J, Li MQ, et al. The decidual stromal cells-secreted CCL2 
induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol. 
2012;145(2):161-73.
142. Wu HX, Jin LP, Xu B, Liang SS, Li DJ. Decidual stromal cells recruit Th17 cells into decidua to 
promote proliferation and invasion of human trophoblast cells by secreting IL-17. Cell Mol Immunol. 
2014;11(3):253-62.
143. Sierra-Filardi E, Nieto C, Dominguez-Soto A, Barroso R, Sanchez-Mateos P, Puig-Kroger A, et al. CCL2 
shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent 
gene expression profile. Journal of immunology (Baltimore, Md : 1950). 2014;192(8):3858-67.
144. Swiecki M, Miller HL, Sesti-Costa R, Cella M, Gilfillan S, Colonna M. Microbiota induces tonic CCL2 
systemic levels that control pDC trafficking in steady state. Mucosal Immunol. 2017;10(4):936-45.
145. Santos-Greatti MMV, da Silva MG, Ferreira CST, Marconi C. Cervicovaginal cytokines, sialidase activity 
and bacterial load in reproductive-aged women with intermediate vaginal flora. Journal of reproductive 
immunology. 2016;118:36-41.
146. Margioula-Siarkou C, Prapas Y, Petousis S, Milias S, Ravanos K, Kalogiannidis I, et al. LIF and LIFR 
expression in the endometrium of fertile and infertile women: A prospective observational casecontrol 
study. Molecular medicine reports. 2016;13(6):4721-8.
147. Marconi C, Santos-Greatti MM, Parada CM, Pontes A, Pontes AG, Giraldo PC, et al. Cervicovaginal 
levels of proinflammatory cytokines are increased during chlamydial infection in bacterial vaginosis but 
not in lactobacilli-dominated flora. Journal of lower genital tract disease. 2014;18(3):261-5.
148. Bisanz JE, Seney S, McMillan A, Vongsa R, Koenig D, Wong L, et al. A Systems Biology Approach 
Investigating the Effect of Probiotics on the Vaginal Microbiome and Host Responses in a Double Blind, 
Placebo-Controlled Clinical Trial of Post-Menopausal Women. PloS one. 2014;9(8):e104511.
MICROBIOTA AND ENDOMETRIAL HEALTH 179
6
149. Sansonetti PJ. War and peace at mucosal surfaces. Nature reviews Immunology. 2004;4(12):953-64.
150. Cénit MC, Matzaraki V, Tigchelaar EF, Zhernakova A. Rapidly expanding knowledge on the role of the 
gut microbiome in health and disease. Biochim Biophys Acta. 2014;1842(10):1981-92.
151. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell 
Biol. 2003;4(2):95-104.
152. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805-20.
153. Botos I, Segal DM, Davies DR. The Structural Biology of Toll-Like Receptors. Structure. 2011;19(4):447-59.
154. Janeway CA, Jr., Medzhitov R. Introduction: the role of innate immunity in the adaptive immune 
response. Semin Immunol. 1998;10(5):349-50.
155. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. A human homologue of the Drosophila Toll protein 
signals activation of adaptive immunity. Nature. 1997;388(6640):394-7.
156. Wira CR, Grant-Tschudy KS, Crane-Godreau MA. Epithelial cells in the female reproductive tract: a 
central role as sentinels of immune protection. Am J Reprod Immunol. 2005;53(2):65-76.
157. Young SL, Lyddon TD, Jorgenson RL, Misfeldt ML. Expression of Toll-like receptors in human endometrial 
epithelial cells and cell lines. Am J Reprod Immunol. 2004;52(1):67-73.
158. Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate Immunity in the Human Female Reproductive Tract: 
Antiviral Response of Uterine Epithelial Cells to the TLR3 Agonist Poly(I:C). Journal of immunology 
(Baltimore, Md : 1950). 2005;174(2):992.
159. Aflatoonian R, Fazeli A. Toll-like receptors in female reproductive tract and their menstrual cycle 
dependent expression. Journal of reproductive immunology. 2008;77(1):7-13.
160. Ghosh M, Shen Z, Fahey JV, Crist SG, Patel M, Smith JM, et al. Pathogen recognition in the human 
female reproductive tract: expression of intracellular cytosolic sensors NOD1, NOD2, RIG-1, and MDA5 
and response to HIV-1 and Neisseria gonorrhea. Am J Reprod Immunol. 2013;69(1):41-51.
161. D’Ippolito S, Tersigni C, Marana R, Di Nicuolo F, Gaglione R, Rossi ED, et al. Inflammosome in the 
human endometrium: further step in the evaluation of the “maternal side”. Fertil Steril. 2016;105(1):111-
8.e1-4.
162. Anders AP, Gaddy JA, Doster RS, Aronoff DM. Current concepts in maternal-fetal immunology: 
Recognition and response to microbial pathogens by decidual stromal cells. Am J Reprod Immunol. 
2017;77(3).
163. Jorgenson RL, Young SL, Lesmeister MJ, Lyddon TD, Misfeldt ML. Human endometrial epithelial cells 
cyclically express Toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA. Hum 
Immunol. 2005;66(5):469-82.
164. Hirata T, Osuga Y, Hamasaki K, Hirota Y, Nose E, Morimoto C, et al. Expression of toll-like receptors 
2, 3, 4, and 9 genes in the human endometrium during the menstrual cycle. Journal of reproductive 
immunology. 2007;74(1):53-60.
165. Aflatoonian R, Tuckerman E, Elliott SL, Bruce C, Aflatoonian A, Li TC, et al. Menstrual cycle-dependent 
changes of Toll-like receptors in endometrium. Human reproduction (Oxford, England). 2007;22(2):586-93.
CHAPTER 6180
166. King AE, Horne AW, Hombach-Klonisch S, Mason JI, Critchley HO. Differential expression and regulation 
of nuclear oligomerization domain proteins NOD1 and NOD2 in human endometrium: a potential role in 
innate immune protection and menstruation. Molecular human reproduction. 2009;15(5):311-9.
167. Nikzad H, Haddad Kashani H, Kabir-Salmani M, Akimoto Y, Iwashita M. Expression of galectin-8 on 
human endometrium: Molecular and cellular aspects. Iran J Reprod Med. 2013;11(1):65-70.
168. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, et al. The Toll-Like Receptor 2 Pathway Establishes 
Colonization by a Commensal of the Human Microbiota. Science. 2011;332(6032):974-7.
169. Petnicki-Ocwieja T, Hrncir T, Liu Y-J, Biswas A, Hudcovic T, Tlaskalova-Hogenova H, et al. Nod2 is 
required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA. 
2009;106(37):15813-8.
170. Sirota I, Zarek SM, Segars JH. Potential influence of the microbiome on infertility and assisted 
reproductive technology. Seminars in reproductive medicine. 2014;32(1):35-42.
171. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ, Relman DA. The application of ecological theory 
toward an understanding of the human microbiome. Science. 2012;336(6086):1255-62.
172. Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nature 
reviews Immunology. 2013;13(11):790-801.
173. Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. 
Nat Immunol. 2013;14(7):685-90.
174. Fabich AJ, Jones SA, Chowdhury FZ, Cernosek A, Anderson A, Smalley D, et al. Comparison of carbon 
nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect Immun. 
2008;76(3):1143-52.
175. Leatham MP, Banerjee S, Autieri SM, Mercado-Lubo R, Conway T, Cohen PS. Precolonized human 
commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-
treated mouse intestine. Infect Immun. 2009;77(7):2876-86.
176. Ubeda C, Djukovic A, Isaac S. Roles of the intestinal microbiota in pathogen protection. Clin Transl 
Immunology. 2017;6(2):e128.
177. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, et al. Precision microbiome reconstitution 
restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517(7533):205-8.
178. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut 
commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci 
USA. 2008;105(52):20858-63.
179. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, et al. Vancomycin-resistant enterococci exploit 
antibiotic-induced innate immune deficits. Nature. 2008;455(7214):804-7.
180. Spurbeck RR, Arvidson CG. Inhibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal 
Lactobacillus species. Infect Immun. 2008;76(7):3124-30.
181. Radtke AL, Quayle AJ, Herbst-Kralovetz MM. Microbial products alter the expression of membrane-
associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell 
model. Biol Reprod. 2012;87(6):132.
MICROBIOTA AND ENDOMETRIAL HEALTH 181
6
182. Yu Y, Lu L, Sun J, Petrof EO, Claud EC. Preterm infant gut microbiota affects intestinal epithelial 
development in a humanized microbiome gnotobiotic mouse model. Am J Physiol Gastrointest Liver 
Physiol. 2016;311(3):G521-32.
183. Banasaz M, Norin E, Holma R, Midtvedt T. Increased enterocyte production in gnotobiotic rats mono-
associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol. 2002;68(6):3031-4.
184. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating 
epithelial barrier function. Gastroenterol. 2007;132(4):1359-74.
185. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by 
indigenous microbes via Paneth cells. Proc Natl Acad Sci USA. 2002;99(24):15451-5.
186. Wexler HM. Bacteroides: the Good, the Bad, and the Nitty-Gritty. Clin Microbiol Rev. 2007;20(4):593-621.
187. Maier E, Anderson R, Roy N. Understanding How Commensal Obligate Anaerobic Bacteria Regulate 
Immune Functions in the Large Intestine. Nutrients. 2015;7(1):45.
188. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-
microbial relationships in the intestine. Science. 2001;291(5505):881-4.
189. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. 
Nat Rev Micro. 2011;9(5):356-68.
190. Murphy CR, Rogers PA, Hosie MJ, Leeton J, Beaton L. Tight junctions of human uterine epithelial cells 
change during the menstrual cycle: a morphometric study. Acta Anat (Basel). 1992;144(1):36-8.
191. Buck VU, Windoffer R, Leube RE, Classen-Linke I. Redistribution of adhering junctions in human 
endometrial epithelial cells during the implantation window of the menstrual cycle. Histochemistry and 
cell biology. 2012;137(6):777-90.
192. Turner JR. Intestinal mucosal barrier function in health and disease. Nature reviews Immunology. 
2009;9(11):799-809.
193. Romero R, Espinoza J, Mazor M. Can endometrial infection/inflammation explain implantation failure, 
spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril. 2004;82(4):799-804.
194. Espinoza J, Erez O, Romero R. Preconceptional antibiotic treatment to prevent preterm birth in women 
with a previous preterm delivery. Am J Obstet Gynecol. 2006;194(3):630-7.
195. Glassing A, Dowd SE, Galandiuk S, Davis B, Chiodini RJ. Inherent bacterial DNA contamination of 
extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass 
samples. Gut Pathog. 2016;8(1):24.
196. Gohl DM, Vangay P, Garbe J, MacLean A, Hauge A, Becker A, et al. Systematic improvement of amplicon 
marker gene methods for increased accuracy in microbiome studies. Nat Biotechnol. 2016;34(9):942-9.
197. Parnell LA, Briggs CM, Mysorekar IU. Maternal microbiomes in preterm birth: Recent progress and 
analytical pipelines. Seminars in perinatology. 2017.
198. Campisciano G, Florian F, D’Eustacchio A, Stankovic D, Ricci G, De Seta F, et al. Subclinical alteration 
of the cervical-vaginal microbiome in women with idiopathic infertility. Journal of cellular physiology. 
2017;232(7):1681-8.
199. Pelzer E, Gomez-Arango LF, Barrett HL, Nitert MD. Maternal health and the placental microbiome. 
Placenta. 2016.
CHAPTER 6182
200. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. 
Cochrane Database Syst Rev. 2007(1).
201. Johnston-MacAnanny EB, Hartnett J, Engmann LL, Nulsen JC, Sanders MM, Benadiva CA. Chronic 
endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. 
Fertil Steril. 2010;93(2):437-41.
202. Laniewski P, Gomez A, Hire G, So M, Herbst-Kralovetz MM. Human Three-Dimensional Endometrial 
Epithelial Cell Model To Study Host Interactions with Vaginal Bacteria and Neisseria gonorrhoeae. Infect 
Immun. 2017;85(3).
203. Yeoman CJ, Thomas SM, Miller ME, Ulanov AV, Torralba M, Lucas S, et al. A multi-omic systems-based 
approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PloS one. 
2013;8(2):e56111.
204. Thaiss CA, Levy M, Korem T, Dohnalova L, Shapiro H, Jaitin DA, et al. Microbiota Diurnal Rhythmicity 
Programs Host Transcriptome Oscillations. Cell. 2016;167(6):1495-510.e12.
205. Kundu P, Blacher E, Elinav E, Pettersson S. Our Gut Microbiome: The Evolving Inner Self. Cell. 
2017;171(7):1481-93.
206. Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UM, Zhong X, et al. Temporal dynamics of the human 
vaginal microbiota. Science translational medicine. 2012;4(132):132ra52.
207. Kunz G, Beil D, Deiniger , Einspanier A, Mall G, Leyendecker G. The Uterine Peristaltic Pump. In: Ivell 
R, Holstein A-F, editors. The Fate of the Male Germ Cell. Boston, MA: Springer US; 1997. p. 267-77.
208. Zervomanolakis I, Ott HW, Hadziomerovic D, Mattle V, Seeber BE, Virgolini I, et al. Physiology of upward 
transport in the human female genital tract. Ann N Y Acad Sci. 2007;1101:1-20.
209. Racicot K, Cardenas I, Wunsche V, Aldo P, Guller S, Means RE, et al. Viral infection of the pregnant 
cervix predisposes to ascending bacterial infection. Journal of immunology (Baltimore, Md : 1950). 
2013;191(2):934-41.
210. Hein M, Valore EV, Helmig RB, Uldbjerg N, Ganz T. Antimicrobial factors in the cervical mucus plug. Am 
J Obstet Gynecol. 2002;187(1):137-44.
211. Hassan SS, Romero R, Pineles B, Tarca AL, Montenegro D, Erez O, et al. MicroRNA expression profiling 
of the human uterine cervix after term labor and delivery. Am J Obstet Gynecol. 2010;202(1):80.e1-8.
212. Ren H, Du M. Role of Maternal Periodontitis in Preterm Birth. Frontiers in immunology. 2017;8:139.
213. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. 
Journal of clinical microbiology. 2005;43(11):5721-32.
214. Kumar PS, Griffen AL, Barton JA, Paster BJ, Moeschberger ML, Leys EJ. New bacterial species 
associated with chronic periodontitis. Journal of dental research. 2003;82(5):338-44.
215. Dortbudak O, Eberhardt R, Ulm M, Persson GR. Periodontitis, a marker of risk in pregnancy for preterm 
birth. Journal of clinical periodontology. 2005;32(1):45-52.
216. Han YW, Ikegami A, Bissada NF, Herbst M, Redline RW, Ashmead GG. Transmission of an uncultivated 
Bergeyella strain from the oral cavity to amniotic fluid in a case of preterm birth. Journal of clinical 
microbiology. 2006;44(4):1475-83.
MICROBIOTA AND ENDOMETRIAL HEALTH 183
6
217. Zaura E, Nicu EA, Krom BP, Keijser BJ. Acquiring and maintaining a normal oral microbiome: current 
perspective. Frontiers in cellular and infection microbiology. 2014;4:85.
218. Jimenez E, Marin ML, Martin R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy 
newborns actually sterile? Res Microbiol. 2008;159(3):187-93.
219. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, et al. Dendritic cells express 




Supplementary Figure 1. Flow chart of the performed literature search to assess the available uterine 16S 
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Antibiotic intervention affects maternal 
immunity during gestation in mice 
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Pregnancy is a portentous stage in life, during which countless events are precisely orchestrated 
to ensure a healthy offspring. Maternal microbial communities are thought to have a profound 
impact on development. Although antibiotic drugs may interfere in these processes, they 
constitute the most frequently prescribed medication during pregnancy to prohibit detrimental 
consequences of infections. Gestational antibiotic intervention is linked to preeclampsia and 
negative effects on neonatal immunity. Even though perturbations in the immune system of 
the mother can affect reproductive health, the impact of microbial manipulation on maternal 
immunity is still unknown. 
Aim
To assess whether antibiotic treatment influences maternal immunity during pregnancy. 
Methods
Pregnant mice were treated with broad-spectrum antibiotics. The maternal gut microbiome was 
assessed. Numerous immune parameters throughout the maternal body, including placenta 
and amniotic fluid were investigated and a novel machine-learning ensemble strategy was used 
to identify immunological parameters that allow distinction between the control and antibiotics-
treated cohort. 
Results
Antibiotic treatment reduced diversity of maternal microbiota, but litter sizes remained unaffected. 
Effects of antibiotic treatment on immunity reached as far as the placenta. Four immunological 
features were identified by recursive feature selection to contribute to the most robust cohort 
classification (splenic T helper 17 cells and CD5+ B cells, CD4+ T cells in mesenteric lymph 
nodes and RORγT mRNA expression in placenta).
Conclusion
In the present study, antibiotic treatment was able to affect the carefully coordinated immunity 
during pregnancy. These findings highlight the importance of inclusion of immunological 
parameters when studying the effects of medication used during gestation. 
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INTRODUCTION
Any medication during pregnancy demands careful consideration, however treatment is 
essential when infections need to be controlled to ensure safe progression of the pregnancy. 
In western society, antibiotics for systemic use are amongst the most frequently prescribed 
drugs during gestation (1). Most commonly, gestational respiratory tract infections or urinary 
tract infections (UTI) require systemic anti-infectious medical intervention (2-4). If left untreated, 
20-40% of asymptomatic UTI advance to acute UTI, which can lead to premature labor in up to 
half of the women affected (5). Antibiotic intervention has been shown to reduce complications 
of UTI such as preterm birth and/or low birth weight (6). Approximately 1 in 5 pregnancies 
is exposed to antimicrobial treatment nowadays (1, 7). While this can safeguard pregnancy, 
microbial intervention during pregnancy is known to have long term effects on the offspring 
as well. Gestational use of antibiotics is associated with an increased risk for the offspring to 
develop non communicable diseases like asthma, obesity, and even increased susceptibility to 
infections (8-10).
In general, antibiotic prescriptions require rational and critical use, not only to limit the selection 
towards drug-resistant pathogens (11). Awareness of how the natural microbiomes’ contribution 
to physiology increases, and a diverse microbiome is key to healthy immunity (12-14). Systemic 
antibiotics drastically reduce the diversity of the gut microbiome and, depending on the 
compound and its target, impact on bacterial taxa can last for years (15, 16). This interference 
through broad-spectrum microbial modulation resulted, among others, in colonic infiltration 
of innate inflammatory cells in mice (17). In addition,  antibiotics treatment  skewed T cells 
towards an activated T helper (Th) 1 profile, together with a reduced proportion of FOXP3+CD4+ 
regulatory T cells (Treg) (17). After antibiotic treatment, a general increase in pro-inflammatory 
transcriptional and cellular responses was observed, such as an activation of dendritic cells and 
upregulation of genes of pro-inflammatory cytokines interleukin 6 (IL-6), IL-8 and CXCL2 (18). The 
adverse effects of this inflammatory state might be limited in young adults (>65 years age) (18) 
but it is unsure if this holds true for pregnant women. 
Pregnancy relies on tightly regulated immunity to allow trophoblast invasion and prevent 
infection, while excessive inflammation of the prenatal environment has to be avoided as well 
(19-27). Especially at the direct fetal environment, dysregulated immunity can cause pregnancy 
complications, such as preeclampsia (PE) and preterm birth, with long-term consequences on 
the offspring’s development (28-30). As such, antibiotic-mediated changes of immunity can 
endanger prenatal development. Based on this, we questioned in this study whether gestational 
antibiotic use translates to maternal immune adaptations with possible impact on reproductive 
health. We here evaluated immunity of different maternal immunological compartments, including 
the placenta, using a murine model of gestational microbial modification. 
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RESULTS
Microbial disruption does not result in pregnancy complications in mice 
Gestational antibiotic intervention of metronidazole, neomycin and polymyxin was previously 
shown to influence immunity of the offspring without observed pregnancy complications (31). 
Following this established treatment regime (Figure 1A), we assessed effective maternal 
microbial modification. 16S rRNA analysis of the gut showed a distinct microbiota composition in 
antibiotic treated mice compared to the control cohort (Figure 1B-C). In total 39 different genera 
showed a significant change in relative abundance as well when both groups were compared 
using ANCOM pipeline (Supplementary Table 1). In addition, a significant decrease of total 
alpha diversity represented by Shannon index diversity was observed in the antibiotic treated 
group (p-value = 0.0001616, Figure 1D). As major microbiota metabolites, SCFAs are involved 
in regulating intestinal integrity and intestinal immunity (32). Antibiotic treatment did not affect 
SCFA levels in maternal cecum, as no significant differences were observed regarding levels 
of acetic acid, propionic acid and butyric acid (Supplementary Figure S1A). Iso-butyric acid, 
valeric acid, and iso-valeric acid were not quantifiable in the cecal content of all sampled mice. 
To investigate a possible direct microbial effect of treatment on the prenatal environment,  the 
16S rRNA profiles of placental tissue were analyzed as well. Although some samples had reads 
as revealed by Qiime2 and DADA2 analysis, these represented mostly unspecific contamination, 
probably due to the high concentration of eukaryotic DNA in the samples. Therefore, based 
on our methods, we could not identify the presence of a specific bacterial community in the 
placentas analyzed. Pregnancy outcome was assessed as the number of pregnancies, intact 
and resorbed fetuses. No statistically significant differences were observed between groups. 
Eleven pregnant mice of the control group, and 8 of the antibiotic-treated group had a mean 
litter size of 7.8 (range 3-11, mean resorption rate 1) and 9.4 (range 3-11, mean resorption 
rate 0.8), respectively (Supplementary Figure S1B+C). No clinical symptoms in the antibiotic-
treated group were observed that would suggest adverse effects on maternal health and as a 
consequence, pregnancy. Building on this intervention model, we then proceeded to analyze the 
consequences of antibiotic treatment on the maternal immune system.
Antibiotic treatment associated with shift in immune parameters differentiating from 
control cohort 
Maternal immunity was assessed by flow cytometry of placenta, spleen, ILN, MLN and peritoneal 
cavity lavage fluid (PCLF), mRNA of intestines and placenta, and cytokine levels of maternal 
serum, amniotic fluid and splenocytes. A total of 129 different parameters were analyzed 
(Supplementary Table 2). To detect the classifying immune alterations occurring upon antibiotic 
treatment,  a previously validated machine learning ensemble classification strategy was used 
(33, 34) suited for robust feature selection in the given low sample size setting. This method 
combines 8 classification algorithms, which compensates for possible biases inherent to the 



























































































































Day -3 0 4 1713AB AB
Figure 1. Antibiotic intervention in pregnant Balb/c mice. 
(A) Schematic representation of the experimental model. After randomly assigning mated mice to the treatment groups, 
11 mice of the control and 8 mice of the treatment cohort were pregnant and included for further analysis. (B) 16S rRNA 
composition of the cecal samples per individual animal (1 sample of the antibiotic treatment cohort excluded due to read 
count <500). (C) Principal component analysis of 16S rRNA sequencing data on genus level. (D) Shannon Index presenting 
microbial diversity. 
individual algorithm. The output of the 8 classifi cation algorithms each yielded a ranked list of 
features, representing the contribution of the 129 immune features to cohort classifi cation. Each 
list was weighted based on coeffi cients and frequency of an individual feature contributing to 
classifi cation (34) to aggregate classifi ers to a single ranking. Classifi cation algorithms were 
repeatedly run using the top 80% of the ensemble ranking (recursive feature selection). Each 
classifi cation run was carried out 10 times, each run being subjected to 10-fold cross validation. 
At a global average accuracy of 90% as cutoff to ensure robust classifi cation (Figure 2A), 
ensemble accuracy for each iteration of feature combinations showed optimal classifi cation 
CHAPTER 7192
when combining 4 features: frequency of Th17 cells and CD5+ B cells of the spleen, fold-change 
of RORγT assessed in placental tissue, and frequencies of CD4+ T cells of MLN (normalized 
expression values, Figure 2B). Principal component analysis illustrated separation of maternal 
immunity after antimicrobial intervention from healthy control (Figure 2C). The area under the 
curve (AUC) of 0.99 of the receiver operating characteristic (ROC) analysis confirmed robust 







Figure 2. Multivariate analysis of immunologic assessment across samples of spleen, mesenteric lymph 
node, inguinal lymph node, peritoneal cavity lavage fluid, amniotic fluid, and placenta. 
(A) Recursive feature reduction used in an ensemble machine-learning strategy to determine the number of top features 
needed to achieve robust (>90% accuracy) cohort classification. (B) Top 4 immune features that allow for distinction 
between cohorts. Normalized expression levels are depicted. (C) Principal component analysis based on the top 4 features 
that allowed for optimal cohort classification. (D) Individual classification algorithms were run with the top 4 features of 
the ensemble ranking. The receiver operating curve of Ridge regression is shown. The same results were observed using 
Passive-Aggressive or Logistic regression. Additional receiver operating curves are depicted in Supplementary Figure 2. AB: 
Cohort treated with antibiotics, MLN: mesenteric lymph nodes. 
Systemic and placental T cell adaptations mediated by gestational antibiotics 
Immune features of adaptive immunity contributed to cohort stratification as shown by machine-
learning. Additionally, by univariate analysis, extra attention was payed to the different T cell 
subsets, whose differentiation is known to be influenced by symbiotic microbiota (35-37). While 
frequencies of Th1 (CD4+ CXCR3+) and Th2 (CD4+ T1/ST2+) in spleen, ILN, MLN and PCLF were 
not affected by treatment (Supplementary Figure S3A and B), a significant increase in placental 
Th2 cell frequencies was observed (29.0% ± 2.8% compared to 20.8% ± 4.4% in the control 
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group, Figure 3A). Percentages of CD4+CCR6+RorγT+ Th17 cells were lower in the spleens of 
mice treated with antibiotics (1.4% ± 0.1% compared to 1.1% ± 0.1% in the control group, Figure 
3B) but no such differences were observed in other tissues. A signifi cantly lower percentage 
of splenic CD4+CD25+FOXP3+ regulatory T cells (Treg) was observed in the antibiotic-treated 
group (5.3% ± 0.4% compared to 6.7% ± 0.3% in the control group, Figure 3C), but not in 
other compartments (Supplementary Figure S3C). Overall, T cell activation as observed through 
CD25 and CD69 expression was not affected in any of the tissues (Supplementary Figure S3D). 
Functional assessment of maternal lymphocytes through splenocytes stimulated ex vivo with LPS 
revealed only limited alterations of detectable cytokine levels in the supernatant. IL-6 production 
was signifi cantly affected by the antibiotic treatment (Figure 3D) and a trend towards a higher 
IL-22 production was observed (p 0.061, Figure 3E). No signifi cant differences were observed for 








Splenocytes (24h LPS) Splenocytes (24h LPS)
Th2
Placenta












































































































Figure 3. Univariate analysis comparing T cell subsets of antibiotic-treated and control mice. 
(A) Frequencies of T helper 2 cells within T cells isolated from placental tissue, staining CD4+T1ST2+. (B) Splenic 
CD4+CD25+FOXP3+ regulatory T cells as frequency of total T cells. (C) CD4+CCR6+RORγ T+ T helper 17 cells isolated 
from spleen, peritoneal cavity lavage fl uid, inguinal lymph nodes, mesenteric lymph nodes, and placenta. Data were 
compared by Mann-Whitney/Wilcoxon tests (non-parametric), * p < 0.05 **p < 0.01. ILN: Inguinal lymph nodes, MLN: 
mesenteric lymph nodes, ns: non-signifi cant. 
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DISCUSSION
In utero exposure to antibiotics could impact neonatal immunity through two different routes: 
by disrupting microbial colonization of the child, needed for healthy immune development, 
or by the antibiotics’ impact on maternal immunity. The latter is associated with pregnancy 
complications known to alter offspring development (38-41). In the current study, we examined 
the effect of antibiotic treatment on maternal immunity using a murine gestational model. The 
chosen microbial intervention strategy was shown to affect offspring immunity (31). In line with 
this previous investigation of this combination of antibiotics, antibiotic treatment significantly 
decreased microbial diversity in the ceca of pregnant mice, but none of the mice were observed to 
have any clinical symptoms or reduced reproductive success. It was however possible to detect 
a maternal shift in immunological profile by using a machine learning ensemble classification 
strategy to assess >100 immune parameters of different sampling sides simultaneously 
(33, 34). Recursive feature elimination reduced the assessed parameters to a selection of 4 
immunological features that distinguished control from antibiotic treated mother animals with an 
accuracy of >90%. Of note, these immune adaptations were observed throughout the maternal 
body, reaching as far as the placenta. 
Antibiotics are known to affect intestinal immunity due to microbial manipulation of this 
immunological compartment (17, 42). Little is known on how this translates to other immune 
sites, especially regarding gestational tissues. In this exploratory approach, samples of placenta 
and amniotic fluid were included, and immune features were obtained through multiple methods, 
i.e. a combination of flow cytometry, mRNA expression, and analysis of soluble factors, to cover 
a wide range of possible effects. Using machine learning and recursive feature selection allowed 
for an open assessment of studied parameters. This dimensionality reduction enabled an 
unbiased focus on the strongest induced changes. Additionally, the applied ensemble strategy 
offered stable feature selection in this low sample size setting. After mating, of the 40 females 
that were randomly allocated to the control and treatment cohort, 11 and 8 mice respectively 
were pregnant and available for a final readout. Small sample size and large variation of the input 
data could weaken reproducibility when single selection algorithms are used, a limitation that 
could be overcome by the applied ensemble approach (34, 43). The presented high accuracy 
of the classification underlines how computational methods may help to reduce the number of 
animals needed for in vivo studies. 
While earlier findings showed that antibiotic treatment resulted in a macrophage-dependent 
increase in inflammatory colonic Th1 responses mice (17), we did not observe any differences 
in Th lymphocyte populations in the MLN, the gut-draining lymph nodes, of the antibiotic 
treated animals. Of note, the study by Scott and colleagues investigated immunity in male 
mice (17) and thus could not take into account the highly specialized immune dynamics of 
GESTATIONAL ANTIBIOTICS AFFECT IMMUNITY 195
7
pregnancy. We additionally investigated placental and amniotic fluid samples, showing that 
systemic immune features do not represent immunity of gestational tissues. For example, 
placental CD4+CD25+FOXP3+ Treg populations remained unaffected, whereas the percentage 
of splenic Treg in antibiotic treated mice was reduced. Especially Treg of the fetal-maternal 
interface are considered critical to maintaining the anti-inflammatory environment necessary 
during the implantation period and throughout gestation (44). The increase in decidual Treg 
upon conception is hypothesized to be facilitated locally; through seminal fluid (45), human 
chorionic gonadrotropin secreted by the blastocyst (46), extravillous trophoblast cells (47), or 
local immune cells such as decidual macrophages (47). This local induction, independent from 
systemic immunity, might be connected to the observed lack of antibiotic effect on placental 
Treg. On the other hand, we detected an increase in the Th2 cell populations in the placentas 
after antibiotic treatment. Based on the premise that gestational immunity depends on a tightly 
regulated Th1/Th2 mediated cytokine balance (48), it is tempting to consider this a protective 
counteraction to prevent from a possible proinflammatory load upon external modifications 
during gestation. Thus, while the underlying mechanisms of how gestational antibiotics may 
perturb maternal immunity and fetal development are not yet clear, our results emphasize the 
need to study parameters of the fetal environment. The observed altered immunological profile 
upon antibiotics may be linked to side effects that were previously exclusively ascribed to its 
antimicrobial effect.
During pregnancy, any dysregulation of immunity might affect placentation and thus fetal 
development (21, 49-51). Gestational immune adaptations are highly specialized to enable 
selective tolerance towards invading fetal cells, immune-competence to overcome pathogenic 
invasion, and immune-mediated support of establishing vascularization during placenta 
formation (52-55). Imbalance of immunity is thought to hamper correct placentation and thus 
contribute to the etiology of preeclampsia (PE) (56, 57). Indeed, prescription of antibiotics during 
pregnancy is associated with an increased risk of PE, which is also concerning considering that 
a fairly large proportion of pregnant women are prescribed antibiotics without an indication (58, 
59). Still, it is unclear whether infections like UTI themselves, or their treatment is associated 
with an increased risk of developing PE (60). In case of an infection that requires antibiotic 
intervention, the involved inflammatory cascade may elicit systemic maternal inflammation 
and endothelial injury, which could also increase the risk of PE (61-65). Nevertheless, in vitro 
assays have shown that an alteration of immune responses can also occur independent of 
altered microbiota as phagocytosis by macrophages was inhibited directly through addition of 
antibiotics (66). Moreover, the current study shows that also in absence of infection, antibiotics 
affect the immune balance during pregnancy. 
In conclusion, either mediated by manipulation of the microbial profile or by direct effects of 
antibiotics, treatment affects the tightly regulated immunity of pregnancy. The associated 
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poorly understood - but possibly far-reaching - consequences underscore the need for careful 
assessment and restraint use of antibiotics during pregnancy. Pregnant women are generally 
excluded from clinical trials, and, other than what can be deduced from retrospective studies, 
few approaches take into account the unique adaptations occurring to maintain a healthy 
pregnancy. These present results highlight the importance of in vivo studies on medication used 
during gestation to employ pregnancy models, taking into account the unique immunological 
properties, and possible tissue-specific effects, of this period. 
MATERIALS AND METHODS
Animals
8-week-old, specific pathogen-free, male C57Bl/6 mice and 8-week-old nulliparous female 
Balb/c, purchased from Envigo (Horst, The Netherlands) were housed at the animal facility of the 
Utrecht University (Utrecht, The Netherlands) on a reversed 12 h light/dark cycle with unlimited 
access to water and semi‐purified AIN‐93G soy protein‐based rodent diet (Ssniff Spezialdiäten 
GmbH, Soest, Germany). Upon arrival, mice were habituated to the laboratory conditions for two 
weeks prior to the start of the study. The male mice were mated with a separate set of Balb/c 
females (Envigo, Horst, The Netherlands) prior to the experiment, and males with proven fertility 
were selected to mate with the experimental females. Males were housed individually before and 
after mating, and female mice were housed 2 per cage. Animal procedures were approved by 
the Ethical Committee for Animal Research of the Utrecht University and conducted according 
to the European Directive 2010/63/EU on the protection of animals used for scientific purposes 
(AVD108002016597). 
Experimental design
After 14 days of acclimatization, bedding from the cages of assigned breeder males was added 
to the cages of experimental female mice to facilitate synchronization of the females’ cycle. After 
three days, males and females were housed together for 72 hours in a 1:2 ratio. Vaginal plugs 
were scored to assess the time of mating. After mating, the females were randomly assigned 
into the control group or the antibiotic treatment group. Antibiotic treatment was carried out by 
adding a mix of 2.5 mg/ml neomycin (Sigma Aldrich, Zwijndrecht, The Netherlands), 0.5 mg/ml 
metronidazole (Sigma Aldrich), and 0.09 mg/ml polymyxin (Sigma Aldrich) in the drinking water. 
The treatment consisted of two courses, starting with 4 days antibiotic treatment with followed 
by 10 days without antibiotics and another 4 days with antibiotics (Figure 1A). The animals were 
weighed before mating and at the end of experiment to evaluate the weight gain. The pregnant 
mice were killed by cervical dislocation on day 17 after mating, after which the number of fetuses 
and resorptions were assessed and tissue samples were collected for further analysis. During 
the sectioning, which was carried out in a laminar flowhood, sterile surgical instruments were 
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used. Pregnant mice were killed in a separate part of the flowhood to avoid contamination of the 
location where murine tissues were collected. The skins of the mice were carefully swabbed with 
ethanol, after which an intraperitoneal lavage was carried out by flushing the peritoneal cavity 
with 2 ml of PBS to collect intraperitoneal leukocytes. Hereafter, the abdominal cavity was opened 
using one set of surgical instruments, carefully avoiding contact of the skin with the abdominal 
cavity by pinning the skin of the animals back. Another set of sterilized surgical instruments 
was used to isolate placental and fetal tissues, and amniotic fluid was collected from individual 
amniotic cavities of the fetuses. Hereafter, other tissues (e.g. spleen, intestinal tissue and lymph 
nodes) were isolated, for which purpose the carcass of the mouse was moved to another section 
of the laboratory, to avoid contamination of the laminar flowhood. Samples isolated for analysis 
of mRNA-expression were immediately snap-frozen using dry ice and stored at -80°C. Samples 
used for flow cytometry or cell culturing were kept on ice until further processing.
Microbiota-analysis placenta & cecum
Total DNA was isolated from 50-225 microgram of cecal content feces and 125-200 microgram of 
placental tissue using the QIAamp Stool DNA mini kit (Qiagen). DNA was quantified by NanoDrop 
assay. The 16S rRNA gene profiling was analyzed as described by Paganelli et al 2019, by the 
Exposome HUB Utrecht. Briefly, 16S rRNA regions V3 and V4 were sequenced with an Illumina 
MiSeq reagent Kit v3 (600‐cycle) on an Illumina MiSeq instrument (Illumina)(67). Samples were 
analyzed with the QIIME™ 2 microbial community analysis pipeline (68). For the cecum samples, 
significant differences between treatment and control groups at genus level were detected 
using the statistical framework analysis of composition of microbiomes (ANCOM)(69). p‐values 
were adjusted for multiple comparisons using false discovery rates. RStudio 1.4.1103 (RStudio 
Team) was used to calculate alpha diversity using the Shannon index, and significance was 
calculated by the Wilcoxon test. The global difference in microbiota composition was assessed 
using principal component analysis (PCA), employing zCompositions, centered log‐ratio (CLR) 
transformation, and ggplot R packages. 
SCFA analysis cecal content
The cecal SCFA levels of acetic, propionic, butyric, isobutyric and valeric acids were quantitatively 
determined as well as levels of lactic acids as described previously (70, 71). The SCFA were 
captured using a Shimadzu GC2010 gas chromatograph (Shimadzu Corporation, Kyoto, 
Japan) equipped with a flame ionisation detector. SCFA concentrations were determined using 
2-ethylbutyric acid as an internal standard. Lactic acids were determined enzymatically using a 
d/l-lactic acid detection kit with d- and l-lactate dehydrogenase (EnzyPlus, BioControl Systems, 
Inc., Bellevue, WA, USA).
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Lymphocyte subset analysis
For flow cytometric analysis of lymphocytes, single cells suspensions were prepared from 
isolated placental tissue, spleens, mesenteric lymph nodes (MLN) and inguinal lymph nodes 
(ILN). ILN and MLN single cell suspensions were obtained by crushing the tissue through 70 µm 
cell strainers on ice. The strainers were washed with RPMI 1640 medium, after which the cells were 
counted, resuspended in PBS and kept on ice until further processing. Splenocytes were similarly 
isolated, but red blood cells were lysed prior to counting the cells using lysis buffer (8.3 g NH4Cl, 
1 g KHC3O, and 37.2 mg EDTA dissolved in 1 L demi water and filter sterilized). Placental tissues 
were cut into small pieces and incubated with Accutase (Stempro, GIBCO Life Technologies, 
Waltham, USA) for 35 min at 37°C under slight agitation. Hereafter, red blood cells were lysed as 
described for splenocytes, and placental cells were washed, counted, resuspended in PBS and 
kept on ice until further processing. Prior to staining cells for flow cytometric analysis, they were 
washed in PBS and 50µl of cell suspension (4.106 cells/ml) was incubated with a fixable viability 
dye eFluor® 780 (eBiosciences, Thermo Fisher Scientific, San Diego, CA, USA) for 30 min at 
4°C. After washing, cells were incubated with anti-mouse CD16/CD32 (1:100 dilution in PBS/1% 
BSA; Mouse BD Fc Block, BD Pharmingen, San Jose, CA, USA) to block non-specific binding 
sites. For flow cytometric analysis of surface marker expression, cells were incubated at room 
temperature for 1 h in the dark with corresponding antibody-cocktails, washed with PBS/1% BSA 
and fixed in 1 % paraformaldehyde-solution until flow cytometric analysis. For the analysis of 
intracellular markers, cells were first stained for extracellular markers, washed with PBS/1% BSA 
and incubated overnight in Fix/Perm buffer (eBiosciences). The following day, cells were washed 
with permeabilization buffer (eBioscience), and incubated with anti-mouse CD16/CD32 for 15 
min at 4°C in the dark. Next, the cells were stained for intracellular markers for 30 min at 4°C in the 
dark, washed in PBS/1% BSA and immediately used for flow cytometric analysis. The following 
fluorochrome-conjugated monoclonal antibodies were used: CD4-PerCP-Cy5.5 (eBioscience), 
CD69-APC (eBioscience), CXCR3-PE (eBioscience), T1ST2-FITC (MD Biosciences, St. Paul, 
MN, USA); CD11b- PerCP-Cy5.5 (eBioscience), NK1.1-APC (eBioscience), CD49b-FITC 
(eBioscience), CD94-PE (eBioscience); CD4- Brilliant Violet 510, CCR6-PE (BioLegend, San 
Diego, CA, United States), CD25-PerCP-Cy5.5, (eBiosciences), CD196 (CCR6)-PE (BioLegend), 
CD127-PE-Vio770 REA (Miltenyi Biotec, Bergisch Gladbach, Germany), Neuropilin-eFluor450 
(eBioscience), RorγT-Alexafluor 647 (BD Pharmingen, San Jose, CA, USA), CD1d-PerCP-Cy5.5 
(BioLegend), CD5-Alexa Fluow 647 (BioLegend), CD19-PE-Cy7 (BD), CD21/CD35-FITC (BD), 
CD23-PE (BD), CD24-Brilliant Violet 510 (BD), Tim-1-Brilliant Violet 421 (BD), Viability-APC-Cy7 
(eBioscience). Results were collected with BD FACSCanto II flow cytometer (Becton Dickinson, 
Franklin Lakes, NJ, USA) and analyzed with FlowLogic software (Inivai Technologies, Mentone, 
VIC, Australia) and Kaluza software (v2.1, Beckman Coulter, Fullerton, CA, USA). 
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Placental and intestinal mRNA-expression analysis
Total RNA was isolated from maternal intestinal tissues and placenta using the RNeasy mini kit 
(Qiagen, Germantown, USA) and cDNA was prepared using the iScript cDNA synthesis kit (Bio 
Rad, Veenendaal, the Netherlands), according to the manufacturer’s instructions. For quantitative 
real-time PCR, the reaction mixture was prepared by adding specific forward and reverse primers 
and iQSYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA) to the cDNA samples, 
and amplifications were performed according to the manufacturer’s instructions using the 
CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA). 
Validated qPCR primers for FOXP3, T-bet, GATA3, ROR-γT, β-Actin and IL-10 were obtained from 
SABiosciences (Qiagen, Germantown, USA). mRNA expression levels were calculated relative to 
the expression of β-actin reference gene with CFX Manager software (version 1.6).
Determination of cytokine profiles (in amniotic fluid, and after ex vivo stimulation of 
splenocytes)
Splenocytes collected from pregnant mice were cultured at a concentration of 4.106 cells/
ml RPMI 1640 culture medium in 96-well U-bottom culture plates at 37°C in a humidified 
environment containing 5% CO2, in the presence or absence of 10 µg/ml lipopolysaccharide 
(LPS) (Sigma). Cell culture supernatants were collected after 24 hours and stored at −20°C until 
further analysis. A ProcartaPlex multiplex protein assay kit (Invitrogen, Thermo Fisher Scientific, 
Waltham, MA, USA) was used to assess the concentrations of interleukin (IL)-1β, IL-2, IL-4, IL-
6, IL-10, IL-22, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ in amniotic fluid and cell 
culture supernatants, according to manufacturer’s instructions. To calculate expression levels of 
cytokines by maternal splenocytes, cytokine concentrations in supernatants of LPS-stimulated 
cells were corrected for those measured in supernatants of unstimulated cells. 
Recursive automatic ensemble feature selection 
To discover the selection of immunological parameters that allow classification as control or 
antibiotics-treated cohort, a previously established ensemble feature selection was used 
(33, 34). This strategy allows for a more general selection of stratifying features than a single 
classifier, overcoming the bias of each individual algorithm. In brief, 8 classifiers (Bagging, 
Gradient Boosting, Logistic regression, Passive-Aggressive regression, Random Forest, Ridge 
Regression, SGD (Stochastic Gradient Descent on linear models), and SVC (Support Vector 
Machines Classifier with a linear kernel) classifier) generated a list of relative feature importance 
that is scored for a combined summary of top most relevant features. To ensure generality 
of the results, each classifier was run 10 times together with a 10-fold cross validation. This 
was repeated in a stepwise reduction of the 129 initial features by 20%, while determining the 
accuracy for each classifier. 
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Univariate analysis
Data were analyzed using R v.4.0.2 and the ggpubr, ggplot2, ggsignif, tidyr packages. Non-
parametric Mann-Whitney test was performed. Values of p <0.05 were considered statistically 
significant.
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Supplementary Figure S2 | Receiver operating characteristic curves of the individual classifiers used in the ensemble strategy after
feature selection. 
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Supplementary Figure S2. Receiver operating characteristic curves of the individual classifiers used in the 
ensemble strategy after feature selection.
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Supplementary Figure S3 | Univariate analysis of T cells. (A) T helper 1 cells, (B) T helper 2 cells, (C) Regulatory T cells, and (D) activated T 
cells. ILN: inguinal lymph nodes, MLN: mesenteric lymph nodes, ns: non-significant, Th: T helper cells. 
3
Su lementary Figure S3. Univariate analysis of T lls.
(A) T helper 1 cells, (B) T helper 2 cells, (C) Regulatory T cells, and (D) activated T cells. ILN: inguinal lymph nodes, MLN: 
mesenteric lymph nodes, ns: non-significant, Th: T helper cells.
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Supplemental Figure S4 | Gating strategy of features included in machine learning approach (see Supplemental Table T2 for list of 
features), continued on page 5. 4
A
B
Supplemental Figure S4. Gating strategy of features included in machine learning approach.
(see Supplemental Table T2 for list of features).
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Supplementary Figure S4 continued | Gating strategy of assessed immune features (see Supplemental Table T2 for list of features). (A)
Flow cytometry plots of B cells and (B-C) T cells from spleen, (D) – (F) flow cytometry plots of macrophages and NK cell features from
placenta. Gates were set based on fluorescence minus one stainings and isotype controls to adjust for autofluorescence. Single stainings




Supplementary Figure S4 continued. 
(A) Flow cytometry plots of B cells and (B-C) T cells from spleen, (D) – (F) flow cytometry plots of macrophages and NK 
cell features from placenta. Gates were set based on fluorescence minus one stainings and isotype controls to adjust for 
autofluorescence. Single stainings were performed to calculate compensation.
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Supplementary Table T1. Genera affected by antibiotic treatment as observed through 16S rRNA analysis 
of cecal microbiota.
Sample_ID Average SD Average SD
Bacteroidaceae_Bacteroides 0,006759 0,01322 0,187006 0,16813
Marinifilaceae, g.Odoribacter                             0,039366 0,03153 0,000874 0,00231
Muribaculaceae, g.Muribaculaceae                          0,047996 0,02772 0,005422 0,00919
Rikenellaceae, g.Rikenella                                0,009005 0,00705 0,002075 0,00549
Tannerellaceae, g.Parabacteroides                         0,002205 0,00303 0,456937 0,22845
Deferribacteraceae, g.Mucispirillum           0,041651 0,03989 0 0
Desulfovibrionaceae, g.Bilophila            0,025431 0,01803 0 0
Desulfovibrionaceae, g.Desulfovibrio        0,013822 0,00826 0 0
Erysipelotrichaceae, g.Dubosiella                          1,88E-05 6,23E-05 0,0303 0,05198
Erysipelotrichaceae, g.Faecalibaculum                      3,75E-05 0,00013 0,079191 0,19371
Erysipelotrichaceae, g.uncultured                          0 0 0,0011 0,00206
Lactobacillaceae, g.Lactobacillus                             0,007371 0,00608 0,002768 0,00512
Lachnospiraceae                                          0,25393 0,04748 0 0
Lachnospiraceae, g.A2                                       0,01104 0,00653 0 0
Lachnospiraceae, g.Acetatifactor                            0,004405 0,00451 0 0
Lachnospiraceae, g.Blautia                                  0,020167 0,01053 0,00273 0,00722
Lachnospiraceae, g.GCA900066575                            0,005693 0,00407 0 0
Lachnospiraceae, g.Lachnoclostridium                        0,021349 0,01669 0 0
Lachnospiraceae, g.Lachnospiraceae_NK4A136_group      0,040543 0,03569 0,000135 0,00036
Lachnospiraceae, g.Lachnospiraceae_UCG006                  0,048969 0,03913 0 0
Lachnospiraceae, g.Roseburia                                0,100611 0,04559 0 0
Lachnospiraceae, g.Tuzzerella                               0,004984 0,00231 0 0
Lachnospiraceae, g.uncultured                               0,015858 0,00927 0 0
Butyricicoccaceae, g.Butyricicoccus                        0,000863 0,00052 0 0
Butyricicoccaceae, g.UCG009                               0,001958 0,00148 0 0
Oscillospiraceae                                        0,042516 0,02367 0,002801 0,00741
Oscillospiraceae, g.Colidextribacter                       0,024567 0,01768 0 0
Oscillospiraceae, g.Oscillibacter                          0,00919 0,00701 0 0
Oscillospiraceae, g.uncultured                             0,039401 0,02487 0 0
Ruminococcaceae                                         0,009283 0,00657 0 0
Ruminococcaceae, g.Anaerotruncus                           0,007639 0,00593 0 0
Ruminococcaceae, g.Harryflintia                            0,000823 0,00125 0 0
Ruminococcaceae, g.Incertae_Sedis                          0,014978 0,00666 0 0
Ruminococcaceae, g.UBA1819                                 0,000903 0,00081 0 0
Ruminococcaceae, g.uncultured                              0,012825 0,00504 0 0
Peptococcaceae, g.Peptococcus                                0,002752 0,00223 0 0
Peptococcaceae, g.uncultured                                 0,004379 0,00163 0 0
Anaerovoracaceae, g.Family_XIII_UCG001 0,000717 0,00066 0 0
Akkermansiaceae, g.Akkermansia 1,88E-05 6,23E-05 0,06528 0,06483
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Supplementary Table T2. Immune features assessed after antibiotic treatment in mice
Technique Tissue Assessed parameters
Flow cytometry Spleen T cells^       
 Placenta T cells       
 MLN T cells       
 ILN T cells       
 Peritoneal cavity T cells       
 Spleen B cells^^  
 Placenta B cells  
 Peritoneal cavity B cells  
 Placenta NK_CD3- CD11b+ CD301+  
CD49b+ F4/80+
Luminex Splenocytes after 
24h stimulation
IL-2 IL-6 IL-10 TNFa IL-1b IFNg IL-22
 Amniotic fluid IL-2 IL-6 IL-10 TNFa IL-1b IL-4 IL-5
qPCR Colon FOXP3 Gata3 Rory T-Bet    
 Placenta FOXP3 Gata3 Rory T-Bet IL-10   
^T cell panel: CD4pos, activated CD4pos, Th1 cells, Th2 cells, Th1Th2 ratio, Th17 cells, Treg cells, CD4pos, Neuropilin-
1pos percent of Treg cells ̂ ^ B cell panel: CD19+, CD1dHi CD5+, CD5+ CD1d+, CD1dHi CD21Hi, B10, CD5-, CD1dlow, 
CD5+, CD1dlow, T2MZP, CD24- CD21+ CD35+, CD24+ CD21- CD35-, CD24+ CD21+ CD35+, CD5- CD23-, CD5+ 
CD23-, CD5+ CD23+, CD1d histogram, CD5 histogram, CD21 histogram, CD23 histogram, CD24 histogram
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Human reproduction depends on complex adaptations of the uterus. Every month, hormones, 
tissue, and local immunity orchestrate the optimal conditions for implantation of a fertilized egg. 
Successful initiation of pregnancy depends on a balanced reciprocal interaction of maternal and 
fetal cells. A key challenge in this interaction is the natural antigenic mismatch between mother 
and child. How does the maternal immune system allow semi-allogeneic fetal cells to connect 
to the uterine circulation enabling formation of the placenta? In this thesis, we investigate this 
fetal-maternal interface to unravel a number of involved immunological adaptations. In Part I of 
this thesis, we investigate the role of uterine immune cells for healthy pregnancy. We illustrate 
how mucosal immunity of the pregnant uterus gain memory throughout gestation. Previously 
unassessed Treg and B cells, unique to the uterus, are part of the complex interaction of local 
immune cells. We show that a combination of immune cell subsets, isolated from the uterus 
and systemically, is altered in women suffering from recurrent pregnancy loss (RPL). In Part II, 
we examine if, and to what extent, microbiota could contribute to the modulation of the uterine 
immune environment. We conclude that microbiota and their compounds have a potential 
influence on receptivity. Maternal immunity is influenced through antibiotics, with possible impact 
on the developing child. This thesis highlights how an open approach is needed to discover new 
pieces in the puzzle that reproductive immunology still poses. 
LOCAL IMMUNITY EVOLVES THROUGHOUT PREGNANCY 
The endometrium, the mucosal lining of the uterus, forms the basis for implantation. Endometrial 
stromal fibroblasts differentiate in the mid-to-late luteal phase of the menstrual cycle to form the 
decidua. Formation of this specialized tissue allows for engulfment of villous cells in species 
such as humans, where trophoblast cells invade beyond the luminal epithelium (hemochorial 
placentation) (1). This transformation, termed decidualization, forms the basis for successful 
placentation. Existing data on uterine immunity mostly focus on specific cell types in either 
endometrium or decidua. We first investigated the immune signature of the non-pregnant uterine 
mucosa in parallel with term decidua to assess pregnancy-induced adaptations (Chapter 2). 
Monthly, in absence of conception, decreasing progesterone levels initiate shedding of the 
superficial layer of the decidualized uterine mucosa to allow for renewal of the receptive surface 
(2). Discharge of the endometrial lining involves an efflux of immune cells that reside in the tissue. 
We asked women to collect menstrual blood using a menstrual cup, to allow for a non-invasive 
access to endometrial lymphocytes. We previously established that the subsequent isolation of 
immune cells yields cells similar to lymphocytes obtained through endometrial biopsies (3). We 
also made use of this now broadly accepted strategy in Chapter 4 and 5. At term, placentae 
can be easily obtained, and the maternal side of the placental membranes (decidua parietalis) 
can be separated from the fetal layers, which allows for the retrieval of maternal uterine cells post 
pregnancy. Analyses of material sampled at either time point, non-pregnant and post-pregnancy, 
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confirmed that we successfully isolated immune cells of the uterine mucosa; the observed NK 
cell profile consisting of almost exclusively NKbright cells displays the phenotype associated 
with uterine cells (4). Additionally, the presence of CD103+, an integrin subunit mostly observed 
on tissue resident cells in combination with the absence of CD62L, a marker associated with 
circulating leucocytes, further confirmed that our observed results reflect uterine immunity rather 
than peripheral blood contamination. 
Our results again reveal the general consensus of NK and T cell fluctuations throughout 
gestation: NK cells are abundant in non-pregnant endometrium but decrease in term decidua 
parietalis (5-7). The opposite is seen for T cells, accumulating throughout gestation (8-10). Of 
note, all samples of uterine mucosa contained, albeit small, a CD19+ B cell fraction. 
Using high dimensional flowcytometry, we showed a gain in immune cell memory from pre-
pregnancy mucosal immunology up to term decidua. Less naïve, and more effector and central 
memory CD4+ and CD8+ T cells were observed in decidua parietalis (Chapter 2). Likewise, 
an increase in B cell memory was observed in the study described in Chapter 4. Especially in 
contrast to lymphocytes of the non-pregnant mucosa, this suggests that cells become activated 
and differentiate over the course of pregnancy. Indeed, in vitro, endometrial cells were able to 
differentiate and display a similar switch in phenotype upon T cell activation. The T cell signature 
we observed in term decidua is in accordance with earlier data by Tilburgs and colleagues that 
highlights the distinct functional profiles of these highly differentiated decidual T cells, compared 
to their counterparts in peripheral blood (11). Building up on this, it was later shown that decidual 
T cells are able to recognize fetal antigen as previously hypothesized (12). Frequencies of HY-
specific T cells, in response to male fetuses, were 10-fold higher in decidua (0,6% of CD8+ T cells) 
compared to peripheral blood highlighting the local character of the occurring recognition. In an 
in vitro mixed lymphocyte reaction, decidual CD4+ and CD8+ T cells were shown to proliferate 
more potently than peripheral blood T cells in response to irradiated fetal cord blood cells. Powell 
and colleagues additionally observed how Treg are essential to control this proliferation (12). 
These and other studies highlight the importance of local Treg to contain inflammation of the 
decidua (8). 
To establish an overview of the evolving immune environment throughout pregnancy, we 
also investigated Th subsets in Chapter 2. The paradigm that a Th2-type immunity, marked 
by IL-4, IL-5, and IL-13 secretion, dominates a Th1-type, characterized by an IL-2, and IFNγ 
secretion profile, dominated the field in the 1980s to 1990s (13). This Th2 profile was thought to 
dampen a harmful Th1-type response of the maternal immune system towards fetal antigens. 
It has now been established that there are more aspects to consider, such as Treg and IL-
17 secreting Th17 cells (13, 14). Likewise, asides from Treg, we investigated a number of Th 
subsets. In the flow cytometric approach used in this study, we assessed Th frequencies using 
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a chemokine receptor-based characterization (15). A limitation of this approach may be that as 
this phenotypical assignment has been established for peripheral blood lymphocytes, marker 
expression might not always refer to cells of equal functional characteristics when examining 
mucosal tissue. We observed relatively more Th1 compared to Th2 cells in uterine samples, 
which is in accordance with previous data (16). Comparing non-pregnant endometrium and 
decidua at term, we observed no significant change in levels of Th1, Th1-like, Th2, and Th17 
cells. However, in this study, we only examined the pregnant mucosa at the very end of gestation. 
Pregnancy complications such as PE and RPL, manifest in the first trimester, during spiral artery 
remodeling. Thus, if fetal/paternal antigens or other possible triggers induce changes in Th 
profiles during the peri-implantation period, this cannot be conclusively investigated with this 
approach that lacks observations of early pregnancy. 
The discovery of immune subsets and immune-modulatory molecules continues. Measuring a 
broad range of cytokine profiles can directly point out pro- or anti-inflammatory trends. Indeed, 
recurrent implantation failure after ART has been associated with dysregulated uterine profiles of 
soluble factors (17). Analyzing endometrial cells obtained from menstrual blood of healthy, fertile 
women offers a way to research profiles of healthy, fertile women in future approaches. 
In the work presented in this thesis, we sought to exemplify that healthy pregnancy, much like the 
immune response in general, depends on the interaction of cells and soluble factors, rather than 
a particular type of cell that, on its own, determines the faith of gestation. The initial, exploratory 
study described in Chapter 2 led us to question what other possible key immune-modulators 
are involved in pregnancy that fulfill roles beyond our current understanding. 
THE DECIDUA CONTAINS SPECIALIZED REGULATORY CELLS: 
REGULATORY T CELLS 
A major focus in studying the maintenance of tolerance at the fetal-maternal interface has been 
put on Treg cells. We observed that compared to non-pregnant endometrium, frequencies of 
CD4+CD25Hi were increased in term decidua (Chapter 2). This is in line with previously reported 
high levels of functional CD4+CD25Hi T cells with suppressive capacities and in vitro experiments 
confirming an induction of CD4+Foxp3+ Treg upon co-culture with EVT (18-20). However, 
additional to a phenotypic overview in Chapter 2, functional assays are needed to confirm if 
the observed T cell subset is truly regulatory, i.e. suppressive. The number of studies assessing 
functional capacities of decidual T cells with a regulatory phenotype is limited (18, 21, 22). 
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In Chapter 3, we advance knowledge on Treg at the fetal-maternal interface. We describe, 
next to CD25Hi Treg, two additional functionally and phenotypically distinct Treg subsets of the 
decidua with regulatory capacities; PD1Hi and TIGIT+ T cells. All three Treg subsets express 
distinct transcriptional profiles compared to their phenotypic counterparts of peripheral 
blood. Both PD1 and TIGIT+ Treg selectively inhibit CD4+ and not CD8+ Teff cells. The ability 
of decidual PD1Hi to induce IL-10 expression in effector T cells suggests a positive feedback 
loop. This emphasizes the heightened capacity of decidual cells to produce IL-10, of which 
reduced presence is associated with pregnancy complications (23-26). Based on their lack 
of FOXP3, high PD1, IFNγ, and granzyme expression, and capacity to suppress CD4+ T cell 
proliferation through IL-10, PD1Hi resemble Tr1 cells. However, they do not express CD49b and 
LAG3, supporting the notion that decidual Treg are a unique result of pregnancy-related antigen 
encounter. Accordingly, direct cell contact with extra villous trophoblast cells induced PD1Hi cells. 
Also decidual macrophages were able to induce CD25Hi and PD1Hi Treg, upregulating FOXP3 
and HELIOS expression. This fits with the timing of the observed differential expression, as 
Helios expression is associated with potent suppressive capacities. This was displayed by first 
trimester-derived decidual Treg, but only to a small extent by Treg isolated from term. In-depth 
mass cytometry-based phenotyping of decidual lymphocytes supports the presented findings of 
decidual Treg as heterogenous population with differential FOXP3 and HELIOS expression (27). 
Bright CD25 and Helios expression is associated with natural Treg (nTreg), which arise from the 
thymus to prevent anti-self-responses, in contrast to induced Treg (iTreg), that can dampen allo-
recognition. It is tempting to speculate, based on our observed marker profiles, that the balance 
between nTreg to iTreg shifts towards more iTreg during gestation. However, the lack of clearly 
defining surface markers to specifically identify nTreg or iTreg leaves us questioning where 
(and to what purpose exactly) decidual Treg are induced. The functional and transcriptional 
differences between the selected Treg subsets of first trimester and term decidua underline that 
both timepoints deserve independent assessment.
THE DECIDUA CONTAINS SPECIALIZED REGULATORY CELLS: IL-10 
PRODUCING B CELLS
The individual comparison of cells isolated from non-pregnant endometrium to decidua parietalis, 
and first trimester decidua to decidua parietalis, point out how focus on one time point will not 
suffice to understand the role of a particular cell at the fetal-maternal interface. We investigated 
lymphocytes isolated from menstrual blood alongside first trimester and term decidua parietalis 
by high-dimensional phenotyping (Chapter 4). All studied time points contained uterine B cells, 
albeit at a low abundance (<2% of total lymphocytes). Systemically, B cells, together with T cells, 
are known as a major mediator of adaptive immunity. Next to their classical antibody-secreting 
function, B cells can act as APC, and modulate the local immune environment through cytokine 
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production (28-30). Especially their capacity to secrete IL-10 has gained attention, starting with 
the observation that the inability of B cell-deficient mice to recover from experimental autoimmune 
encephalomyelitis stems from the lack of IL-10 producing B cells (31, 32). The idea that B cells 
are not the cause, but a suppressor of autoimmune disease contrasted all other approaches 
focusing on auto-antibody production. The intriguing observation that a major part of decidual 
B cell samples, especially of the second trimester, expressed CD24 and CD38 to a high extent 
(Chapter 4), often connected to the ability to produce IL-10, sparked a new question: could B cells 
of the fetal-maternal interface contribute to local maintenance of tolerance? Recently, few studies 
have started to acknowledge a possible role for B cells in healthy pregnancy. Rolle et al. initially 
demonstrated that systemic B cells of pregnant women were able to suppress TNFα production 
of CD4+ T cells, which could not be mimicked in the same setting by non-pregnant donors (33). 
An increase in the pool of CD19+CD24HiCD27+ B cells due to pregnancy was not shared by 
women who had suffered from a spontaneous abortion. Serum of women during pregnancy, but 
not after pregnancy loss, was able to induce IL-10 production by B cells of peripheral blood (33). 
This was attributed to pregnancy-induced high levels of human chorionic gonadotropin (hCG) 
as 95% of CD19+CD24HiCD27+ expressed the hCG receptor and CD19+ cells produced IL-10 
upon hCG stimulation (33). HCG is secreted by the blastocyst even before its implantation and 
before serum levels are measurable (34, 35). In this period, it likely serves a juxtacrine function 
by modulating levels of e.g. metalloproteinases, insulin-like growth factor-binding protein -1 
(IGFBP-1), Leukemia Inhibitory Factor (LIF), M-CSF, vascular endothelial growth factor (VEGF) 
(36). Its local action in stimulating IL-10 production by B cells was then shown in co-cultures of 
trophoblast cell lines, and murine placental explants, with B cells. The interaction of these fetal 
cells and B cells induced IL-10, but this was abrogated when hCG was blocked (37). Supporting 
the notion that induction of IL-10 production of B cells is a local phenomenon upon trophoblast 
encounter, we observed that decidual B cells are potent producers of IL-10 upon CpG/CD40L 
stimulation, an accepted strategy to detect IL-10 secretion by B cells (38-40), and do so to a 
higher extent than systemic B cells. This fits the results of Fettke et al., who pointed out that co-
culture with fetal cells had an additive effect on IL-10 levels compared to CD40L/CpG stimulation 
alone (37). Likewise, we observed that, in a number of samples, decidual B cells produced IL-10 
without the need for CpG/CD40L stimulation supporting the idea that B cells have already been 
primed in utero, through hCG, trophoblast cells, or other trophoblast related receptor-ligand 
interactions, to secrete IL-10. 
Our observation that B cells are located in clusters, together with T cells, points out that even 
though their numbers are limited, decidual B cells might facilitate IL-10 mediated inhibition of 
neighboring cells. Of note, lymphocyte clusters could not be found for all decidual samples 
that we investigated by immunohistochemistry, but in approximately half of all cases. This might 
be sampling issue, clusters might not be located all throughout the decidua and only a small 
proportion of tissue is embedded for imaging. Another possible explanation might be time 
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dynamics; induction of clusters might occur at specific time points during gestation, which may 
vary between individuals. Although the presence of uterine B cells as being a part of healthy 
pregnancy has been disputed in the past, several studies now confirm their presence and they 
clearly warrant additional investigation (41-44). 
Where do these B cells come from? Circulatory B cells are decreased from mid-gestation to 
delivery, which might result from a gestational reduction in lymphopoiesis, as shown in mice (45-
50). This might not be the only explanation for reduced systemic B cells; evidence supporting a 
relocation of B cells to the uterus increases. Placental explants are able to attract B cells through 
CCL20 (placenta) - CCR6 (B cell) interaction (51). Also, data on decidua support the notion that 
B cells are retained within the uterus during gestation. Matching our observation that naïve B 
cells can be isolated from all decidual samples, an increased proportions of mature/naïve B cells 
were found within the intervillous space (51). However, probably not all of the observed decidual 
B cells are the result of pregnancy-induced homing to the uterus as menstrual blood samples 
also contain B cells. This hints towards a tissue-resident population independent of implantation. 
Furthermore, we observed that B cells of the decidua contain subsets with phenotypes distinct 
from peripheral blood. Either the adaptations to the uterine environment itself, or pregnancy 
induced interaction with B cells causes differential marker expression of local B cells. As such, 
primary human samples of the fetal-maternal interface cannot be replaced by investigation of 
systemic cells. 
A QUESTION OF TIMING
Origin of immune cells, as well as gestational duration, strongly impacts immune phenotype 
and function. In our efforts to understand the source of pregnancy complications, we need 
to consider the characteristics of the immune cells at the respective time point involved in 
the physiological adaptation needed for a healthy continuation of pregnancy. Generating an 
overview of the immunological fingerprints associated with the different gestational time points, 
we assessed general lymphocyte composition from menstrual blood, to first and second 
trimester decidua, and up to decidua parietalis. Unsupervised-clustering offers analysis of flow 
cytometry data without the need for manual gating which depends on arbitrary, biased selection 
of cell populations to assign a classification. This confirmed that CD4+ T cells and NK cells 
are the most stratifying features of uterine lymphocytes allowing for assignment of an immune-
profile to its respective gestational time point (Chapter 4). Both NK and T cells frequencies 
strongly change upon onset of pregnancy. Of note, in MMC, a relatively large variation in NK 
and T cells frequencies was observed, and some donors presented with similar lymphocyte 
levels as observed in first trimester decidua samples. We can only speculate whether this lack 
of difference compared to the gestational profile is due to natural variation, or to an underlying 
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and undetected pathologic cause. For example, we do not have data on whether the samples 
were collected at the end of a cycle during which unprotected intercourse took place. Exposure 
to seminal fluid or even failed implantation could affect the lymphocyte composition observed 
in menstrual blood-derived lymphocytes (52-54). Moreover, fertility status was confirmed for 
about half of the participating women, as they gave birth in the past. Thus, while we made 
the assumption that the majority of women was able to conceive, it might be possible that for 
some this was not the case and consequently women with aberrant immunological profile were 
included. We investigated in how far menstrual blood can identify an unfavorable immunological 
environment connected to RPL in Chapter 5. 
The decidualized endometrium forms the “fertile ground” for a healthy placenta; successful 
crosstalk of the blastocyst and the decidua determines if correct placenta formation can be 
initiated (55). Immune alterations can impact the trophoblast invasion, and endometrial biopsies 
showed a reduction in NKbright and CD8+ T cell frequencies compared to healthy controls (56). 
However, the number and extent of these data is limited, and establishing an immunological profile 
of the endometrium of healthy women is challenging when relying on tissue from biopsies. Not 
only the invasive nature of the procedure, and thus ethical concerns, hamper sample collection, 
but the number of lymphocytes isolated from a single tissue sample limits the information that 
can be gathered from each volunteer. We were able to analyze more than 10 times more cells 
through non-invasive menstrual blood collection and cell isolation. This way, in Chapter 5, we 
investigated the immunological landscape of the non-pregnant uterus in women suffering from 
recurrent pregnancy loss. The general immune profiling strategy as described in Chapter 2 was 
expanded with an additional investigation of B cell subsets based on our findings of Chapter 
4. Using machine learning, we were able to define key immune subsets of either peripheral or 
menstrual blood that allow for correct classification. Thus, RPL is connected to altered immunity. 
Of note, B cell subsets contributed to cohort distinction for both sample types, emphasizing the 
possible value of considering B cells in future approaches. 
We included cytomegalovirus (CMV) seropositivity of our donors in the analysis. CMV causes 
lifelong latent infection and with, a prevalence of estimated 40 to 100 percent globally, affects 
a majority of women, especially with increasing age (57). While it rarely elicits symptoms in 
immunocompetent individuals, it persistently affects immunity (58). Immune evasion mechanisms 
of CMV are known to especially alter NK and T cell responses, as both are major components of 
the defense against the virus (59). As such, whether or not a woman has encountered CMV has 
to be considered a possible confounder. Primary CMV infection during pregnancy is the most 
frequent cause for congenital disease in developed countries, but it is unclear whether latent 
CMV infection also deserves a negative connotation with regard to healthy pregnancy. CMV has 
coevolved with human development for millions of years. Hampering reproduction of its host 
would negatively impact persistence of the virus. The data presented in Chapter 5 show that 
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CMV seropositivity did not contribute to classification as healthy control or RPL patient. Likewise, 
in Chapter 3, CMV infection did not affect the EVT’s ability to induce Treg. The human immune 
system is not just exploited by the virus to allow persistence, but relies on being shaped by early 
infection. The neonatal immune system is vulnerable to viral infections, but while not suffering 
from disease, the young child gets equipped with an alert immune system enabling efficient 
elimination of harmful pathogens (60). Lifelong CMV infection was shown to improve pathogen 
recognition, by allowing for recruitment of a broad cross-reactive antigen repertoire in mice (61). 
Pregnancy-induced training of uterine NK cells, hypothesized to be connected with improved 
placentation (62), was shown to be dependent on CMV-seropositivity (63). 
CMV seropositivity caused a segregation in frequencies of B cell subtypes of the RPL cohort. 
Without taking CMV status into account, switched memory B cells and naïve B cells are present at 
similar frequencies in control vs RPL patients. Higher frequencies of CD27 positivity of B cells, a 
marker for activation, were observed in the CMVpos group of the RPL cohort. Increased abundance 
of CD27 on B cells is a known association with CMV seropositivity (64). Unfortunately, information 
on CMV status was limited for donors of peripheral blood in this study. Frasca et al. compared 
vaccine responses based on CMV status, showing that a pre-activation of B cells, also reflected 
in increased intracellular TNF-α levels, negatively impacted their ability to undergo class switch 
recombination, and generate proper antibody and memory response (65). The authors propose 
that a CMV-mediated proinflammatory profile can be kept under control in young individuals, 
while elderly present with higher inflammatory levels. It remains to be elucidated whether CMV 
seropositivity poses a risk factor for RPL in case of additional deregulation of tolerance. In 
that case, failure to suppress a CMV-related proinflammatory profile might negatively impact 
implantation. An earlier study by Radcliffe et al. pointed out the difficulty to assess an association 
of CMV and RPL based on measuring anti-CMV antibodies as performed in Chapter 5: the 
authors observed an inability of RPL patients to respond to CMV through proliferation or antibody 
secretion (66). The difficulty of these individuals to adequately mount a humoral response to 
specifically CMV infection, not to control stimulation, underlines the importance to study CMV 
and B cells with regard to RPL in future approaches. 
HUMAN REPRODUCTION AND MICROBIOTA ARE INSEPARABLE 
The concept that human immunity is naturally shaped through foreign influence is manifested 
in immunology. The term microbiome, describes all genomes from microorganisms inside the 
body is often also referred to as microbiota, which describes the specific microorganisms. The 
microbiome does not only refer to natural colonization by bacteria, but also covers viruses, fungi, 
protozoa, and archaea (67, 68). The importance of microbial colonization of the human body 
has been extensively reviewed, focusing especially on the contribution of the gut microbiome 
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to systemic immunity (69-74). In Chapter 6, we studied the available evidence regarding the 
possible impact of microbiota on endometrial immunology and fertility. With the chance to 
analyze microbial composition through measuring 16S rRNA rather than culturing methods, 
even rare species, and low biomass colonization, can be assessed. The discussion on the 
contribution of a local microbiome for healthy pregnancy lifted off with the exposure of a possible 
placental microbiome in 2014 (75). At the same time, bacteria were also observed within cells 
of the placenta, without signs of inflammation such as accumulation of immune cells in the 
proximity (76, 77). As outlined throughout this thesis, the placenta evolves from, and depends 
on, a healthy endometrium. Therefore, we assume that in theory, the placental microbiome stems 
from microbiota of the endometrium, but both may differ to a large extent in composition. The 
microbiome is known to adapt due to gestation (78, 79). For example, when pregnant, 70% of 
women present with increased fractions of gut microbiota that are associated with inflammation 
(80). It has been suggested, that this compositional shift is dictated by pregnancy hormones (81). 
The same hormones also reach the uterine cavity, and can thus impact the local microbiome. 
In Chapter 6, we focus on the endometrial microbiome as a contributor to setting the stage 
for conception. We extrapolate known contributions of gut microbiota to possible mechanisms 
at play within the uterus. Even though only limited endometrial profiles of healthy women were 
available at the time point of the study, we conclude that, if bacteria are present within the uterus, 
a physiological role for maintenance of uterine adaptation and immunity is inevitable. 
THE STERILE WOMB PARADIGM
Based on the hypothesis that newborns acquire their initial bacterial colonization through birth, 
rather than in the uterus, the dogma of the “sterile womb” was manifested by French pediatrician 
Henry Tissier (82). This concept has proven persistent; whether the uterus harbors a microbiome, 
or whether this is merely an artefact of sampling or detection, is still under heavy debate; research 
has not reached consensus regarding when the baby is initially colonized by bacteria (83-85). 
An overview of arguments supporting and refuting antenatal microbial exposure exceeds the 
scope of this thesis. It remains to be established how the neonatal microbiome relates to a 
gestational uterine microbiome, and might consequently disrupted upon microbial modulation 
during pregnancy. In Chapter 6, we stress how controlling for contamination, and a standardized 
approach to detect 16S rRNA can support a worthwhile search to find consensus on uterine 
microbiota. In the years following publication of this chapter, a rapid increase in studies, that 
support a shift in perspective on the microbiome and the uterus, could be observed (86-89). 
Even now, species composition of the healthy endometrium is yet to be determined. Contrary 
to the well-studied, and well-defined, mucosal microbiome of the gut or the vagina, the uterine 
cavity contains only a very low biomass of microbiota (90). Low biomass does not equal sterility; 
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combining copy numbers from qPCR and 16S rRNA gene amplicon sequencing showed 
detectable reads above potential background noise and negative controls (90, 91). The example 
of Lactobacilli (e.g. L.iners or L.crispatus), identified as dominant by some (92-94), or as rare 
to absent by others (91) underlines how a joint, standardized effort might be needed to unite 
the side of researchers who support the notion that uterine microbiota deserve to be studied. 
Multicentered studies with strict guidelines regarding all steps from cohort selection to sampling, 
sample processing to analysis, are needed to credibly replace the concept of the sterile womb 
by the definition of a healthy endometrial microbiome. 
Recent investigations showing an altered microbial profile prior to RPL, or in case of IUGR, 
support the notion that, whether as cause or consequence, varying uterine microbiota 
profiles are associated with different reproductive outcomes (94, 95). Increasing knowledge 
on a healthy endometrial microbiome, prior to pregnancy, might lead to treatment options for 
women struggling to conceive. Diet and medication can steer a microbial profile (96-100). The 
beneficial effect of interfering with microbiota to improve reproductive outcome can be illustrated 
by bacterial vaginosis, an imbalance of the vaginal flora correlating with poor reproductive 
outcome (101, 102). Its association with PTB can be counteracted with antibiotic intervention, 
if occurring in the first half of gestation (103). The importance of timing reflects that healthy 
pregnancy is determined in its early stages. The altered immunological profile observed in 
menstrual blood of RPL patients (Chapter 5) might (for some individuals) be connected to an 
unfavorable microbial profile. In that case, proper diagnosis might offer therapeutic options. 
16S rRNA sequencing becomes increasingly accessible, and currently, self-testing of vaginal 
microbiota is already commercially available to predict ART success (104-106). As there is only 
limited overlap between uterine microbiota and the vaginal microbiome (90, 92), including the 
immune profile of menstrual blood, or sampling endometrial microbiome directly (although 
warranting a professional approach rather than at-home swabs) might offer improved prediction 
of reproductive outcome or pinpoint treatment targets. 
MANIPULATING MICROBIOTA: CHANCES AND THREATS
As shown by the example of successful reduction of PTB risk in case of bacterial vaginosis, 
treating antibiotic disbalance to improve reproductive outcome is tempting to consider. Indeed, 
antibiotic treatment can alter endometrial microbiota (107). However, antibiotic intervention 
around the time of, or after, conception needs to be treated extremely carefully. A central theme 
of this thesis is how reproductive immunology relies on well-balanced, connected mechanisms, 
and, as such, any interference can be detrimental. However, in many cases, gestational use of 
antibiotics cannot be avoided as progression of an infection would be detrimental to mother and 
child. Urinary tract infections (UTI) are one of the most common pregnancy complications (108). 
SUMMARY AND DISCUSSION 229
8
UTI itself is a risk factor for PE, which is hypothesized to originate from an increase in the systemic 
inflammatory burden (109-111). In Chapter 7, we investigate in how far antibiotic intervention in 
pregnant mice causes changes in systemic, as well as local (placenta) immunity. We observed 
that while the medication did not affect reproductive success, microbial manipulation translated 
to altered immunology of the mother, reaching as far as the placenta. We based our microbial 
intervention on the combination of antibiotics published by Tormo-Badia et al., who showed 
lasting immunological effects in offspring of non-obese diabetic mice treated with antibiotics 
(112). The authors observed a reduced diversity of intestinal microbiota and limited activation 
of T cells in the pups. Altered immunity of the offspring might not only result from their own 
altered microbial profile, but from treatment effects on the fetal prenatal environment such as 
demonstrated by our results. The presented data illustrate that the effect of gestational antibiotics 
on the offspring need to be studied in light of the treatment’s effect on maternal immunity. 
Unfortunately, low bacterial yield upon sequencing of placental microbiota prohibited us to 
draw conclusions on exact species composition, or a treatment-induced switch in frequencies 
or abundance. However, few samples in which detection was possible, indicate a shift in 
placental species distribution. It is tempting to speculate that this indicates altered prenatal 
microbial exposure. Could microbial priming of the developing child occur in utero, with possible 
lifelong effect on the offspring? Various studies have linked the gestational use of antibiotics to 
an increased risk for the child to develop asthma, atopic dermatitis, and allergic disease and 
increased childhood hospitalization of the offspring (113-116). While the possible confounding 
effect of other underlying causes of disease, linking maternal and fetal health, needs to be kept 
in mind (117), murine studies could also confirm the link in antibiotic intervention studies (118-
120). Still, the causative relationship and etiology of disease needs to be elucidated. Systemic 
immune adaptations of the mother, immune modulation reaching the baby, direct effects of 
(metabolites of) the microbial intervention, effects passed on during breastfeeding, a shift in 
microbial prenatal exposure; the list of possible medication-related impact on the offspring is 
long. Neither route probably impacts childhood health exclusively. The need to treat pregnant 
women with antibiotics will persist in order to save mother and child of an acute threat. It remains 
to be revealed how gestational antibiotics are linked to long-term effects on immunity. Our study 
points out that effects due to an altered uterine environment have to be considered as a part of 
this investigation. 
GENERAL CONCLUSION AND FUTURE PERSPECTIVES 
Healthy pregnancy depends on a broad variety anatomic, endocrine, metabolic, and immunologic 
adaptations, which orchestrate local immunity (Figure 1). The findings discussed in this thesis 
point out that uterine immunity is highly dynamic, and is affected by even more factors than 
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meets the eye. The endometrium forms the basis for all immune adaptations occurring upon 
initiation of pregnancy. If dysregulated, complications like pregnancy loss, PE, and IUGR can 
arise. Pregnancy is accompanied by a general increase in a memory phenotype of T cells and B 
cells, and shifts in their respective subsets. Both key players of adaptive immunity infl uence the 
local immune environment, through direct suppressive effects, or cytokine secretion. Ultimately, 
reproductive immunology demands complex regulatory mechanisms allowing for trophoblast 
invasion, whilst maintaining reactivity towards infectious threats. We showed that Treg and B cells 
contribute to this intricate balance. Local differentiation or modifi cation equips uterine immune 
cells for their pregnancy-specifi c regulatory tasks. Natural colonization by a uterine microbiome 
can infl uence these delicate interactions needed for implantation, progression of pregnancy, and 


















Fertility & healthy 
pregnancy
Figure 1. Interacting mechanisms direct uterine health. Only correctly orchestrated conditions allow for 
conception and healthy pregnancy. 
The presented data underline the extraordinary characteristics of uterine immune cells, in 
absence of, or during, pregnancy. These investigations are challenging to model in vitro when 
using readily accessible sources of lymphocytes. No cell lines are available that are identical to 
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uterine lymphocytes. Even co-culture of decidual lymphocytes and commercially available target 
cell lines hold their limitations. Decidual NK cells spare fi rst trimester trophoblast from cytotoxicity, 
but not the widely-used target cell lines (121). Peripheral blood offers a source to study systemic 
immunity of pregnant women, as the act of drawing blood is no threat to the baby, and can be 
done as part of routine checkups. However, mechanisms at play at the fetal-maternal interface, in 
preparation for, or during, implantation or placenta formation are to a large extent unique to local 
immunity. Future investigations to increase our understanding of principles underlying all human 
life thus strongly rely on primary samples. As outlined in this thesis, patient-derived tissue can be 
obtained without the need for invasive biopsies. We isolated lymphocytes from menstrual blood, 
fi rst and second trimester abortions, and placentae obtained upon delivery. As no additional 
procedures or change in behavior are required from donors, approval for use of this material by 
the local ethical committee can be relatively straightforward in the Netherlands (considered “niet-
wmo-plichtig”). The use of menstrual cups as female hygiene product becomes increasingly 
popular, and, consequently, collection of the effl uent is of limited additional effort. Increased 
use of the presented primary cells can also help to reduce animal studies effectively, especially 
since “only humans have human placentas” and other species might not present with identical 
mechanisms at play (122). Rather than considered waste material, menstrual blood cannot only 
be vital to research, but it also holds many opportunities for large-scale screenings. Prior to 
planned conception, especially during ART, women want to ensure that all conditions are optimal 
to support a healthy pregnancy. Not knowing the underlying cause of an unfulfi lled child-wish 
comes with a large medical and emotional burden. Harnessing the diagnostic value of menstrual 
blood holds many opportunities. The method can only gain strength if the taboos around female 
health are lifted. Funding bodies might contribute to support that menstrual blood becomes just 
as attractive as the seemingly easier act of drawing blood for in-depth analysis. 
 “The biologist of today […] is in much the same position as an Egyptian astronomer exploring 
the secrets of the universe with the naked eye.” (Roberts and Lowe, 1975, The Lancet, “Where 
have all the conceptions gone”)
This thesis explored how understanding of reproductive immunology demands a change 
in perspective. A number of presented dogmas were established before holistic detection 
options were available. Systems biology approaches and computational analysis allow for 
an open approach, moving away from a biased target selection or a selective readout. Next 
to the presented microbiome analysis, examples of such comprehensive approaches are 
transcriptomics (123, 124), use of mass cytometry (27), enabling highly multiplexed fl ow 
cytometry, or mass imaging, expanding our abilities for structural analysis. Increased availability 
of these in-depth omics approaches will allow for a better understanding of phenotype and 
function of uterine immune cells. Healthy pregnancy depends on the integration of all these 
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different pieces of the puzzle (Figure 2). Bioinformatic approaches will aid to make connections 
between the different omics strategies that we cannot fathom. Reproductive immunology not 
only affects fertility but sets the start for all prenatal development, which, on its turn, sets the 
stage for a healthy future (125). Development of effective screening methods, throughout, or 
even prior to, pregnancy will allow detection, and hopefully treatment of, diseases that manifest 
too late to alter their perinatal outcome. Pregnancy still seems mysterious; there are many pieces 
to put together, and discover, in order to understand this fascinating puzzle. However, the fi nal 
picture for research to work on is clearly defi ned. The aim will always be to offer the best possible 












Figure 2. Reproductive immunology demands integration of multiple disciplines.
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Science can be fuzzy, dark, and obtuse. There comes a point where words fail and it’s easier to 












Pregnancies aected in developed countries 
Healthy 
     Placenta
Healthy 
     Ospring
Healthy 
     Uterus
• Uterine health is closely linked to placentation and thus development of the unborn child.
• Pregnancy complications affect a large part of all pregnancies.
• Understanding how formation of placental connection is regulated is paramount to improving 
diagnostic methods and developing treatments. 
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How is the right balance between tolerance and infl ammation maintained at the fetal-
maternal interface ? 
1. Trophoblasts possess mechanisms to facilitate immune evasion. 
2. Cells of the uterine tissue infl uence the local immune environment.
3. External factors, such as bacteria contribute to a tolerance-favoring milieu. 




CHAPTER 2 |  HUMAN UTERINE LYMPHOCYTES ACQUIRE A MORE 
























































How does the uterine immune environment change during pregnancy?
• Decreased abundance of naïve T cells in decidua parietalis. 
• Increase in central/effector memory T cells. 
• More regulatory T cells at the end of pregnancy.
• Mucosal cells differ in phenotype from peripheral blood. 
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CHAPTER 3 |  THREE TYPES OF FUNCTIONAL REGULATORY T CELLS 























Treg are induced by decidual macrophages and HLA-G+ EVT











• Three decidual Treg types suppress Teff responses in human pregnancy.
• Decidual PD1HI Tregs suppress T cell proliferation in an IL-10- dependent manner.
• EVTs and decidual macrophages directly increase FOXP3+ Tregs, while EVTs also increase 
PD1HI Tregs.
• Induction of PD1HI Tregs by EVTs may involve antigen-specifi city for HLA-C.
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CHAPTER 4|  CLUSTERS OF TOLEROGENIC B CELLS FEATURE IN THE 














• B cells obtained from the fetal-maternal interface gain memory during gestation.
• Unsupervised analysis shows B cell subsets with marker expression unique to the uterus.
• Decidual B cells are able to secrete IL-10.
• Clusters of decidual B cells also contain T cells, including Foxp3+ T cells.
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CHAPTER 5 |  A COMBINATION OF IMMUNE CELL TYPES, IDENTIFIED 
THROUGH AN ENSEMBLE MACHINE LEARNING STRATEGY, 








Systemic & uterine immune 
cell subsets allow classication 
Dierences in immune prole 





• Altered immune profi les in women who experienced recurrent pregnancy loss. 
• Systemic and uterine immunity are both affected but different cell types contribute to 
classifi cation. 
• High accuracy � possible diagnostic value upon further validation.
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CHAPTER 6 | HOW UTERINE MICROBIOTA MIGHT BE RESPONSIBLE FOR A 
RECEPTIVE, FERTILE ENDOMETRIUM






Minimizing systemic threat anatomically
Limited contact between bacteria and epithelia
Rapid detection and killing upon barrier breach
Needed: Given in endometrium?
Strong tight junctions endometrial epithelia
Secretion of anti-microbial molecules













Modulation of host immunity
T
cell
EndometriumIntestinal mucosa Lumen Uterine cavity













CHAPTER 7|  ANTIBIOTIC INTERVENTION AFFECTS MATERNAL IMMUNITY 






















Antibiotics cause  gestational 
immune modication
reaching as far as the placenta
?
!
• Antibiotic treatment reduced microbial diversity maternal gut but litter size remained 
unaffected.
• Immune features altered due to treatment reached as far as placenta (splenic T helper 
17 cells and CD5+ B cells, CD4+ T cells in mesenteric lymph nodes and RORγT mRNA 
expression in placenta).
• Unique immunological properties of pregnancy have to be considered in safety studies. 
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• Uterine immune regulation depends on a complex interplay of cells.
• Even cells types or microbes that are not abundantly present can make a difference.
• The unique local processes depend on studies looking at the involved tissues. Commercially 
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EEN KWETSBARE FASE
Zwangerschap verandert het leven van de ouders op veel niveaus. 
Lichamelijke aanpassingen van de moeder, lokaal in de baarmoeder 
en ook systemisch, zijn cruciaal om de optimale ontwikkeling van 
het kind te faciliteren. Maternale steun begint als het ware bij de 
interactie met de bevruchte eicel: de slijmvliezen van de baarmoeder 
moeten een geschikte basis voor innesteling vormen. Alleen als 
de blastocyst en het endometrium samen op de juiste manier een 
verbinding aangaan, kan een zwangerschap succesvol verlopen. Een 
gezonde zwangerschap is dus verre van vanzelfsprekend: 30% van de 
zwangerschappen gaat verloren voordat de moeder wist zwanger te 
zijn. Evenveel zwangerschappen eindigen in een miskraam, een heftige 
ervaring die bijna een kwart van alle vrouwen een keer in haar leven 
meemaakt. Daarnaast worden veel zwangerschappen gecompliceerd 
door pre-eclampsie (PE) of HELLP-syndroom. Wereldwijd krijgt zo’n 
6-8% (1-3% in Nederland) van alle zwangerschappen de diagnose 
PE. Deze zwangerschapshypertensie kan gepaard gaan met 
langetermijngevolgen voor moeder en kind, bijvoorbeeld als het 
kind te vroeg moet worden geboren om ernstige cardiologische of 
nefrologische gevolgen voor de moeder te voorkomen. Ook al weten 
we niet wat de oorzaak van PE is, een hoofdrol wordt toegeschreven 
aan de foutieve aanleg van de placenta.
Vraagstelling van dit proefschrift 
Het afweersysteem speelt een belangrijke rol bij de ontwikkeling van 
de placenta. Maternaal weefsel en trofoblastcellen moeten nauw op 
elkaar afgestemd zijn. Alleen als dit goed verloopt kan een gezond 
kind geboren worden. Het doel van dit proefschrift was om vanuit 
mogelijke nieuwe invalshoeken de betrokken immuun-regulatie te 
onderzoeken. Pas als meer bekend is over de cruciale mechanismen 
en wat er mogelijk misgaat als zwangerschapscomplicaties optreden, 
zijn ontwikkeling van vroege herkenningsmethodes en interventies 
mogelijk.  
Waarom is het immuunsysteem belangrijk bij de aanleg van de 
placenta? 
Het immuunsysteem herkent elke niet-lichaamseigen cel. Er volgt 
een afweer-, oftewel ontstekingsreactie, om verder binnendringen en 
Blastocyst
 Bevruchte eicel na 5-6 
dagen celdeling. Een 
celmassa binnenin het 
cluster zal de embryo 
vormen, cellen aan de 
buitenkant vormen het 
foetale deel van de placenta 
(zie trofoblast).
Endometrium 
 Slijmvliezen (med.:mucosa) 




aanwezigheid van eiwit in de 
urine (proteïnurie) en hoge 
bloeddruk. Kan overgaan 
in HELLP-syndroom 
(hemolyse, elevated 
liver enzymes, and low 





 Cel type van foetale 
oorsprong die invasief in de 
baarmoederwand groeien.
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mogelijke schade te voorkomen. Cellen van foetale oorsprong zijn 
maar voor 50% lichaamseigen, omdat de helft van de genetische 
opmaak van de bevruchte eicel door de vader wordt bijgedragen. 
Het maternale immuunsysteem herkent de trofoblastcellen die de 
spiraalarteriën van de baarmoeder binnendringen om de placentale 
connectie tussen moeder en kind te vormen. Dit wordt beschouwd als 
een immunologische paradox: in tegenstelling tot de afweerreactie die 
optreedt bij herkenning van een donororgaan bij een transplantatie, 
vormt de reactie op de deels vreemde cellen géén bedreiging voor 
zwangerschap. Deze herkenning en enige mate van ontstekingsreactie 
binnen de decidua is zelfs nodig om de juiste mate van innesteling 
te faciliteren. Hierbij staat de immunologische balans centraal: elke 
reactie van het afweersysteem wordt gedempt door regulerende 
cellen, die via celcontact of afgifte van oplosbare factoren reacties van 
omliggende cellen onderdrukken. Voor een gezonde zwangerschap 
is het essentieel dat een activatie van het immuunsysteem niet uit de 
hand loopt. Hoge ontstekingswaardes ontregelen de aanleg van de 
placenta, kunnen een vroegtijdige geboorte inleiden en negatieve 
invloed hebben op de ontwikkeling van het kind. Het onderzoeksveld 
van de reproductie-immunologie bestudeert de bijzondere controle- 
en regulatie mechanismen die voor elke zwangerschap van belang 
zijn. De immuunregulatie die is betrokken bij het vormen van de 
placenta is samen te vatten in 3 hoofdlijnen: 
1. Mechanismes van de trofoblast om een sterke afweerreactie te 
voorkomen.
2. Bijzondere eigenschappen van de maternale immuuncellen 
tijdens zwangerschap/in de baarmoeder. 
3. Externe factoren die mogelijk tolerantie bevorderen, zoals 
componenten van zaadvloeistof, of natuurlijk-voorkomende 
bacteriën. 
Deze elementen beïnvloeden elkaar, maar zijn te divers om als geheel 
te worden onderzocht. De verschillende puzzelstukjes moeten dus 
apart worden bestudeerd. In dit proefschrift werd zo veel mogelijk 
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endometrium, vanaf het 
einde van elke menstruele 
cyclus. Functioneel 
gedeelte van het slijmvlies 
wat betrokken is bij de 
innesteling en aanleg van de 
placenta. 
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DIT PROEFSCHRIFT
Zwangerschap induceert een toename in geheugen van 
afweercellen in de baarmoeder 
In hoofdstuk 2 gaven we een overzicht van de verschillende cellen 
van het afweersysteem die in de baarmoeder betrokken zijn bij 
zwangerschap. We bestudeerden hiervoor endometriale cellen van 
niet-zwangere vrouwen. In eerdere studies werd dit vooral gedaan 
door een biopt van het endometrium te nemen, een invasieve 
methode die niet zomaar wordt toegepast als er geen medische 
noodzakelijkheid voor de ingreep is. Dit maakt het moeilijk om een 
controle-cohort te rekruteren die een beeld van de immuun-omgeving 
bij gezonde vrouwen kan geven. Dit probleem kan worden verholpen 
door de betrokken cellen uit menstruatiebloed (MB) te isoleren. Elke 
maand wordt de functionele laag van het endometrium samen met 
de hierin voorkomende cellen van het afweersysteem afgestoten. 
De vloeistof kan met een menstruatiecup, een milieuvriendelijk 
alternatief voor tampons, worden opgevangen. Op deze manier 
kunnen er zonder invasieve behandeling vele malen meer cellen 
worden verkregen en onderzocht. Deze techniek is ook gebruikt 
voor het onderzoek dat is beschreven in de hoofdstukken 4 en 5. In 
hoofdstuk 2 lieten we door flowcytometrie zien, dat de leukocyten uit 
MB inderdaad de typische kenmerken van uteriene cellen vertonen. 
De onderzochte MB-cellen hadden een ander fenotype dan cellen 
uit het bloed, wat bewijst dat ze van mucosale oorsprong zijn. We 
vergeleken de MB-cellen met leukocyten die we uit de decidua 
parietalis van à terme zwangerschappen isoleerden. Zij representeren 
het afweersysteem aan het einde van een gezonde zwangerschap 
en geven dus informatie hoe het lokale immuunsysteem verandert 
als gevolg van zwangerschap. Na 9 maanden zwangerschap waren 
de lokale immuuncellen minder naïef, dat wil zeggen dat de T-cellen 
geactiveerd zijn geraakt en geheugen hebben opgebouwd. Verder zijn 
in de d.parietalis meer cellen aanwezig die met tolerantie in verbinding 
worden gebracht, zoals regulatoire T-cellen (Tregs). Inmiddels is 
bekend dat differentiatie van deciduale T-cellen optreedt na contact 
met foetale cellen, een lokale reactie die maar in geringe mate in de 
circulatie terug te zien is. Een inductie van Tregs helpt om te voorkomen 
dat deze herkenning oploopt tot een (te) sterke ontstekingsreactie. 
Flowcytometrie
 Techniek om d.m.v. 
gelabelde antistoffen de 
uiterlijke kenmerken van een 
cel in kaart te brengen. Aan/
afwezigheid van receptoren 
geeft uitkomst over het 
exacte cel type.
Leukocyten 








opmaak van een cel
Decidua parietalis 
 Maternale laag van 
de placentale vliezen. 
Gevormd als foetale 
lagen (amnion, chorion) 
met gedecidualiseerd 
endometrium een verbinding 
aangaan.
À terme periode 
 Tijd rond de uitgerekende 
datum van bevalling 
(zwangerschapsduur tussen 
37 en 42 weken). 
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Drie verschillende regulatoire T-cellen reguleren de T-cel 
respons waar maternale en foetale cellen bij elkaar komen 
De betrokken Tregs, gekenmerkt door hun vermogen om T-cellen te 
onderdrukken, werden in meer detail onderzocht in hoofdstuk 3. 
Deze cellen zijn dus vooral betrokken bij de initiële fase van 
zwangerschap, wanneer er continu moet worden gewaarborgd dat er 
niet te veel immuunactivatie optreedt. Om deze cellen te onderzoeken 
zijn er dus cellen van het eerste zwangerschapstrimester nodig. Dit is 
mogelijk door immuuncellen uit de stukjes decidua te isoleren die bij 
een abortus vrijkomen. Naast het meest bekende soort Treg lieten we 
twee additionele Treg- types zien, gekenmerkt door unieke feno- en 
genotypes. Trofoblastcellen en deciduale macrofagen zijn in staat om 
deze Tregs te induceren. 
Clusters van B-cellen als onderdeel van de immuunomgeving 
tijdens zwangerschap in de baarmoeder 
Naast Tregs komt er steeds meer aandacht voor een ander cel type dat 
mogelijk een belangrijke bijdrage levert aan het in stand houden van 
tolerantie: interleukine-10 (IL-10) producerende B-cellen. In hoofdstuk 
4 lieten we zien dat deciduale B-cellen in sterkere mate IL-10 kunnen 
produceren dan B-cellen uit het bloed. We hebben het fenotype van 
leukocyten uit MB, eerste trimester decidua, tweede trimester decidua 
en à terme decidua in kaart gebracht en vergeleken met B-cellen uit 
het bloed. Door een geautomatiseerde analyse waarbij hun kenmerken 
objectief worden geclassificeerd werd duidelijk dat uteriene B-cellen 
los staan van circulerende B-cellen. Door hun positie op knooppunten, 
waar ook T-cellen aanwezig zijn, zouden ze ondanks hun lage aantallen 
cruciaal kunnen zijn voor de lokale immuunbalans. B-cellen verdienen 
dus aandacht in vervolgonderzoek van het uterine immuunsysteem. 
Veranderd patroon afweercellen bij herhaalde-
miskraampatiënten 
In hoofdstuk 5 hebben we onderzocht of vrouwen die herhaaldelijk 
een miskraam hebben gehad, op basis van afwijkingen in hun 
afweersysteem gediagnostiseerd kunnen worden. Naast de veel 
bestudeerde NK en T-cel subtypes waren ook B-cellen en hun 
subpopulaties onderdeel van de immunologische profielen die van 
MB en perifeer bloed werden gemaakt. Door middel van een machine-






uitgescheiden door cellen 




 In plaats van één specifiek 
machine-learning algoritme 
worden er meerdere 
gebruikt voor classificatie. 
Het resultaat is een 
betrouwbare ranking van 
parameters die nodig zijn 
om onderscheid tussen 
cohorten te maken. 
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van immunologische parameters betrouwbaar vrouwen met herhaalde 
miskramen kan identificeren. Zowel het systemische afweersysteem 
als ook de lokale immuun-cellen zijn hiervoor geschikt. De cel types 
die samen een diagnostische waarde hebben zijn echter niet dezelfde 
voor de twee compartimenten, op NKbright cellen na. Het viel op dat 
in MB vooral cellen die met regulatie in verbinding worden gebracht 
afwijken (zoals Tregs of bepaalde B-cellen). 
Een mogelijke bijdrage van het uteriene microbioom aan 
vruchtbaarheid 
De hoge mate aan regulatie die nodig is voor een gezonde 
zwangerschap zou ook door micro-organismen ondersteund kunnen 
worden. Het is bekend dat bacteriën op veel plaatsen in ons lichaam 
een belangrijke rol hebben bij het aansturen van het afweersysteem. 
In hoofdstuk 6 geven we een overzicht van de kennis op het gebied 
van endometriale bacteriën en hun mogelijke rol. Alhoewel er nog 
geen duidelijk profiel van een uterien microbioom bekend is, zullen de 
aanwezige soorten een bijdrage leveren aan de lokale immunologische 
balans en mogelijk ook aan de aanpassingen van het weefsel die 
nodig zijn voor het vormen van de placenta. Veel studies laten zien 
dat we er niet meer van uit kunnen gaan dat de baarmoeder steriel 
is, dus compleet vrij van bacteriën. Er is dus een kans dat problemen 
rond vruchtbaarheid, of complicatie in de aanleg van de placenta, 
voortkomen uit een ongunstige microbiële balans.  
Behandeling met antibiotica heeft effect of afweercellen van de 
placenta 
Behandelingen met antibiotica verstoren de natuurlijke bacteriële flora 
en hebben mogelijk invloed op processen die mede door bacteriën 
worden bepaald. Dit zou ook het verloop van een zwangerschap 
kunnen beïnvloeden. Tijdens één op de vijf zwangerschappen is 
echter wel een behandeling met antibiotica nodig, bijvoorbeeld als een 
urine- of luchtweginfectie gepaard gaat met een hoge systemische 
ontsteking. Gebruik van antibiotica is gekoppeld aan een verhoogd 
risico op PE, maar de causale link is niet bekend. Tijdens zwangerschap 
worden er alleen antibiotica gebruikt die veilig geacht worden voor de 
ontwikkeling van het ongeboren kind. Toch zijn er steeds meer bewijzen 
voor schadelijke gevolgen op de lange termijn. In hoofdstuk 7 laten 
we zien dat antibioticabehandeling bij muizen tijdens zwangerschap 
consequenties heeft voor het maternale immuunsysteem. Ook bij 
NKbright








  Alle micro-organismen 
(virussen, fungi, 
protozoa en archaea) 
die op natuurlijke manier 
aanwezig zijn op een 
bepaalde plek in het 
lichaam. 
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deze studie werd gebruik gemaakt van ensemble machine-learning 
om de verschillen in het immunologische samenspel van cel types te 
bestuderen. De immunologische veranderingen zijn ook in de placenta 
terug te vinden. Hieruit volgt dat er bij de beoordeling van medicatie 
op veilig gebruik tijdens zwangerschap een mogelijke impact op de 
directe prenatale immuun-omgeving moet worden overwogen. 
Noodzaak voor multidisciplinair onderzoek 
Dit proefschrift laat zien dat ook cel types of microbiota die in lage 
hoeveelheden aanwezig zijn belangrijk kunnen zijn voor een gezonde 
zwangerschap. Als er complicaties tijdens zwangerschap optreden is dit 
waarschijnlijk niet het gevolg van één enkel mechanisme wat ontspoort. 
Een complex samenspel van processen waarborgt de balans die 
nodig is voor het vormen van de placenta: het immuunsysteem, lokaal 
en systemisch, microbiota en aanpassingen van het endometrium 
hangen allemaal met elkaar samen. We lieten zien dat een open blik op 
elke factor de moeite waard kan zijn om beter te begrijpen wat er nodig 
is voor een goede ontwikkeling van het ongeboren kind. Om dit verder 
te kunnen onderzoeken is samenwerking van verschillende disciplines 
cruciaal. Alleen als we openstaan voor de inbreng van experts en voor 
nieuwe perspectieven kunnen we zwangerschapscomplicaties beter 
detecteren en behandelen. 
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EMPFINDLICHE PHASE
Eine Schwangerschaft verändert das Leben der Eltern grundlegend. 
Diese Veränderungen sind für die Mutter schon früh spürbar, da 
die körperlichen Anpassungen für die optimale Entwicklung des 
Kindes essenziell sind. Diese Adaptionen erfolgen sowohl lokalisiert 
(in der Gebärmutter), als auch systemisch (in der Blutzirkulation). 
Mütterliche Unterstützung beginnt bereits bei der Interaktion mit der 
befruchteten Eizelle, da die Gebärmutterschleimhaut eine geeignete 
Basis formen muss, um die Einnistung zu ermöglichen. Nur, wenn 
Blastozyste und Endometrium korrekt in Verbindung kommen kann 
eine Schwangerschaft erfolgreich verlaufen. Demnach ist eine 
Schwangerschaft lange nicht selbstverständlich und dreißig Prozent 
aller Schwangerschaften enden bevor sie überhaupt bemerkt wurden. 
Der gleiche Anteil an Schwangerschaften führt zu einer Fehlgeburt, 
eine besonders belastende Erfahrung, die fast ein Viertel aller Frauen 
einmal in ihrem Leben macht. Mit einer weltweiten Prävalenz von 6-8% 
(2-3% in Deutschland) sind viele Schwangerschaften außerdem von 
Komplikationen wie Präeklampsie (PE) oder dem HELLP-Syndrom, dem 
Hauptgrund aller mütterlichen Todesfälle, betroffen. Neben möglicher 
akuter Unterversorgung des Kindes drohen auch Langzeitschäden, 
z.B. wenn dauerhafte kardiologische und nephrologische Schäden 
der Mutter eine frühzeitige Geburt unvermeidbar machen. Die 
genaue Ursache der PE ist bislang unbekannt, jedoch wird allgemein 
angenommen, dass eine fehlerhafte Entwicklung der Plazenta eine 
zentrale Rolle spielt.  
Fragestellung der Dissertation
Beim Entwicklungsprozess der Plazenta spielt das Abwehrsystem 
eine entscheidende Rolle. Maternales Gewebe und Trophoblastzellen 
müssen exakt auf einander abgestimmt sein um die Geburt eines 
gesunden Kindes zu ermöglichen. Das Ziel dieser Dissertation war es, 
um aus einem neuen Blickwinkel die hierfür nötige Immunregulation zu 
erforschen. Ein genaues mechanistisches Verständnis der Ursachen, 
die der Entstehung von Schwangerschaftskomplikationen zugrunde 
liegen, ist ausschlaggebend um die Entwicklung von frühzeitigen 
Diagnose- und Behandlungsmethoden zu ermöglichen. 
Blastozyst
 Befruchtete Eizelle nach 5-6 
Tagen Zellteilung. Aus der 
Zellmasse im Inneren wird 
sich der Embryo entwickeln. 
Zellen des äußeren Randes 
formen den fötalen Teil 






 Früher auch EPH-Gestose 
genannt, die typischen 
Symptome umschreibend: 
Edema (engl Ödem, 
Wasseransammlung), 
Protein (Eiweißausscheidung 




wobei zusätzlich zu 
den PE Symptomen 
Blutgerinnungsstörung 
(Hämolyse), erhöhte 
Leberwerte (elevated liver 
enzymes) und Reduzierung 
der Blutplättchen (low 
platelet count) diagnostiziert 
werden.
Trophoblast
 Zellen fötalen Ursprungs 
die invasiv in die 
Gebärmutterwand wachsen. 
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Die Bedeutung des Immunsystems bei der Plazentabildung
Unser Immunsystem erkennt jede körperfremde Zelle und reagiert auf 
diese zum Schutz vor Infektionen mit einer Abwehr-, beziehungsweise 
Entzündungsantwort. Auch fötale Zellen werden vom maternalen 
Immunsystem entdeckt, da die genetische Information dieser Zellen 
zur Hälfte vom Vater stammt und sie damit nur zu 50% körpereigen 
sind. Dennoch werden sie nicht aktiv bekämpft; die Trophoblastzellen 
dürfen trotz ihrer Fremdheit in die Spiralarterien eindringen um die 
plazentale Verbindung zwischen Mutter und Kind zu initiieren. Dies 
wird allgemein als ein „immunologisches Paradox“ betrachtet. Anders 
als bei einer Abstoßungsreaktion, die bei einer Organtransplantation 
nach der Erkennung des gespendeten, fremden Gewebes auftritt, 
stellt die immunologische Reaktion auf die fötalen Zellen keine 
Bedrohung für die Schwangerschaft dar. Stärker noch, ein gewisser 
Grad an Entzündungsreaktion innerhalb der Dezidua ist sogar 
förderlich um die notwendige Verbindung zwischen Mutter und 
Embryo herzustellen. Das korrekte Funktionieren des Immunsystems 
ist von einer kontinuierlichen Balance zwischen Immunaktivierung und 
-toleranz abhängig. Jede Abwehrreaktion wird durch regulierende 
Zellen gedämpft um eine optimale Kontrolle des Entzündungsniveaus 
zu gewährleisten. Für eine gesunde Schwangerschaft ist es von 
äußerster Bedeutung, dass die Aktivierung des Immunsystems 
niedrig gehalten wird und nicht aus dem Gleichgewicht gerät. Erhöhte 
Spiegel von Entzündungsfaktoren können die plazentale Entwicklung 
stören oder gar zur Frühgeburt führen, was mit negativen Folgen für 
das heranwachsende Kind einhergeht. Das Forschungsgebiet der 
Reproduktionsimmunologie beschäftigt sich mit den besonderen 
Kontrollmechanismen, die beim Heranwachsen der Plazenta und 
dem Verlauf jeder Schwangerschaft eine wichtige Rolle spielen. 
Diese Prozesse zur Immunregulierung lassen sich in 3 Hauptthemen 
zusammenfassen: 
1. Anpassungen der Trophoblasten um eine starke Abwehrreaktion 
zu unterdrücken. 
2. Besondere Eigenschaften der systemischen (Blut) und 




Endometrium, ab dem Ende 
des Menstruationszykluses. 
Funktioneller Teil der 
Schleimhaut, der bei der  
Einnistung der Eizelle 
und der Verankerung der 
Plazenta mitwirkt.
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3. Externe Faktoren, z.B. Komponenten der Samenflüssigkeit 
oder natürlich vorkommende Bakterien, die möglicherweise zur 
Immuntoleranz beitragen. 
All diese Elemente beeinflussen einander und die Thematik ist 
insgesamt zu komplex um im Ganzen erforscht werden zu können. 
Wir können also lediglich jedes Puzzleteil gesondert betrachten. In 
dieser Dissertation wurde besonders auf die Verbindung der einzelnen 
Teile geachtet, um diese wichtigen Erkenntnisse in Zusammenhang 
miteinander zu bringen. 
INHALT DIESER ARBEIT
Schwangerschaft induziert immunologisches Gedächtnis der 
Gebärmutter
In Kapitel 2 geben wir eine Übersicht der verschiedenen Zellen 
der Gebärmutter, die bei einer Schwangerschaft mitwirken. Hierfür 
wurden Zellen des Endometriums von nicht-schwangeren Frauen 
analysiert. In früheren Studien wurden zur Erforschung des uterinen 
Immunsystems hauptsächlich Gewebeproben begutachtet. Dabei 
wurde Material verwendet, das bei medizinischer Indikation als 
Biopsie invasiv entnommen werden konnte und dann für Studien 
zur Verfügung gestellt wurde. Dies erschwert Aussagen bezüglich 
eines gesunden Immunsystems. Wir konnten dieses Problem durch 
die Aufarbeitung von Menstruationsblut (MB) umgehen. Monatlich 
wird am Ende des weiblichen Zyklus die funktionale Schicht des 
Endometriums, einschließlich der darin vorkommenden Zellen, 
abgestoßen. Menstruationstassen, umweltfreundliche Alternativen zu 
Tampons, fangen diese Flüssigkeit auf und ermöglichen die Isolierung 
und Analyse von einer großen Anzahl von uterinen Immunzellen; 
auch von Frauen ohne Fertilitätsproblematik. Diese Methode wurde 
auch in Kapitel 4 und 5 angewendet. In Kapitel 2 zeigten wir mithilfe 
von Durchflusszytometrie, dass Leukozyten aus MB in der Tat die 
typischen Kennzeichen von Abwehrzellen der Gebärmutter aufweisen. 
Die analysierten MB-Zellen unterschieden sich im Phänotyp deutlich 
von Zellen der Zirkulation. Wir verglichen MB-Zellen des Weiteren 
mit Leukozyten der decidua parietalis von vollendeten, gesunden 
Schwangerschaften (> 37. Schwangerschaftswoche, SSW), um 
Durchflusszytometrie 
  Zell-Vermessungsverfahren, 













Lymphozyten (T-,B- NK 
Zellen) und dendritische 
Zellen. 
Phänotyp
  Merkmale einer 
Zelle. Ermöglicht z.B. 
Rückschlüsse bezüglich 
des Zelltyps, Herkunft 
der Zelle oder deren 
Aktivierung. 
Decidua parietalis 
  Maternale Lage der 
Eihaut (ugs. Fruchtblase). 
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zu untersuchen inwieweit sich das lokale Abwehrsystem durch eine 
Schwangerschaft verändert. Nach neunmonatiger Schwangerschaft 
war das Immunsystem der Gebärmutter weniger naiv, bzw. unerfahren. 
Das bedeutet, dass T-Zellen aktiviert wurden und ein Immungedächtnis 
aufbauen konnten. Des Weiteren fanden wir in der d.parietalis mehr 
Zellen, die mit Immuntoleranz in Verbindung gebracht werden, wie 
z.B. regulatorische T-Zellen (TReg). Mittlerweile ist auch bekannt, dass 
diese Differenzierung durch den Kontakt der T-Zellen mit fötalen Zellen 
vor Ort induziert wird und nur ein geringer Teil dieser spezifischen 
Reaktion in der Zirkulation zurückzufinden ist. Das erhöhte Vorkommen 
der TReg Zellen wirkt einer möglichen (zu) starken Reaktion der 
T-Gedächtniszellen entgegen. 
Drei unterschiedliche regulatorische T-Zellen steuern die 
Begegnung von fötalen und maternalen Zellen 
In Kapitel 3 wurden TRegs, bekannt wegen ihrer Fähigkeit 
Immuntoleranz zu fördern, näher untersucht. Diese Zellen sind 
vor allem in der ersten Phase einer Schwangerschaft essentiell, da 
die partielle Unterdrückung der Immunantwort in diesem Zeitraum 
entscheidend ist. Um die speziellen Anpassungen der involvierten 
TRegs zu analysieren, wurden daher Abwehrzellen aus der 
Gebärmutterschleimhaut isoliert, die beim Schwangerschaftsabbruch 
des ersten Trimesters teils entnommen wurde. Neben der meist 
untersuchten Art der TRegs konnten wir außerdem zwei weitere TReg-
Populationen isolieren. Alle drei Zelltypen unterscheiden sich sowohl 
im Pheno-, als auch im Genotypen voneinander. Trophoblastzellen und 
Makrophagen der Dezidua konnten die Differenzierung von naiven 
T-Zellen zu diesen TReg-Zellen induzieren. 
B-Zell-Cluster gehören während der Schwangerschaft zum 
Immunsystem der Gebärmutter 
Neben TReg Zellen scheinen auch weitere Zelltypen einen wichtigen 
Beitrag zur Induktion der Toleranz leisten, nämlich die Interleukin-10 
(IL-10)-produzierenden B-Zellen. In Kapitel 4 konnten wir zeigen, dass 
B-Zellen der Dezidua verglichen mit B-Zellen der Zirkulation erhöhte 
Kapazitäten zur IL-10-Synthese haben. Wir verglichen die Phenotypen 
von B-Zellen der Gebärmutterschleimhaut zu verschiedenen 
Zeitpunkten vor (MB-Zellen), während (erstes und zweites Trimester) 
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miteinander und mit Zellen der Blutzirkulation. Eine automatische 
Computeranalyse dieser Zellen ermöglichte eine objektive Beurteilung 
und zeigte, dass uterine B-Zellen sich nicht nur in ihrer Funktion, 
sondern auch im Phenotyp, von B-Zellen der Zirkulation unterscheiden. 
Abweichende Abwehrzellmuster bei Frauen, die wiederholt 
Fehlgeburten erleiden
In Kapitel 5 untersuchten wir mögliche Veränderungen im 
Immunsystem bei Frauen mit wiederholtem Spontanabort (WSA). 
Hierbei wurde die Frage gestellt, ob WSA-Patientinnen auf Basis 
ihres Immunsystems als solche identifiziert werden können. Neben 
den meist untersuchten NK- und T-Zellen, waren auch B-Zellen 
Teil der Immunzellübersicht, die wir sowohl für MB, als auch Blut 
der Zirkulation, erstellt haben. Mithilfe einer Machine-Learning-
Ensemble-Strategie konnten wir zeigen, dass Frauen ohne 
Schwangerschaftsproblematik von Frauen mit WSA auf Basis von 
fünf (Zirkulation) bzw. sieben (MB) Immunparametern unterschieden 
werden können. Demnach sind sowohl das Abwehrsystem der 
Zirkulation, als auch das der Gebärmutter, bei WSA-Patientinnen 
verändert. Die hierbei ausschlaggebenden Zelltypen sind jedoch in 
den beiden Kompartimenten unterschiedlich, bis auf NKbright-Zellen, 
die in beiden Datensets wichtig sind. Auffallend war auch, dass in MB 
vor allem Zelltypen mit regulatorischer Kapazität (TReg oder bestimme 
B-Zelltypen), von der Kontrollgruppe abweichen. 
Möglicher Beitrag des Mikrobioms zur Fruchtbarkeit 
Das hohe Maß an Mechanismen zur Immunregulierung, ohne das 
eine gesunde Schwangerschaft nicht zu Stande kommen kann, 
könnte auch durch Mikroorganismen unterstützt werden. Es ist bereits 
bewiesen, dass Bakterien an verschiedensten Stellen des Körpers 
natürliche Prozesse beeinflussen und sogar steuern. Kapitel 6 
fasst unser Wissen bezüglich eines möglichen Beitrags von uterinen 
Bakterien zur Fruchtbarkeit zusammen. Obwohl noch nicht konkret 
gezeigt werden konnte aus welcher Spezieszusammenstellung ein 
gesundes Mikrobiom der Gebärmutter besteht, ist deutlich, dass man 
den Uterus nicht als steril betrachten kann und die Anwesenheit von 
Bakterien damit eine unabkömmliche Rolle für das Gewebe spielen 
muss. Die nachgewiesenen Mikroorganismen können sowohl das 
lokale Immunsystem, als auch die Entwicklung der Mukosa, und 
Wiederholter
Spontanabort (WSA)
 Definiert als ≥3 Fehlgeburten 
vor der 20. SSW. Betrifft 




 Kombination von mehreren 
Machine-Learning 
Algorithmen. Hieraus folgt 
ein valides Ranking von 
Parametern, auf deren Basis 




 Unterart der NK-Zellen, 
die vor allem mit einer 
regulierenden Rolle in 
Verbindung gebracht 
wird. Dem gegenüber 




 Natürliche vorkommende 
Mikroorganismen (Bakterien, 
Pilzen, Viren und Archaeen), 
die zusammen eine Stelle 
des Körpers kolonisieren. 
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somit die der Plazenta, beeinflussen. Demnach wäre es möglich, dass 
Pathologien der Fruchtbarkeit oder der plazentalen Entwicklung mit 
einem ungünstigen Mikrobiom im Zusammenhang stehen. 
Antibiotika beeinflussen Abwehrzellen der Plazenta
Die natürliche bakterielle Flora kann nicht nur bei einer Infektion aus dem 
Gleichgewicht geraten. Auch Antibiotika beeinflussen das Mikrobiom 
und haben dementsprechend Effekt auf Prozesse, die diesem 
unterliegen. Somit könnte eine Antibiotikabehandlung den natürlichen 
Verlauf einer Schwangerschaft verändern. Ein derartiges Eingreifen 
ist in ungefähr einer von fünf Schwangerschaften unabdingbar, z.B. 
wenn es eine Harn- oder Luftweginfektion zu kontrollieren gilt, die 
womöglich auch in eine systemische Entzündung überzugehen 
droht. Allgemein sind nur ausgewählte Medikamente, die als sicher 
für die Kindesentwicklung ausgewiesen sind, für den Einsatz während 
einer Schwangerschaft zugelassen. Dennoch sammeln sich die 
Beweise, dass auch diese Mittel möglicherweise Langzeitfolgen mit 
sich bringen. Eine Antibiose bei Schwangeren erhöht das Risiko auf 
PE, allerdings ist die Ursache für diesen Zusammenhang noch nicht 
bekannt. In Kapitel 7 zeigten wir, dass eine Antibiotikabehandlung 
Auswirkungen auf das Immunsystem von trächtigen Mäusen hat. 
Auch in dieser Studie konnte eine Machine-Learning-Ensemble-
Strategie die wichtigsten Unterschiede zwischen den Testgruppen 
aufzeigen. Die immunologischen Veränderungen konnten bis in die 
Plazenta nachgewiesen werden. Diese Ergebnisse heben hervor, dass 
bei der Beurteilung von Medikamenten zur Anwendung während der 
Schwangerschaft Rücksicht auf die besonderen immunologischen 
Umstände dieser Phase genommen werden muss. Hierbei darf 
die mögliche Manipulation der pränatalen Immunumgebung nicht 
vergessen werden. 
Multidisziplinäre Forschung gefragt
Die hier vorgelegte Arbeit zeigt, dass sogar Zelltypen oder 
Mikroorganismen, die wegen ihrer geringen Anzahl häufig nicht im Fokus 
stehen, einen wichtigen Beitrag zur Schwangerschaft leisten können. 
Komplikationen während der Schwangerschaft sind wahrscheinlich 
nicht auf einen einzigen, isolierten, fehlerhaften Prozess zurück 
zu führen. Die komplexe Interaktion verschiedener Mechanismen 
muss in Balance sein, um die korrekte Entstehung der Plazenta zu 
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gewährleisten. Das Immunsystem der Gebärmutter und der Zirkulation, 
sowie Mikroorganismen des Endometriums stehen miteinander in 
Verbindung um die besonderen Anforderungen einer Schwangerschaft 
zu gewährleisten. Der unbefangene Blick der vorliegenden Arbeit 
ermöglichte damit neue Einsichten bezüglich dieser diversen Faktoren 
und ihrem Einfluss auf die gesunde Kindesentwicklung. Um dies weiter 
zu untersuchen ist es essenziell, dass die einzelnen Forschungsfelder 
verknüpft werden. Nur, wenn wir den verschiedenen Experten offen 
begegnen und zusammen neue Blickwinkel schaffen, können wir 






A plea for being open to a new approach
  – Changing perspectives based on evidence 
Reproductive immunology comprises a field of many unknowns. The related conferences have 
an active debate culture; many meals are accompanied by a lively back and forth on opposing 
hypotheses. The wish to provide solutions for fertility and pregnancy complications creates 
an urgency in developments. In many countries, clinicians will provide diagnostic tools and 
treatment before the needed proven efficacy, which adds to the pool of uncertainty regarding the 
topic. Still, the scientific discussion depends on evidence rather than opposing thoughts. Which 
concepts are we going to build on when we try to fill a knowledge gap? 
We thought that this thesis started with a proposal based on commonly accepted positions 
of the field. As a starting PhD candidate, this goes along with the expectation that with a solid 
foundation and the right assumptions, the project is going to follow a straight path. In the end, 
the projects turned out rather different than we planned in 2015. Apparently, this is the classic, 
unpredictable path that most PhD projects follow. Likewise, the frustrations going along with 
failed experiments are not hugely surprising. Looking back, a lot of learning happened especially 
in that time of what seemed like failure. Professor Uri Alon termed this phase of frustrations The 
Cloud1 , as summarized on the following page, with his kind approval.
I am writing this Behind the Scenes chapter for all those, who might have started a PhD project, 
but who struggle because nothing seems to go according to plan. Without The Cloud, most 
of this thesis’ chapters would not have been written. Just like young researchers and their 
supervisors, reproductive immunology will thrive, when we are open to a change of plans and 
concepts.   















In reality, we start at A but despite all plans, there is no direct 
path to B. Experiments do not work,  other projects demand 
immediate attention, or personal ones come up. Sometimes 
we might think that we get closer to B, until we discover that 
we cannot even see B anymore.  We may also start doubting 
A (and many other things…). 
The diverting path has led us to The Cloud. On top of 
the stress that we still do not have results of B to show, 
frustration builds up about the fact that A � B seemingly 
works for everyone else.  
Continuing to work in the cloud, a new outcome that is worth 
pursuing often comes into view.  The truth is, we likely read 
someone’s story of how they got from A � C (like the content 
of this thesis).  C might be based on new assumptions based 
on all the “failed” experiments. While B was useful to get the 
project going, C is much more innovative. 
In science, we learn about the results, not the process. 
Likewise, this thesis presents questions and answers based 
on the gathered evidence. If all is well (written), the process 
sounds very straightforward: We identify a knowledge gap 
and then venture out to prove an assumption through a 
logical sequence of experiments.
Thus, the period of uncertainty is the part that enabled innovation. While C has never been the 
initial plan, C is more worth pursuing than B. The more this period of uncertainty is just related 
to science, and not insecurities about funding or other additional sources of pressure, the more 
opportunities for creative problem solving are created. By creating a supportive environment that 
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'What is the bravest thing you've ever said? asked the boy.
'Help,' said the horse.
'Asking for help isn't giving up,' said the horse. 'It's refusing to give up.'
− Charlie Mackesy, The Boy, the Mole, the Fox and the Horse
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